Journal Articles Published In 2024

2775998 TCMBXKKM 2024 1 padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe 50 date desc year 4354 https://www.iedea-sa.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22WGDWSC39%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ruffieux%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRuffieux%2C%20Yann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMwansa-Kambafwile%2C%20Judith%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMetekoua%2C%20Carole%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTombe-Nyahuma%2C%20Tinashe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBohlius%2C%20Julia%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20HIV-1%20Viremia%20and%20Cancer%20Risk%20in%202.8%20Million%20People%3A%20the%20South%20African%20HIV%20Cancer%20Match%20Study.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20ciae652.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae652%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae652%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV-1%20Viremia%20and%20Cancer%20Risk%20in%202.8%20Million%20People%3A%20the%20South%20African%20HIV%20Cancer%20Match%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22Ruffieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Mwansa-Kambafwile%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%22%2C%22lastName%22%3A%22Metekoua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinashe%22%2C%22lastName%22%3A%22Tombe-Nyahuma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mazvita%22%2C%22lastName%22%3A%22Muchengeti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Most%20research%20on%20HIV-1%20viremia%20and%20cancer%20risk%20is%20from%20high-income%20countries.%20We%20evaluated%20the%20association%20between%20HIV-1%20viremia%20and%20the%20risk%20of%20various%20cancer%20types%20among%20people%20with%20HIV%20%28PWH%29%20in%20South%20Africa.%5CnMETHODS%3A%20We%20analysed%20data%20from%20the%20South%20African%20HIV%20Cancer%20Match%20study%2C%20based%20on%20laboratory%20measurements%20from%20the%20National%20Health%20Laboratory%20Services%20and%20cancer%20records%20from%20the%20National%20Cancer%20Registry%20from%202004-2014.%20Using%20Cox%20proportional%20hazards%20models%2C%20we%20estimated%20hazard%20ratios%20%28HR%29%20for%20cancer%20incidence%20per%20unit%20increase%20in%20time-updated%20Log10%20HIV-1%20RNA%20viral%20load%20copies%5C%2FmL.%20We%20created%20partially%20adjusted%20%28sex%2C%20age%2C%20calendar%20year%29%20and%20fully%20adjusted%20models%20%28additionally%20including%20time-updated%20CD4%20count%29.%5CnRESULTS%3A%20We%20included%202%2C770%2C200%20PWH%20with%2010%2C175%20incident%20cancers%3B%20most%20common%20were%20cervical%20cancer%20%28N%3D2%2C481%29%2C%20Kaposi%20sarcoma%20%28N%3D1%2C902%29%2C%20breast%20cancer%20%28N%3D1%2C063%29%2C%20and%20non-Hodgkin%20lymphoma%20%28N%3D863%29.%20Hazard%20ratios%20for%20the%20association%20of%20HIV-1%20viremia%20and%20cancer%20risk%20changed%20after%20partial%20and%20full%20adjustment%20and%20were%20generally%20attenuated%20for%20infection-related%20cancers%20but%20tended%20to%20increase%20for%20infection-unrelated%20cancers.%20In%20the%20fully%20adjusted%20model%2C%20HIV-1%20viremia%20was%20associated%20with%20an%20increased%20risk%20of%20Kaposi%20sarcoma%20%28HR%20per%20unit%20increase%20in%20Log10%20HIV-1%20RNA%20viral%20load%3A%201.38%2C%2095%25%20CI%201.35-1.42%29%2C%20leukemia%20%28HR%3A%201.28%2C%2095%25%20CI%201.13-1.45%29%2C%20non-Hodgkin%20lymphoma%20%28HR%3A%201.24%2C%2095%25%20CI%201.19-1.29%29%2C%20conjunctival%20cancer%20%28HR%3A%201.19%2C%2095%25%20CI%201.11-1.25%29%2C%20and%20colorectal%20cancer%20%28HR%3A%201.11%2C%2095%25%20CI%201.02-1.21%29.%20Associations%20with%20other%20cancer%20types%20were%20weaker%20or%20absent.%5CnCONCLUSIONS%3A%20Our%20findings%20underline%20the%20importance%20of%20sustained%20viral%20suppression%20for%20cancer%20prevention%20among%20PWH%20in%20South%20Africa.%22%2C%22date%22%3A%222024-12-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciae652%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-04-14T13%3A34%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22243VDCVH%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Siedentop%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSiedentop%2C%20Berit%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKachalov%2C%20Viacheslav%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWitzany%2C%20Christopher%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEgger%2C%20Matthias%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKouyos%2C%20Roger%20D.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20effect%20of%20combining%20antibiotics%20on%20resistance%3A%20A%20systematic%20review%20and%20meta-analysis.%20%26lt%3Bi%26gt%3BeLife%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20RP93740.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.93740%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.93740%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20effect%20of%20combining%20antibiotics%20on%20resistance%3A%20A%20systematic%20review%20and%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Siedentop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viacheslav%20N.%22%2C%22lastName%22%3A%22Kachalov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Witzany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%20D.%22%2C%22lastName%22%3A%22Kouyos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Bonhoeffer%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Under%20which%20conditions%20antibiotic%20combination%20therapy%20decelerates%20rather%20than%20accelerates%20resistance%20evolution%20is%20not%20well%20understood.%20We%20examined%20the%20effect%20of%20combining%20antibiotics%20on%20within-patient%20resistance%20development%20across%20various%20bacterial%20pathogens%20and%20antibiotics.%5CnMETHODS%3A%20We%20searched%20CENTRAL%2C%20EMBASE%2C%20and%20PubMed%20for%20%28quasi%29-randomised%20controlled%20trials%20%28RCTs%29%20published%20from%20database%20inception%20to%2024%20November%202022.%20Trials%20comparing%20antibiotic%20treatments%20with%20different%20numbers%20of%20antibiotics%20were%20included.%20Patients%20were%20considered%20to%20have%20acquired%20resistance%20if%2C%20at%20the%20follow-up%20culture%2C%20a%20resistant%20bacterium%20%28as%20defined%20by%20the%20study%20authors%29%20was%20detected%20that%20had%20not%20been%20present%20in%20the%20baseline%20culture.%20We%20combined%20results%20using%20a%20random%20effects%20model%20and%20performed%20meta-regression%20and%20stratified%20analyses.%20The%20trials%26%23039%3B%20risk%20of%20bias%20was%20assessed%20with%20the%20Cochrane%20tool.%5CnRESULTS%3A%2042%20trials%20were%20eligible%20and%2029%2C%20including%205054%20patients%2C%20qualified%20for%20statistical%20analysis.%20In%20most%20trials%2C%20resistance%20development%20was%20not%20the%20primary%20outcome%20and%20studies%20lacked%20power.%20The%20combined%20odds%20ratio%20for%20the%20acquisition%20of%20resistance%20comparing%20the%20group%20with%20the%20higher%20number%20of%20antibiotics%20with%20the%20comparison%20group%20was%201.23%20%2895%25%20CI%200.68-2.25%29%2C%20with%20substantial%20between-study%20heterogeneity%20%28I2%3D77%25%29.%20We%20identified%20tentative%20evidence%20for%20potential%20beneficial%20or%20detrimental%20effects%20of%20antibiotic%20combination%20therapy%20for%20specific%20pathogens%20or%20medical%20conditions.%5CnCONCLUSIONS%3A%20The%20evidence%20for%20combining%20a%20higher%20number%20of%20antibiotics%20compared%20to%20fewer%20from%20RCTs%20is%20scarce%20and%20overall%20compatible%20with%20both%20benefit%20or%20harm.%20Trials%20powered%20to%20detect%20differences%20in%20resistance%20development%20or%20well-designed%20observational%20studies%20are%20required%20to%20clarify%20the%20impact%20of%20combination%20therapy%20on%20resistance.%5CnFUNDING%3A%20Support%20from%20the%20Swiss%20National%20Science%20Foundation%20%28grant%20310030B_176401%20%28SB%2C%20BS%2C%20CW%29%2C%20grant%2032FP30-174281%20%28ME%29%2C%20grant%20324730_207957%20%28RDK%29%29%20and%20from%20the%20National%20Institute%20of%20Allergy%20and%20Infectious%20Diseases%20%28NIAID%2C%20cooperative%20agreement%20AI069924%20%28ME%29%29%20is%20gratefully%20acknowledged.%22%2C%22date%22%3A%222024-12-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.93740%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-17T16%3A35%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22SGP6MQZU%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carlucci%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCarlucci%2C%20James%20G.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHuntington%2C%20Thomas%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTechnau%2C%20Karl-Gunter%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYotebieng%2C%20Marcel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLeroy%2C%20Valeriane%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20High%20Prevalence%20of%20Unconfirmed%20Positive%20HIV%20Polymerase%20Chain%20Reaction%20Test%20Results%20Among%20African%20Infants%20With%20HIV%20Exposure%20in%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20Consortium.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%26%23x202F%3B%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B79%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%201475%26%23x2013%3B1478.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae251%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae251%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High%20Prevalence%20of%20Unconfirmed%20Positive%20HIV%20Polymerase%20Chain%20Reaction%20Test%20Results%20Among%20African%20Infants%20With%20HIV%20Exposure%20in%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20Consortium.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20G.%22%2C%22lastName%22%3A%22Carlucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Huntington%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-Gunter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeriane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madeleine%22%2C%22lastName%22%3A%22Amorissani-Folquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%5D%2C%22abstractNote%22%3A%22In%20a%20large%2C%20multiregional%20cohort%20of%20African%20infants%20with%20human%20immunodeficiency%20virus%20%28HIV%29%20exposure%2C%2044%25%20of%20those%20with%20a%20positive%20HIV%20polymerase%20chain%20reaction%20test%20lacked%20a%20confirmatory%20positive%20test.%20Efforts%20are%20needed%20to%20ensure%20high-fidelity%20implementation%20of%20HIV%20testing%20algorithms%20so%20that%20all%20positive%20results%20are%20confirmed.%22%2C%22date%22%3A%222024%20Dec%2017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciae251%22%2C%22ISSN%22%3A%221537-6591%201058-4838%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A22%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22N6HZL79Q%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Phillips%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPhillips%2C%20Tamsin%20K.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGomba%2C%20Yolanda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMogoba%2C%20Pheposadi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPhelanyane%2C%20Florence%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAnderson%2C%20Kim%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Routine%20Electronic%20Mother-Infant%20Data%20%28REMInD%29%3A%20a%20proof-of-concept%20Data%20to%20Care%20study%20to%20support%20retention%20in%20maternal%20HIV%20treatment%20and%20infant%20HIV%20testing%20in%20Cape%20Town%2C%20South%20Africa.%20%26lt%3Bi%26gt%3BResearch%20Square%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20rs.3.rs-5626699.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-5626699%5C%2Fv1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-5626699%5C%2Fv1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Routine%20Electronic%20Mother-Infant%20Data%20%28REMInD%29%3A%20a%20proof-of-concept%20Data%20to%20Care%20study%20to%20support%20retention%20in%20maternal%20HIV%20treatment%20and%20infant%20HIV%20testing%20in%20Cape%20Town%2C%20South%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamsin%20K.%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yolanda%22%2C%22lastName%22%3A%22Gomba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pheposadi%22%2C%22lastName%22%3A%22Mogoba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Phelanyane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20H.%22%2C%22lastName%22%3A%22Chi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Clouse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucia%22%2C%22lastName%22%3A%22Knight%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Landon%22%2C%22lastName%22%3A%22Myer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%20J.%22%2C%22lastName%22%3A%22Abrams%22%7D%5D%2C%22abstractNote%22%3A%22Data%20to%20Care%20%28D2C%29%20strategies%20-%20using%20routine%20data%20to%20facilitate%20identification%20and%20linkage%20back%20to%20care%20of%20people%20living%20with%20HIV%20who%20are%20not%20in%20care%20-%20have%20shown%20promise%20in%20high-income%20settings%20but%20received%20little%20attention%20in%20lower%20resourced%20or%20vertical%20HIV%20transmission%20prevention%20%28VTP%29%20contexts.%20In%20this%20proof-of-concept%20study%2C%20we%20monitored%20existing%20linked%20electronic%20medical%20records%20in%20near%20real-time%20to%20identify%20key%20gaps%20in%20postpartum%20VTP%20steps%20among%20336%20mothers%20living%20with%20HIV%20and%20their%20infants%20in%20Cape%20Town%2C%20South%20Africa%20%28recruited%20March%202021%20-%20April%202022%29.%20We%20attempted%20to%20confirm%20observed%20gaps%20through%20source%20data%20systems%20and%20telephonic%20tracing%2C%20and%20facilitated%20re-engagement%20in%20care%20where%20needed.%20There%20were%20302%20gaps%20observed%20in%20the%20routine%20data%3B%20123%20%2841%25%29%20were%20false%20gaps%20and%20179%20%2859%25%29%20were%20considered%20probable%20gaps%20%28133%20mother-infant%20pairs%29.%20Overall%2C%2054%20mothers%20%2816%25%29%20did%20not%20link%20to%20HIV%20care%20within%2012%20weeks%20of%20delivery%2C%2043%20mothers%20%2813%25%29%20linked%20to%20care%20but%20had%20a%20gap%20in%20ART%20dispensing%20by%20nine%20months%20postpartum%2C%2025%20infants%20%2810%25%29%20did%20not%20have%20an%20HIV%20test%20around%2010%20weeks%20and%2057%20%2817%25%29%20had%20no%20HIV%20test%20around%206%20months%20of%20age.%20Only%20100%20of%20the%20probable%20gaps%20%2856%25%29%20could%20be%20confirmed%20through%20telephonic%20tracing%20and%2C%20of%20those%2C%20only%2047%20were%20successfully%20re-linked%20to%20care.%20Mobility%20and%20clinic%20transfer%2C%20fear%20of%20stigma%20and%20employment-related%20challenges%20were%20commonly%20reported%20reasons%20for%20gaps%20in%20VTP%20steps.%20This%20study%20highlights%20that%20linked%20routine%20data%20sources%20linking%20mother-infant%20pairs%20across%20health%20facilities%20has%20the%20potential%20to%20streamline%20tracing%20efforts%3B%20however%2C%20implementation%20is%20challenging%20and%2C%20even%20when%20gaps%20are%20identified%2C%20re-engagement%20in%20care%20may%20be%20difficult.%20Further%20research%20is%20needed%20to%20combine%20D2C%20strategies%20with%20interventions%20addressing%20broader%20social%20and%20structural%20determinants%20of%20health%2C%20and%20to%20tailor%20D2C%20strategies%20to%20fit%20available%20resources%20and%20data%20sources%20in%20low-resource%20settings.%22%2C%22date%22%3A%222024-12-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21203%5C%2Frs.3.rs-5626699%5C%2Fv1%22%2C%22ISSN%22%3A%222693-5015%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-17T16%3A27%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22TSITSWJA%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brenner%20et%20al.%22%2C%22parsedDate%22%3A%222024-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrenner%2C%20Isaac%20Ravi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFlanagan%2C%20Clare%20F.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPenazzato%2C%20Martina%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWebb%2C%20Karen%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHorsfall%2C%20Stephanie%20B.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Cost-effectiveness%20of%20viral%20load%20testing%20for%20transitioning%20antiretroviral%20therapy-experienced%20children%20to%20dolutegravir%20in%20South%20Africa%3A%20a%20modelling%20analysis.%20%26lt%3Bi%26gt%3BThe%20Lancet.%20Global%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%20%2812%29%2C%20S.%20e2068%26%23x2013%3Be2079.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2214-109X%2824%2900381-4%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2214-109X%2824%2900381-4%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cost-effectiveness%20of%20viral%20load%20testing%20for%20transitioning%20antiretroviral%20therapy-experienced%20children%20to%20dolutegravir%20in%20South%20Africa%3A%20a%20modelling%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20Ravi%22%2C%22lastName%22%3A%22Brenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clare%20F.%22%2C%22lastName%22%3A%22Flanagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Penazzato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%20A.%22%2C%22lastName%22%3A%22Webb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20B.%22%2C%22lastName%22%3A%22Horsfall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20P.%22%2C%22lastName%22%3A%22Hyle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%22%2C%22lastName%22%3A%22Abrams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Bacha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20M.%22%2C%22lastName%22%3A%22Neilan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Intira%20Jeannie%22%2C%22lastName%22%3A%22Collins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siobhan%22%2C%22lastName%22%3A%22Crichton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20A.%22%2C%22lastName%22%3A%22Freedberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20L.%22%2C%22lastName%22%3A%22Ciaranello%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20For%20children%20with%20HIV%20on%20antiretroviral%20therapy%20%28ART%29%2C%20transitioning%20to%20dolutegravir-containing%20regimens%20is%20recommended.%20The%20aim%20of%20this%20study%20was%20to%20assess%20whether%20introducing%20viral%20load%20testing%20to%20inform%20new%20nucleoside%20or%20nucleotide%20reverse%20transcriptase%20inhibitors%20%28NRTIs%29%20for%20children%20with%20HIV%20and%20viraemia%20alongside%20dolutegravir-based%20ART%20is%20beneficial%20and%20of%20good%20economic%20value.%5CnMETHODS%3A%20We%20used%20the%20Cost-Effectiveness%20of%20Preventing%20AIDS%20Complications-Pediatric%20model%20to%20project%20clinical%20and%20cost%20implications%20of%20three%20strategies%20among%20a%20simulated%20cohort%20of%20South%20African%20children%20aged%208%20years%20with%20HIV%20receiving%20abacavir-lamivudine-efavirenz%3A%20%281%29%20continue%20current%20ART%20%28no%20dolutegravir%3B%20abacavir-lamivudine-efavirenz%29%3B%20%282%29%20transition%20all%20children%20with%20HIV%20to%20dolutegravir%2C%20keeping%20current%20NRTIs%20%28dolutegravir%3B%20abacavir-lamivudine-dolutegravir%29%3B%20or%20%283%29%20transition%20to%20dolutegravir%20based%20on%20viral%20load%20testing%20%28viral%20load%20plus%20dolutegravir%29%2C%20keeping%20current%20NRTIs%20if%20virologically%20suppressed%20%28abacavir-lamivudine-dolutegravir%2C%2070%25%20of%20cohort%29%20or%20switching%20abacavir%20to%20zidovudine%20%28zidovudine%29%20if%20viraemic%20%28zidovudine-lamivudine-dolutegravir%2C%2030%25%29.%20We%20assumed%2050%25%20of%20children%20who%20had%20viraemia%20after%20abacavir-lamivudine%20exposure%20had%20NRTI%20resistance%3B%20with%20resistance%2C%20we%20assumed%20zidovudine-lamivudine-dolutegravir%20was%20more%20effective%20than%20abacavir-lamivudine-dolutegravir.%20We%20designated%20a%20strategy%20as%20preferred%20if%20it%20was%20most%20effective%20and%20least%20costly%20or%20had%20an%20incremental%20cost-effectiveness%20ratio%20less%20than%20half%20the%20South%20African%202020%20gross%20domestic%20product%20per%20capita.%5CnFINDINGS%3A%20Under%20base-case%20assumptions%2C%20the%20viral%20load%20plus%20dolutegravir%20strategy%20would%20be%20the%20most%20effective%20%28projected%20undiscounted%20life%20expectancy%20of%2039%5Cu00b772%20life-years%29%20and%20least%20costly%20strategy%20%28US%2424%5Cu2009600%20per%20person%29%3B%20the%20no%20dolutegravir%20strategy%20was%20the%20least%20effective%20%2834%5Cu00b749%20life-years%29%20and%20most%20expensive%20%28%2426%5Cu2009480%20per%20person%29.%20In%20sensitivity%20analyses%2C%20the%2024-week%20virological%20suppression%20probability%20and%20subsequent%20monthly%20virological%20failure%20risks%20%28ie%2C%20late%20failure%29%20were%20most%20influential%20on%20cost-effectiveness.%20Only%20with%20a%20high%20late-failure%20risk%20for%20zidovudine-lamivudine-dolutegravir%20%28ie%2C%20%5Cu22650%5Cu00b73%25%20per%20month%20in%20the%20base%20case%20or%20%26gt%3B0%5Cu00b75%25%20per%20month%20if%20abacavir%20also%20confers%20low%20virological%20suppression%20probability%20in%20the%20presence%20of%20NRTI%20resistance%20%5B65%25%5D%29%20would%20the%20dolutegravir%20strategy%20become%20preferred%20above%20the%20viral%20load%20plus%20dolutegravir%20strategy.%5CnINTERPRETATION%3A%20For%20programmes%20transitioning%20to%20dolutegravir-based%20regimens%2C%20our%20model%20predicted%20that%20doing%20so%20would%20be%20more%20effective%20and%20less%20costly%20than%20continuing%20current%20ART%20regimens%2C%20regardless%20of%20NRTI%20choice.%20Whether%20viral%20load%20testing%20for%20children%20with%20HIV%20is%20necessary%20to%20inform%20NRTI%20choice%20depends%20substantially%20on%20the%20comparative%20outcomes%20of%20abacavir%20and%20zidovudine%20after%20switching%20to%20dolutegravir-containing%20ART.%5CnFUNDING%3A%20The%20Eunice%20Kennedy%20Shriver%20Institute%20for%20Child%20Health%20and%20Human%20Development%2C%20the%20National%20Institute%20of%20Allergy%20and%20Infectious%20Diseases%2C%20the%20Massachusetts%20General%20Hospital%20Executive%20Committee%20on%20Research%2C%20the%20Massachusetts%20General%20Hospital%2C%20and%20the%20Medical%20Research%20Council.%22%2C%22date%22%3A%222024-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2214-109X%2824%2900381-4%22%2C%22ISSN%22%3A%222214-109X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A49%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22P4JBXGFH%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Musonda%20et%20al.%22%2C%22parsedDate%22%3A%222024-11-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMusonda%2C%20Taonga%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWallace%2C%20Michael%20S.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPatel%2C%20Hailey%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMartin%2C%20Owen%20P.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BOetheimer%2C%20Christopher%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20New%20Window%20Into%20Hepatitis%20B%20in%20Africa%3A%20Liver%20Sampling%20Combined%20With%20Single-Cell%20Omics%20Enables%20Deep%20and%20Longitudinal%20Assessment%20of%20Intrahepatic%20Immunity%20in%20Zambia.%20%26lt%3Bi%26gt%3BThe%20Journal%20of%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B230%26lt%3B%5C%2Fi%26gt%3B%20%285%29%2C%20S.%20e1171%26%23x2013%3Be1175.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae054%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjiae054%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22New%20Window%20Into%20Hepatitis%20B%20in%20Africa%3A%20Liver%20Sampling%20Combined%20With%20Single-Cell%20Omics%20Enables%20Deep%20and%20Longitudinal%20Assessment%20of%20Intrahepatic%20Immunity%20in%20Zambia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taonga%22%2C%22lastName%22%3A%22Musonda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Wallace%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hailey%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Owen%20P.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Oetheimer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simutanyi%22%2C%22lastName%22%3A%22Mwakamui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edford%22%2C%22lastName%22%3A%22Sinkala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bright%22%2C%22lastName%22%3A%22Nsokolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annie%22%2C%22lastName%22%3A%22Kanunga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georg%22%2C%22lastName%22%3A%22Lauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20T.%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debika%22%2C%22lastName%22%3A%22Bhattacharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Kelly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadia%22%2C%22lastName%22%3A%22Alatrakchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Vinikoor%22%7D%5D%2C%22abstractNote%22%3A%22In%20Lusaka%2C%20Zambia%2C%20we%20introduced%20liver%20fine-needle%20aspiration%20biopsy%20%28FNAB%29%20into%20a%20research%20cohort%20of%20adults%20with%20treatment-naive%20chronic%20hepatitis%20B%20virus%20%28HBV%29%20infection%2C%20with%20and%20without%20human%20immunodeficiency%20virus%20%28HIV%29%20coinfection%2C%20as%20well%20as%20with%20acute%20HBV%20infection.%20From%20117%20enrollment%20and%2047%20longitudinal%20FNABs%20%28at%201-year%20follow-up%29%2C%20we%20established%20participant%20acceptability%20and%20safety.%20We%20also%20demonstrated%20the%20quality%20of%20the%20material%20through%20single-cell%20RNA%20sequencing%20of%20selected%20enrollment%20FNAs%2C%20which%20revealed%20a%20range%20of%20immune%20cells.%20This%20approach%20can%20drive%20new%20insights%20into%20HBV%20immunology%2C%20informing%20cure%20strategies%2C%20and%20can%20improve%20our%20understanding%20of%20HBV%20natural%20history%20in%20Africa.%22%2C%22date%22%3A%222024-11-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjiae054%22%2C%22ISSN%22%3A%221537-6613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-17T16%3A16%3A13Z%22%7D%7D%2C%7B%22key%22%3A%227GP8K3Y5%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Waal%20et%20al.%22%2C%22parsedDate%22%3A%222024-11-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3Bde%20Waal%2C%20Rene%26%23xE9%3B%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWools-Kaloustian%2C%20Kara%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAlthoff%2C%20Keri%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJaquet%2C%20Antoine%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Global%20trends%20in%20CD4%20count%20measurement%20and%20distribution%20at%20first%20antiretroviral%20treatment%20initiation.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20ciae548.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae548%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae548%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20trends%20in%20CD4%20count%20measurement%20and%20distribution%20at%20first%20antiretroviral%20treatment%20initiation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rene%5Cu00e9%22%2C%22lastName%22%3A%22de%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingeswaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodora%22%2C%22lastName%22%3A%22Savory%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Justice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%20K.%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20K.%20U.%22%2C%22lastName%22%3A%22Pasayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agness%22%2C%22lastName%22%3A%22Thawani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pelagie%22%2C%22lastName%22%3A%22Babakazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maile%22%2C%22lastName%22%3A%22Karris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Yong%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noela%20C.%22%2C%22lastName%22%3A%22Owarwo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Niyongabo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%20C.%22%2C%22lastName%22%3A%22Marconi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22Petoumenos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20people%20with%20HIV%20%28PWH%29%20start%20antiretroviral%20treatment%20%28ART%29%20regardless%20of%20CD4%20count%2C%20CD4%20measurement%20remains%20crucial%20for%20detecting%20advanced%20HIV%20disease%20and%20evaluating%20ART%20programmes.%20We%20explored%20CD4%20measurement%20%28proportion%20of%20PWH%20with%20a%20CD4%20result%20available%29%20and%20prevalence%20of%20CD4%20%26lt%3B200%20cells%5C%2F%5Cu00b5L%20at%20ART%20initiation%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20global%20collaboration.%5CnMETHODS%3A%20We%20included%20PWH%20at%20participating%20ART%20programmes%20who%20first%20initiated%20ART%20at%20age%2015-80%20years%20during%202005-2019.%20We%20described%20proportions%20of%20PWH%20%28i%29%20with%20CD4%20%28measured%20within%206%20months%20before%20to%202%20weeks%20after%20ART%20initiation%29%3B%20and%20%28ii%29%20among%20those%20with%20a%20CD4%2C%20with%20CD4%20%26lt%3B200%3B%20by%20year%20of%20ART%20initiation%20and%20region.%5CnRESULTS%3A%20We%20included%201%2C355%2C104%20PWH%20from%2042%20countries%20in%207%20regions%3B%2063%25%20were%20female.%20Median%20%28interquartile%20range%29%20age%20at%20ART%20initiation%20was%2037%20%2831-44%29%20in%20men%20and%2032%20%2826-39%29%20in%20women.%20CD4%20measurement%20initially%20increased%2C%20or%20remained%20stable%20over%20time%20until%20around%202013%2C%20but%20then%20declined%20to%20low%20levels%20in%20some%20regions%20%28Southern%20Africa%2C%20except%20South%20Africa%3A%20from%2054%20to%2013%25%3B%20East%20Africa%2085%20to%2031%25%3B%20Central%20Africa%2072%20to%2020%25%3B%20West%20Africa%3A%2091%20to%2053%25%3B%20and%20Latin%20America%3A%2087%20to%2056%25%29.%20Prevalence%20of%20CD4%26lt%3B200%20declined%20over%20time%20in%20all%20regions%2C%20but%20plateaued%20after%202015%20at%20%5Cu226530%25.%5CnCONCLUSIONS%3A%20CD4%20measurement%20has%20declined%20sharply%20in%20recent%20years%2C%20especially%20in%20sub-Saharan%20Africa.%20Among%20those%20with%20a%20CD4%2C%20the%20prevalence%20of%20CD4%20%26lt%3B200%20remains%20concerningly%20high.%20Scaling%20up%20CD4%20testing%20and%20securing%20adequate%20funding%20are%20urgent%20priorities.%22%2C%22date%22%3A%222024-11-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciae548%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-04-14T13%3A33%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22TKZ5KNTG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yotebieng%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BYotebieng%2C%20Marcel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZotova%2C%20Natalia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBernard%2C%20Charlotte%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGoodrich%2C%20Suzanne%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAwoh%2C%20Ajeh%20Rogers%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Accuracy%20of%20nine-item%20Patient%20Health%20Questionnaire%20against%20psychiatric%20diagnosis%20for%20depression%20among%20people%20with%20HIV.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B38%26lt%3B%5C%2Fi%26gt%3B%20%2812%29%2C%20S.%201765%26%23x2013%3B1773.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003963%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003963%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accuracy%20of%20nine-item%20Patient%20Health%20Questionnaire%20against%20psychiatric%20diagnosis%20for%20depression%20among%20people%20with%20HIV%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22Goodrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajeh%20Rogers%22%2C%22lastName%22%3A%22Awoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%22%2C%22lastName%22%3A%22Watnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambu%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%20Flore%20Tchiengang%22%2C%22lastName%22%3A%22Moungang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20Laure%20Nguemo%22%2C%22lastName%22%3A%22Noumedem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%20Calvin%20Nko%27o%22%2C%22lastName%22%3A%22Mbongo%27o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moussa%22%2C%22lastName%22%3A%22Seydi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Gandou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukoye%22%2C%22lastName%22%3A%22Atwoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20The%20aim%20of%20this%20study%20was%20to%20assess%20the%20performance%20of%20the%20nine-item%20Patient%20Health%20Questionnaire%20%28PHQ-9%29%20against%20psychiatrist%20diagnosis%20in%20people%20with%20HIV%20%28PWH%29.%5CnDESIGN%3A%20Cross-sectional%20analysis%20of%20data%20collected%20between%20January%202018%20and%20July%202022%20across%20five%20sites%20in%20Cameroon%2C%20Cote%20d%26%23039%3BIvoire%2C%20Kenya%2C%20Senegal%2C%20and%20the%20Republic%20of%20Congo.%20Participants%20were%20%5Cu226518%5Cu200ayears%20and%20receiving%20HIV%20care%20at%20the%20participating%20site.%20PHQ-9%20was%20administered%20by%20study%20staff%20followed%20by%20a%20psychiatrist%26%23039%3Bs%20evaluation%20within%203%5Cu200adays.%5CnRESULTS%3A%20Overall%2C%20778%20participants%20with%20complete%20data%20were%20included%3A%20297%20%2838.2%25%29%20in%20Cameroon%2C%20132%20%2817.0%25%29%20in%20Congo%2C%20148%20%2819.0%25%29%20in%20Cote%20d%26%23039%3BIvoire%2C%2098%20%2812.6%25%29%20in%20Kenya%2C%20and%20103%20%2813.2%25%29%20in%20Senegal.%20The%20area%20under%20the%20curve%20for%20PHQ-9%20score%20was%20generally%20high%20ranging%20from%200.935%20%5B95%25%20confidence%20interval%20%28CI%29%3A%200.893%2C%200.977%5D%20in%20Cote%20d%26%23039%3BIvoire%20to%200.768%20%2895%25%20CI%3A%200.589%2C%200.947%29%20in%20Congo.%20However%2C%20for%20the%20common%20cut-off%20score%20%5Cu226510%2C%20sensitivity%20was%20low%3A%2050%25%20or%20lower%20in%20Cameroon%2C%20Congo%20and%20Senegal%2C%2066.7%25%20in%20Kenya%20and%2070.6%25%20in%20Cote%20d%26%23039%3BIvoire.%20But%20negative%20predictive%20values%20%28NPV%29%20were%20high%3A%2098.9%25%20%2895%25%20CI%3A%2096.9%25%2C%2099.8%25%29%20in%20Cameroon%2C%2096.1%20%2895%25%20CI%3A%2091.1%2C%2098.7%29%20in%20Cote%20d%26%23039%3BIvoire%2C%2096.3%25%20%2895%25%20CI%3A%2089.7%25%2C%2099.2%25%29%20in%20Kenya%2C%2095.7%25%20%2895%25%20CI%3A%2090.2%25%2C%2098.6%25%29%20in%20Congo%2C%20and%2089.0%25%20%2895%25%20CI%3A%2081.2%25%2C%2094.4%25%29%20in%20Senegal.%5CnINTERPRETATION%3A%20Across%20all%20countries%2C%20PHQ-9%20score%20%5Cu226510%20performed%20very%20poorly%20%28low%20sensitivity%29%20as%20a%20tool%20to%20identify%20psychiatrist%20diagnosed%20depression.%20However%2C%20the%20observed%20high%20NPV%20suggests%20it%20can%20be%20used%20to%20rule%20out%20depression.%22%2C%22date%22%3A%222024-10-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000003963%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A14%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22B454NC8K%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anderson%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAnderson%2C%20Kim%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3Bvan%20Zyl%2C%20Gert%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHsiao%2C%20Nei-Yuan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BClaassen%2C%20Mathilda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMudaly%2C%20Vanessa%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20HIV%20Drug%20Resistance%20in%20Newly%20Diagnosed%20Young%20Children%20in%20the%20Western%20Cape%2C%20South%20Africa.%20%26lt%3Bi%26gt%3BThe%20Pediatric%20Infectious%20Disease%20Journal%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B43%26lt%3B%5C%2Fi%26gt%3B%20%2810%29%2C%20S.%20970%26%23x2013%3B976.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004482%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004482%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20Drug%20Resistance%20in%20Newly%20Diagnosed%20Young%20Children%20in%20the%20Western%20Cape%2C%20South%20Africa.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gert%22%2C%22lastName%22%3A%22van%20Zyl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nei-Yuan%22%2C%22lastName%22%3A%22Hsiao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilda%22%2C%22lastName%22%3A%22Claassen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Mudaly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%22%2C%22lastName%22%3A%22Voget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexa%22%2C%22lastName%22%3A%22Heekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Kalk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Phelanyane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gayathri%22%2C%22lastName%22%3A%22Sridhar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%22%2C%22lastName%22%3A%22Ragone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vani%22%2C%22lastName%22%3A%22Vannappagari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Pretreatment%20of%20HIV%20drug%20resistance%20among%20children%20living%20with%20HIV%20%28CLHIV%29%20can%20compromise%20antiretroviral%20therapy%20%28ART%29%20effectiveness.%20Resistance%20may%20be%20transmitted%20directly%20from%20mothers%20or%20acquired%20following%20exposure%20to%20antiretrovirals%20consumed%20through%20breastfeeding%20or%20administered%20as%20prophylaxis.%20METHODS%3A%20We%20performed%20resistance%20testing%20in%20children%20aged%20%26lt%3B3%20years%2C%20newly%20diagnosed%20with%20HIV%20in%20Western%20Cape%2C%20South%20Africa%20%282021-2022%29%2C%20who%20either%20%281%29%20acquired%20HIV%20via%20possible%20breastfeeding%20transmission%20from%20mothers%20who%20received%20ART%20%28any%20regimen%29%20during%20pregnancy%5C%2Fpostpartum%20and%5C%2For%20%282%29%20were%20exposed%20to%20protease%20inhibitors%20or%20integrase%20strand%20transfer%20inhibitors%20%28INSTIs%29%20in%20utero.%20Possible%20breastfeeding%20transmission%20was%20defined%20as%20testing%20HIV-polymerase%20chain%20reaction%20positive%20at%20age%20%26gt%3B28%20days%2C%20after%20previously%20testing%20negative.%20We%20used%20surveillance%20drug-resistance%20mutation%20lists%20to%20define%20mutations.%20RESULTS%3A%20We%20included%20135%20CLHIV.%20Most%20mothers%20started%20ART%20prepregnancy%20%2873%25%29.%20Overall%2C%2057%25%20%2877%5C%2F135%29%20of%20children%20had%20resistance%20mutations%20detected.%20Nonnucleoside%20reverse%20transcriptase%20inhibitor-%20associated%2C%20nucleoside%20reverse%20transcriptase%20inhibitor-associated%2C%20protease%20inhibitor-associated%20and%20INSTI-associated%20mutations%20were%20found%20in%2055%25%20%2874%5C%2F135%29%2C%2010%25%20%2813%5C%2F135%29%2C%20%26lt%3B1%25%20%281%5C%2F135%29%20and%20%26lt%3B1%25%20%281%5C%2F122%29%20of%20children%20tested%2C%20respectively.%20One%20child%20with%20breastfeeding%20transmission%20had%20high-%20level%20INSTI%20resistance%20detected%20at%20HIV%20diagnosis%2C%20aged%2018%20months%20%28E138K%20and%20G118R%20mutations%29.%20CONCLUSIONS%3A%20Although%20not%20clinically%20relevant%2C%20nonnucleoside%20reverse%20transcriptase%20inhibitor-associated%20mutations%20were%20common.%20Dolutegravir%20is%20currently%20the%20preferred%20first-line%20treatment%20for%20adults%20and%20CLHIV%20age%20%26gt%3B%5C%2F%3D4%20weeks%2C%20and%20although%20very%20low%20INSTI%20resistance%20levels%20have%20been%20observed%20in%20adults%2C%20limited%20data%20exist%20on%20genotyping%20the%20integrase%20region%20in%20children.%20Pretreatment%20INSTI%20resistance%20in%20children%20is%20likely%20to%20be%20unusual%2C%20but%20future%20surveillance%2C%20including%20longitudinal%20studies%20with%20paired%20mother-child%20resistance%20testing%2C%20is%20needed.%22%2C%22date%22%3A%222024%20Oct%201%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FINF.0000000000004482%22%2C%22ISSN%22%3A%221532-0987%200891-3668%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%224HQSQPK4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222024-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BParcesepe%2C%20Angela%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStockton%2C%20Melissa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBernard%2C%20Charlotte%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKanguya%2C%20Tukiya%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKwobah%2C%20Edith%20Kamaru%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Prevalence%20and%20co-occurrence%20of%20symptoms%20of%20mental%20and%20substance%20use%20disorders%20among%20people%20with%20HIV%20age%2040%20and%20older%20in%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%2810%29%2C%20S.%20e26359.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26359%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26359%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prevalence%20and%20co-occurrence%20of%20symptoms%20of%20mental%20and%20substance%20use%20disorders%20among%20people%20with%20HIV%20age%2040%20and%20older%20in%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tukiya%22%2C%22lastName%22%3A%22Kanguya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22Goodrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Musabyimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Smita%22%2C%22lastName%22%3A%22Nimkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22IeDEA%22%2C%22lastName%22%3A%22Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Due%20to%20the%20increased%20effectiveness%20of%20and%20access%20to%20antiretroviral%20therapy%20%28ART%29%2C%20people%20with%20HIV%20%28PWH%29%20are%20living%20longer.%20As%20a%20result%2C%20the%20population%20of%20older%20PWH%20has%20increased.%20Mental%20and%20substance%20use%20disorders%20%28MSDs%29%20are%20common%20and%20frequently%20co-occurring%20among%20PWH%20and%20are%20associated%20with%20poor%20HIV%20care%20outcomes.%20Research%20into%20the%20prevalence%20and%20co-occurrence%20of%20MSDs%20among%20ageing%20PWH%20remains%20limited%2C%20particularly%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29.%5CnMETHODS%3A%20We%20analysed%20data%20collected%20between%202020%20and%202022%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Sentinel%20Research%20Network%20cohort%20of%20PWH%20aged%2040%20years%20or%20older%20on%20ART%20at%2011%20HIV%20clinics%20in%20Brazil%2C%20C%5Cu00f4te%20d%26%23039%3BIvoire%2C%20India%2C%20Kenya%2C%20Mexico%2C%20Uganda%2C%20Rwanda%2C%20Togo%2C%20Vietnam%2C%20Zambia%20and%20Zimbabwe.%20We%20estimated%20the%20prevalence%20and%20co-occurrence%20of%20unhealthy%20alcohol%20use%20%28AUDIT-C%20%5Cu22653%20for%20women%2C%20%5Cu22654%20for%20men%29%2C%20unhealthy%20drug%20use%20%28ASSIST%20%26gt%3B3%20for%20cannabis%2C%20cocaine%2C%20amphetamines%2C%20inhalants%2C%20sedatives%2C%20hallucinogens%20and%5C%2For%20opioids%29%2C%20and%20moderate%20to%20severe%20symptoms%20of%20depression%20%28PHQ-9%20%5Cu226510%29%2C%20anxiety%20%28GAD-7%20%5Cu226510%29%20and%20post-traumatic%20stress%20disorder%20%28PTSD%29%20%28PCL-5%20%5Cu226533%29.%20Psychiatric%20multimorbidity%20was%20defined%20as%20having%20symptoms%20of%20two%20or%20more%20disorders%20assessed.%20Log%20binomial%20models%20assessed%20the%20association%20between%20socio-demographic%20and%20HIV%20care%20characteristics%20and%20symptoms%20of%20anxiety%2C%20depression%2C%20PTSD%20or%20unhealthy%20substance%20use.%5CnRESULTS%3A%20Of%202821%20participants%2C%20the%20prevalence%20of%20unhealthy%20alcohol%20and%20drug%20use%20was%2021%25%20and%205%25%2C%20respectively.%20The%20prevalence%20of%20moderate%20to%20severe%20symptoms%20of%20depression%2C%20anxiety%20and%20PTSD%20was%2014%25%2C%209%25%20and%206%25%2C%20respectively.%20Overall%2C%20the%20prevalence%20of%20psychiatric%20multimorbidity%20was%2011%25.%20Among%20those%20with%20symptoms%20of%20at%20least%20one%20mental%20health%20or%20substance%20use%20outcome%20assessed%20%28n%20%3D%201036%29%2C%20the%20prevalence%20of%20psychiatric%20multimorbidity%20was%2031%25.%20In%20binomial%20models%2C%20the%20prevalence%20of%20symptoms%20of%20depression%20and%20anxiety%20was%20higher%2C%20while%20the%20prevalence%20of%20unhealthy%20alcohol%20and%20drug%20use%20was%20lower%20among%20women%20than%20men.%5CnCONCLUSIONS%3A%20Unhealthy%20alcohol%20use%20and%20symptoms%20of%20depression%20were%20most%20commonly%20reported%2C%20among%20this%20cohort%20of%20PWH%20aged%2040%20or%20older%20across%2011%20LMICs.%20Integration%20of%20MSD%20screening%20and%20treatment%20into%20HIV%20care%20should%20be%20prioritized.%20The%20effectiveness%20and%20implementation%20of%20transdiagnostic%20or%20multi-focus%20mental%20health%20treatment%20approaches%20in%20HIV%20care%20settings%20should%20be%20examined.%22%2C%22date%22%3A%222024-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26359%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A35%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22HR94XNMG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schwab%20et%20al.%22%2C%22parsedDate%22%3A%222024-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSchwab%2C%20Tiana%20Carina%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPerrig%2C%20Lisa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGoller%2C%20Pauline%20Carlotta%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGuebely%20De%20la%20Hoz%2C%20Freddy%20Fernando%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLahousse%2C%20Adrien%20Philippe%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Targeted%20next-generation%20sequencing%20to%20diagnose%20drug-resistant%20tuberculosis%3A%20a%20systematic%20review%20and%20meta-analysis.%20%26lt%3Bi%26gt%3BThe%20Lancet.%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%20%2810%29%2C%20S.%201162%26%23x2013%3B1176.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2824%2900263-9%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2824%2900263-9%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeted%20next-generation%20sequencing%20to%20diagnose%20drug-resistant%20tuberculosis%3A%20a%20systematic%20review%20and%20meta-analysis.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiana%20Carina%22%2C%22lastName%22%3A%22Schwab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Perrig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pauline%20Carlotta%22%2C%22lastName%22%3A%22Goller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Freddy%20Fernando%22%2C%22lastName%22%3A%22Guebely%20De%20la%20Hoz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrien%20Philippe%22%2C%22lastName%22%3A%22Lahousse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatrice%22%2C%22lastName%22%3A%22Minder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22Gunther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orestis%22%2C%22lastName%22%3A%22Efthimiou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaheed%20Vally%22%2C%22lastName%22%3A%22Omar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Targeted%20next-generation%20sequencing%20%28NGS%29%20can%20rapidly%20and%20simultaneously%20detect%20mutations%20associated%20with%20resistance%20to%20tuberculosis%20drugs%20across%20multiple%20gene%20targets.%20The%20use%20of%20targeted%20NGS%20to%20diagnose%20drug-resistant%20tuberculosis%2C%20as%20described%20in%20publicly%20available%20data%2C%20has%20not%20been%20comprehensively%20reviewed.%20We%20aimed%20to%20identify%20targeted%20NGS%20assays%20that%20diagnose%20drug-resistant%20tuberculosis%2C%20determine%20how%20widely%20this%20technology%20has%20been%20used%2C%20and%20assess%20the%20diagnostic%20accuracy%20of%20these%20assays.%20METHODS%3A%20In%20this%20systematic%20review%20and%20meta-analysis%2C%20we%20searched%20MEDLINE%2C%20Embase%2C%20Cochrane%20Library%2C%20Web%20of%20Science%20Core%20Collection%2C%20Global%20Index%20Medicus%2C%20Google%20Scholar%2C%20ClinicalTrials.gov%2C%20and%20the%20WHO%20International%20Clinical%20Trials%20Registry%20Platform%20for%20published%20and%20unpublished%20reports%20on%20targeted%20NGS%20for%20drug-%20resistant%20tuberculosis%20from%20Jan%201%2C%202005%2C%20to%20Oct%2014%2C%202022%2C%20with%20updates%20to%20our%20search%20in%20Embase%20and%20Google%20Scholar%20until%20Feb%2013%2C%202024.%20Studies%20eligible%20for%20the%20systematic%20review%20described%20targeted%20NGS%20approaches%20to%20predict%20drug%20resistance%20in%20Mycobacterium%20tuberculosis%20infections%20using%20primary%20samples%2C%20reference%20strain%20collections%2C%20or%20cultured%20isolates%20from%20individuals%20with%20presumed%20or%20confirmed%20tuberculosis.%20Our%20search%20had%20no%20limitations%20on%20study%20type%20or%20language%2C%20although%20only%20reports%20in%20English%2C%20German%2C%20and%20French%20were%20screened%20for%20eligibility.%20For%20the%20meta-analysis%2C%20we%20included%20test%20accuracy%20studies%20that%20used%20any%20reference%20standard%2C%20and%20we%20assessed%20risk%20of%20bias%20using%20the%20Quality%20Assessment%20of%20Diagnostic%20Accuracy%20Studies-2%20tool.%20The%20primary%20outcomes%20for%20the%20meta-analysis%20were%20sensitivity%20and%20specificity%20of%20targeted%20NGS%20to%20diagnose%20drug-resistant%20tuberculosis%20compared%20to%20phenotypic%20and%20genotypic%20drug%20susceptibility%20testing.%20We%20used%20a%20Bayesian%20bivariate%20model%20to%20generate%20summary%20receiver%20operating%20characteristic%20plots%20and%20diagnostic%20accuracy%20measures%2C%20overall%20and%20stratified%20by%20drug%20and%20sample%20type.%20This%20study%20is%20registered%20with%20PROSPERO%2C%20CRD42022368707.%20FINDINGS%3A%20We%20identified%20and%20screened%202920%20reports%2C%20of%20which%20124%20were%20eligible%20for%20our%20systematic%20review%2C%20including%2037%20review%20articles%20and%2087%20reports%20of%20studies%20collecting%20samples%20for%20targeted%20NGS.%20Sequencing%20was%20mainly%20done%20in%20the%20USA%20%2814%20%5B16%25%5D%20of%2087%29%2C%20western%20Europe%20%28ten%20%5B11%25%5D%29%2C%20India%20%28ten%20%5B11%25%5D%29%2C%20and%20China%20%28nine%20%5B10%25%5D%29.%20We%20included%2024%20test%20accuracy%20studies%20in%20the%20meta-analysis%2C%20in%20which%2023%20different%20tuberculosis%20drugs%20or%20drug%20groups%20were%20assessed%2C%20covering%20first-line%20drugs%2C%20injectable%20drugs%2C%20and%20fluoroquinolones%20and%20predominantly%20comparing%20targeted%20NGS%20with%20phenotypic%20drug%20susceptibility%20testing.%20The%20combined%20sensitivity%20of%20targeted%20NGS%20across%20all%20drugs%20was%2094.1%25%20%2895%25%20credible%20interval%20%5BCrI%5D%2090.9-96.3%29%20and%20specificity%20was%2098.1%25%20%2897.0-98.9%29.%20Sensitivity%20for%20individual%20drugs%20ranged%20from%2076.5%25%20%2852.5-92.3%29%20for%20capreomycin%20to%2099.1%25%20%2898.3-99.7%29%20for%20rifampicin%3B%20specificity%20ranged%20from%2093.1%25%20%2888.0-96.3%29%20for%20ethambutol%20to%2099.4%25%20%2898.3-99.8%29%20for%20amikacin.%20Diagnostic%20accuracy%20was%20similar%20for%20primary%20clinical%20samples%20and%20culture%20isolates%20overall%20and%20for%20rifampicin%2C%20isoniazid%2C%20ethambutol%2C%20streptomycin%2C%20and%20fluoroquinolones%2C%20and%20similar%20after%20excluding%20studies%20at%20high%20risk%20of%20bias%20%28overall%20sensitivity%2095.2%25%20%5B95%25%20CrI%2091.7-97.1%5D%20and%20specificity%2098.6%25%20%5B97.4-99.3%5D%29.%20INTERPRETATION%3A%20Targeted%20NGS%20is%20highly%20sensitive%20and%20specific%20for%20detecting%20drug%20resistance%20across%20panels%20of%20tuberculosis%20drugs%20and%20can%20be%20performed%20directly%20on%20clinical%20samples.%20There%20is%20a%20paucity%20of%20data%20on%20performance%20for%20some%20currently%20recommended%20drugs.%20The%20barriers%20preventing%20the%20use%20of%20targeted%20NGS%20to%20diagnose%20drug-resistant%20tuberculosis%20in%20high-burden%20countries%20need%20to%20be%20addressed.%20FUNDING%3A%20National%20Institutes%20of%20Allergy%20and%20Infectious%20Diseases%20and%20Swiss%20National%20Science%20Foundation.%22%2C%22date%22%3A%222024%20Oct%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2824%2900263-9%22%2C%22ISSN%22%3A%221474-4457%201473-3099%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22S5ZQS6AG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Technau%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-20%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTechnau%2C%20Karl-G%26%23xFC%3Bnter%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMaskew%2C%20Mhairi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNattey%2C%20Cornelius%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHwang%2C%20Candice%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3Bvan%20Dongen%2C%20Nicola%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Cohort%20profile%3A%20Rahima%20Moosa%20Mother%20and%20Child%20Hospital%20maternal%20HIV%20cohort%2C%20Johannesburg%2C%20South%20Africa.%20%26lt%3Bi%26gt%3BBMJ%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%20%289%29%2C%20S.%20e085082.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-085082%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-085082%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cohort%20profile%3A%20Rahima%20Moosa%20Mother%20and%20Child%20Hospital%20maternal%20HIV%20cohort%2C%20Johannesburg%2C%20South%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mhairi%22%2C%22lastName%22%3A%22Maskew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cornelius%22%2C%22lastName%22%3A%22Nattey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Candice%22%2C%22lastName%22%3A%22Hwang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22van%20Dongen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thalia%22%2C%22lastName%22%3A%22Ferreira%20Brizido%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Wise%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20Rahima%20Moosa%20Mother%20and%20Child%20Hospital%20%28RMMCH%29%20maternal%20HIV%20cohort%20originated%20from%20data%20systems%20that%20were%20developed%20to%20support%20HIV-related%20birth%20care%20and%20track%20outcomes%20of%20a%20complete%20birth%20cohort%20of%20HIV-exposed%20infants%20at%20Rahima%20Moosa%20Hospital%20and%20their%20mothers%20living%20with%20HIV.%5CnPARTICIPANTS%3A%20Supported%20by%20the%20Empilweni%20Services%20and%20Research%20Unit%2C%20maternal%20and%20infant%20data%20from%2013%5Cu2009654%20pregnant%20women%20living%20with%20HIV%20who%20delivered%20their%20infants%20%28and%20a%20subset%20also%20attended%20antenatal%20care%29%20were%20collected%20at%20RMMCH%20in%20Johannesburg%2C%20South%20Africa%20since%202013.%20Maternal%20data%20were%20collected%20using%20counsellor-administered%20interviews%20and%20the%202013-2018%20subset%20of%20this%20cohort%20was%20linked%20to%20the%20National%20Health%20Laboratory%20Services%20%28NHLS%29%20national%20HIV%20cohort-a%20longitudinal%20cohort%20of%20people%20living%20with%20HIV%20accessing%20care%20in%20the%20public%20sector%20antiretroviral%20therapy%20programme%20in%20South%20Africa%20that%20can%20observe%20national%20access%20to%20HIV%20care%20through%20laboratory%20testing%20data.%5CnFINDINGS%20TO%20DATE%3A%20Topics%20addressed%20by%20the%20cohort%20include%20antenatal%20care%20history%2C%20HIV%20treatment%20exposure%2C%20delivery%5C%2Fbirth%20management%2C%20prophylaxis%20and%20maternal%20blood%20results%20relevant%20to%20HIV%20captured%20at%20delivery.%20The%20cohort%20was%20also%20one%20of%20the%20first%20to%20describe%20implementation%20of%20early%20infant%20diagnosis%20procedures%20in%20South%20Africa%20including%20evaluations%20of%20novel%20point-of-care%20testing%20strategies%20demonstrating%20improvements%20in%20uptake%20of%20HIV%20care%20among%20infants%20accessing%20point-of-care%20services.%5CnFUTURE%20PLANS%3A%20Annual%20linkage%20of%20infant%20delivery%20and%20testing%20data%20to%20longitudinal%20laboratory%20test%20data%20in%20the%20NHLS%20national%20HIV%20cohort%20is%20planned%20to%20allow%20for%20analysis%20of%20both%20infant%20continuity%20of%20care%20outcomes%20and%20as%20well%20as%20evaluation%20of%20maternal-infant%20pair%20treatment%20and%20mobility%20outcomes%20in%20the%20post%20partum%20and%20later%20period.%22%2C%22date%22%3A%222024-09-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2024-085082%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A14%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22CTS44ZKW%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuniholm%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKuniholm%2C%20Mark%20H.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShumbusho%2C%20Fabienne%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPlaisy%2C%20Marie%20K.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20living%20with%20hiv%20in%20low-%20and%20middle-income%20countries.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004012%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20cardiovascular%20disease%20risk%20with%20liver%20steatosis%20and%20fibrosis%20in%20people%20living%20with%20hiv%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20H.%22%2C%22lastName%22%3A%22Kuniholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Shumbusho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20K.%22%2C%22lastName%22%3A%22Plaisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ephrem%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlotta%22%2C%22lastName%22%3A%22Riebensahm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%20V.%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niharika%22%2C%22lastName%22%3A%22Samala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20S.%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Chanyachukul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohidas%22%2C%22lastName%22%3A%22Borse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dung%20T.%20H.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez-Iniguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20understand%20the%20relationship%20between%20cardiovascular%20disease%20%28CVD%29%20risk%20and%20liver%20steatosis%20and%20fibrosis%20among%20people%20living%20with%20HIV%20%28PLWH%29%20%5Cu226540%5Cu200ayears%20on%20antiretroviral%20therapy%20%28ART%29%20in%20low-%20and%20middle-income%20countries%20%28LMIC%29.%5CnDESIGN%3A%20We%20used%20cross-sectional%20behavioral%20and%20clinical%20data%20collected%20during%20study%20enrollment%20visits%20in%202020-2022%20for%20the%20Sentinel%20Research%20Network%20of%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28SRN%20of%20IeDEA%29.%5CnMETHODS%3A%20Ten-year%20CVD%20risk%20was%20calculated%20using%202019%20World%20Health%20Organization%20non-laboratory%20and%20laboratory%20models.%20Transient%20elastography%20%28TE%29%20was%20used%20to%20assess%20liver%20disease.%20Presence%20of%20steatosis%20and%20significant%20fibrosis%20were%20defined%20by%20Controlled%20Attenuation%20Parameter%20%28CAP%29%20%5Cu2265248%5Cu200adB%5C%2Fm%20and%20liver%20stiffness%20measurement%20%28LSM%29%20%5Cu22657.1%5Cu200akPa%2C%20respectively.%20Participants%20with%20viral%20hepatitis%2C%20hazardous%20alcohol%20consumption%20and%20unsuppressed%20HIV%20viral%20load%20were%20excluded%20from%20the%20analysis.%20Logistic%20regression%20was%20used%20to%20estimate%20odds%20ratios%2C%20adjusting%20for%20study%20site%2C%20CD4%5Cu200aT%20cell%20count%2C%20stavudine%20and%20didanosine%20exposure%2C%20and%20in%20models%20stratified%20by%20sex%20and%20geographic%20region.%5CnRESULTS%3A%20There%20were%201%2C750%20participants%20from%20nine%20LMIC.%20Median%20CVD%20risk%20was%203%25%20for%20both%20non-laboratory%20and%20laboratory-based%20models.%20Adjusted%20odds%20ratios%20%28ORs%29%20for%20steatosis%20and%20significant%20fibrosis%20associated%20with%20laboratory%20CVD%20risk%20%28%5Cu226510%25%20vs.%20%26lt%3B5%25%29%20were%20OR%5Cu200a%3D%5Cu200a1.83%20%2895%25%20confidence%20interval%3A%28CI%29%5Cu200a%3D%5Cu200a1.21-2.76%3B%20P%5Cu200a%3D%5Cu200a0.004%29%20and%20OR%5Cu200a%3D%5Cu200a1.62%20%2895%25%20CI%5Cu200a%3D%5Cu200a0.85-3.07%3B%20P%5Cu200a%3D%5Cu200a0.14%29%2C%20respectively.%20Associations%20of%20CVD%20risk%20with%20steatosis%20were%20stronger%20in%20males%20and%20among%20participants%20at%20study%20sites%20outside%20Africa.%5CnCONCLUSIONS%3A%20Higher%20CVD%20risk%20was%20associated%20with%20steatosis%20but%20not%20with%20significant%20fibrosis%20in%20PLWH%20in%20our%20LMIC%20cohort.%22%2C%22date%22%3A%222024-09-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000004012%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-07-15T14%3A52%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22DH7Q539B%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zaniewski%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BZaniewski%2C%20Elizabeth%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSkrivankova%2C%20Veronika%20Whitesell%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAvihingsanon%2C%20Anchalee%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCardoso%2C%20Sandra%20Wagner%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Transition%20to%20dolutegravir-based%20ART%20in%2035%20low-%20and%20middle-income%20countries%3A%20a%20global%20survey%20of%20HIV%20care%20clinics.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004007%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000004007%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transition%20to%20dolutegravir-based%20ART%20in%2035%20low-%20and%20middle-income%20countries%3A%20a%20global%20survey%20of%20HIV%20care%20clinics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronika%20Whitesell%22%2C%22lastName%22%3A%22Skrivankova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henri%22%2C%22lastName%22%3A%22Chenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rossana%20A.%22%2C%22lastName%22%3A%22Ditangco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Vanes%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20George%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%20Madalitso%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20Kouassi%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20Kla%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Muleebwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjay%22%2C%22lastName%22%3A%22Mundhe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%20R.%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20Mahambou%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20M.%22%2C%22lastName%22%3A%22Obatsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%20Walter%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Supattra%22%2C%22lastName%22%3A%22Rungmaitree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%20Semwendero%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moussa%22%2C%22lastName%22%3A%22Seydi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nosisa%22%2C%22lastName%22%3A%22Sipambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tavitiya%22%2C%22lastName%22%3A%22Sudjaritruk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20We%20studied%20the%20transition%20to%20dolutegravir-containing%20antiretroviral%20therapy%20%28ART%29%20at%20HIV%20treatment%20clinics%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%5CnDESIGN%3A%20Site-level%20survey%20conducted%20in%202020-2021%20among%20HIV%20clinics%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29.%5CnMETHODS%3A%20We%20assessed%20the%20status%20of%20dolutegravir%20rollout%20and%20viral%20load%20and%20drug%20resistance%20testing%20practices%20for%20patients%20on%20ART%20switching%20to%20dolutegravir-based%20regimens.%20We%20used%20generalized%20estimating%20equations%20to%20assess%20associations%20between%20clinic%20rollout%20of%20both%20first-%20and%20second-line%20dolutegravir-based%20ART%20regimens%20%28dual%20rollout%29%20and%20site-level%20factors.%5CnRESULTS%3A%20Of%20179%20surveyed%20clinics%2C%20175%20%2898%25%29%20participated%3B%20137%20%2878%25%29%20from%20Africa%2C%2030%20%2817%25%29%20from%20the%20Asia-Pacific%2C%20and%208%20%285%25%29%20from%20Latin%20America.%20Most%20clinics%20%2880%25%29%20were%20in%20low-%20or%20lower-middle-income%20countries%2C%20and%20there%20were%20a%20mix%20of%20primary-%2C%20secondary-%20and%20tertiary-level%20clinics.%20Ninety%20percent%20reported%20rollout%20of%20first-line%20dolutegravir%2C%2059%25%20of%20second-line%2C%2094%25%20of%20first-%20or%20second-line%20and%2055%25%20of%20dual%20rollout.%20The%20adjusted%20odds%20of%20dual%20rollout%20were%20higher%20among%20tertiary-level%20%28aOR%204.00%3B%2095%25%20CI%201.39%20to%2011.47%29%20and%20secondary-level%20clinics%20%28aOR%203.66%3B%2095%25%20CI%202.19%20to%206.11%29%20than%20in%20primary-level%20clinics.%20Over%20half%20%2859%25%29%20of%20clinics%20that%20introduced%20first-%20or%20second-line%20dolutegravir-based%20ART%20required%20recent%20viral%20load%20testing%20before%20switching%20to%20dolutegravir%2C%20and%2015%25%20performed%20genotypic%20resistance%20testing%20at%20switch.%5CnCONCLUSIONS%3A%20Dolutegravir-based%20ART%20was%20rolled%20out%20at%20nearly%20all%20IeDEA%20clinics%20in%20LMICs%2C%20yet%20many%20switched%20patients%20to%20dolutegravir%20without%20recent%20viral%20load%20testing%20and%20drug%20resistance%20testing%20was%20rarely%20performed.%20Without%20such%20testing%2C%20drug%20resistance%20among%20patient%20switching%20to%20dolutegravir%20may%20go%20undetected.%22%2C%22date%22%3A%222024-09-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000004007%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A22%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22NHTU387L%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ruffieux%20et%20al.%22%2C%22parsedDate%22%3A%222024-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRuffieux%2C%20Yann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFolb%2C%20Naomi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGrimsrud%2C%20Anna%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHislop%2C%20Michael%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDunn%2C%20Liezl%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Courier%20delivery%20of%20antiretroviral%20therapy%3A%20a%20cohort%20study%20of%20a%20South%20African%20private-sector%20HIV%20programme.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%289%29%2C%20S.%20e26360.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26360%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26360%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Courier%20delivery%20of%20antiretroviral%20therapy%3A%20a%20cohort%20study%20of%20a%20South%20African%20private-sector%20HIV%20programme.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22Ruffieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Folb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Grimsrud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Hislop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liezl%22%2C%22lastName%22%3A%22Dunn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Maria%22%2C%22lastName%22%3A%22Namubiru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chido%22%2C%22lastName%22%3A%22Chinogurei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Maartens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Courier%20delivery%20has%20become%20a%20popular%20antiretroviral%20therapy%20%28ART%29%20distribution%20method%20in%20some%20HIV%20care%20settings%2C%20yet%20data%20on%20ART%20courier%20delivery%20and%20how%20it%20relates%20to%20ART%20outcomes%20are%20scarce.%20We%20studied%20the%20differences%20in%20viral%20suppression%20rates%20between%20individuals%20from%20a%20South%20African%20private%20sector%20HIV%20programme%20receiving%20ART%20by%20courier%20delivery%20and%20those%20receiving%20ART%20through%20traditional%20retail%20dispensing.%20METHODS%3A%20Individuals%20aged%2015%20years%20or%20older%20who%20were%20actively%20enrolled%20in%20the%20Aid%20for%20AIDS%20programme%20between%20January%202011%20and%20July%202022%20were%20eligible%20for%20the%20analysis.%20The%20outcome%20of%20interest%20was%20viral%20suppression%20defined%20as%20a%20viral%20load%20%28VL%29%20%26lt%3B400%20copies%20per%20ml.%20We%20calculated%20adjusted%20odds%20ratios%20%28OR%29%20for%20the%20association%20between%20the%20ART%20distribution%20method%20and%20viral%20suppression%2C%20comparing%20those%20receiving%20refills%20through%20courier%20pharmacies%20versus%20retail%20dispensing%20at%20the%20time%20of%20the%20VL%20testing.%20We%20used%20generalized%20estimating%20equations%20to%20account%20for%20repeated%20VL%20testing%20of%20the%20same%20individual.%20The%20models%20were%20adjusted%20for%20age%2C%20sex%2C%20calendar%20year%2C%20ART%20regimen%2C%20history%20of%20mental%20illness%20and%20medical%20insurance%20scheme.%20We%20computed%20adjusted%20ORs%20for%20the%20calendar%20periods%202011-2013%2C%202014-2016%2C%202017-2019%2C%202020-2022%20and%20overall.%20RESULTS%3A%20We%20extracted%20442%2C619%20VL%20measurements%20from%2068%2C720%20eligible%20individuals%2C%2039%2C406%20%2857.3%25%29%20were%20women.%20The%20median%20number%20of%20VL%20measurements%20per%20individual%20was%206%20%28IQR%203-10%29.%20VL%20suppression%20was%20detected%20in%20398%2C901%20%2890.1%25%29%20tests%2C%20and%20185%2C701%20%2842.0%25%29%20of%20the%20tests%20were%20taken%20while%20the%20individual%20was%20receiving%20ART%20by%20courier%20delivery.%20Overall%2C%20courier%20delivery%20was%20associated%20with%205%25%20higher%20odds%20of%20viral%20suppression%20than%20retail%20dispensing%20%28adjusted%20OR%201.05%2C%2095%25%20CI%201.02-1.08%29.%20The%20strength%20and%20direction%20of%20this%20association%20varied%20by%20calendar%20period%2C%20with%20an%20adjusted%20OR%20of%201.37%20%2895%25%20CI%201.27-1.48%29%20in%202011-2013%20and%201.02%20%2895%25%20CI%200.97-1.07%29%20in%202020-2022.%20CONCLUSIONS%3A%20Courier%20delivery%20of%20ART%20is%20a%20viable%20alternative%20to%20retail%20dispensing%20in%20the%20South%20African%20private%20sector%2C%20as%20it%20was%20associated%20with%20higher%20viral%20suppression%20until%202016%20and%20similar%20suppression%20rates%20in%20recent%20years.%20Further%20research%20is%20needed%20to%20investigate%20the%20potential%20benefits%20and%20drawbacks%20of%20courier%20delivery%20of%20ART%20in%20both%20private%20and%20public%20healthcare%20settings.%22%2C%22date%22%3A%222024%20Sep%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26360%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22XY975M2U%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Egger%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEgger%2C%20Matthias%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSauermann%2C%20Mamatha%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLoosli%2C%20Tom%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHossmann%2C%20Stefanie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRiedo%2C%20Selma%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20HIV-1%20subtype-specific%20drug%20resistance%20on%20dolutegravir-based%20antiretroviral%20therapy%3A%20protocol%20for%20a%20multicentre%20study%20%28DTG%20RESIST%29.%20%26lt%3Bi%26gt%3BBMJ%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20e085819.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-085819%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-085819%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV-1%20subtype-specific%20drug%20resistance%20on%20dolutegravir-based%20antiretroviral%20therapy%3A%20protocol%20for%20a%20multicentre%20study%20%28DTG%20RESIST%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mamatha%22%2C%22lastName%22%3A%22Sauermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%22%2C%22lastName%22%3A%22Loosli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Hossmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selma%22%2C%22lastName%22%3A%22Riedo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niko%22%2C%22lastName%22%3A%22Beerenwinkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Giandhari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%20D.%22%2C%22lastName%22%3A%22Kouyos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Lessells%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20HIV%20drug%20resistance%20poses%20a%20challenge%20to%20the%20United%20Nation%26%23039%3Bs%20goal%20of%20ending%20the%20HIV%5C%2FAIDS%20epidemic.%20The%20integrase%20strand%20transfer%20inhibitor%20%28InSTI%29%20dolutegravir%2C%20which%20has%20a%20higher%20resistance%20barrier%2C%20was%20endorsed%20by%20the%20WHO%20in%202019%20for%20first-line%2C%20second-line%20and%20third-line%20antiretroviral%20therapy%20%28ART%29.%20This%20multiplicity%20of%20roles%20of%20dolutegravir%20in%20ART%20may%20facilitate%20the%20emergence%20of%20dolutegravir%20resistance.%5CnMETHODS%20AND%20ANALYSIS%3A%20Nested%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%2C%20DTG%20RESIST%20is%20a%20multicentre%20study%20of%20adults%20and%20adolescents%20living%20with%20HIV%20in%20sub-Saharan%20Africa%2C%20Asia%2C%20and%20South%20and%20Central%20America%20who%20experienced%20virological%20failure%20on%20dolutegravir-based%20ART.%20At%20the%20time%20of%20virological%20failure%2C%20whole%20blood%20will%20be%20collected%20and%20processed%20to%20prepare%20plasma%20or%20dried%20blood%20spots.%20Laboratories%20in%20Durban%2C%20Mexico%20City%20and%20Bangkok%20will%20perform%20genotyping.%20Analyses%20will%20focus%20on%20%281%29%20individuals%20who%20experienced%20virological%20failure%20on%20dolutegravir%20and%20%282%29%20those%20who%20started%20or%20switched%20to%20such%20a%20regimen%20and%20were%20at%20risk%20of%20virological%20failure.%20For%20population%20%281%29%2C%20the%20outcome%20will%20be%20any%20InSTI%20drug%20resistance%20mutations%2C%20and%20for%20population%20%282%29%20virological%20failure%20is%20defined%20as%20a%20viral%20load%20%26gt%3B1000%20copies%5C%2FmL.%20Phenotypic%20testing%20will%20focus%20on%20non-B%20subtype%20viruses%20with%20major%20InSTI%20resistance%20mutations.%20Bayesian%20evolutionary%20models%20will%20explore%20and%20predict%20treatment%20failure%20genotypes.%20The%20study%20will%20have%20intermediate%20statistical%20power%20to%20detect%20differences%20in%20resistance%20mutation%20prevalence%20between%20major%20HIV-1%20subtypes%3B%20ample%20power%20to%20identify%20risk%20factors%20for%20virological%20failure%20and%20limited%20power%20for%20analysing%20factors%20associated%20with%20individual%20InSTI%20drug%20resistance%20mutations.%5CnETHICS%20AND%20DISSEMINATION%3A%20The%20research%20protocol%20was%20approved%20by%20the%20Biomedical%20Research%20Ethics%20Committee%20at%20the%20University%20of%20KwaZulu-Natal%2C%20South%20Africa%20and%20the%20Ethics%20Committee%20of%20the%20Canton%20of%20Bern%2C%20Switzerland.%20All%20sites%20participate%20in%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20and%20have%20obtained%20ethics%20approval%20from%20their%20local%20ethics%20committee%20to%20collect%20additional%20data.%5CnTRIAL%20REGISTRATION%20NUMBER%3A%20NCT06285110.%22%2C%22date%22%3A%222024-08-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2024-085819%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22ZF8VXG2C%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ruffieux%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRuffieux%2C%20Yann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFernandez%20Villalobos%2C%20Nathalie%20V.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDidden%2C%20Christiane%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHaas%2C%20Andreas%20D.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChinogurei%2C%20Chido%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Prostate%20Cancer%20Diagnosis%20Rates%20among%20Insured%20Men%20with%20and%20without%20HIV%20in%20South%20Africa%3A%20A%20Cohort%20Study.%20%26lt%3Bi%26gt%3BCancer%20Epidemiology%2C%20Biomarkers%20%26amp%3B%20Prevention%26%23x202F%3B%3A%20A%20Publication%20of%20the%20American%20Association%20for%20Cancer%20Research%2C%20Cosponsored%20by%20the%20American%20Society%20of%20Preventive%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B33%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%201057%26%23x2013%3B1064.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1055-9965.EPI-24-0137%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1055-9965.EPI-24-0137%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prostate%20Cancer%20Diagnosis%20Rates%20among%20Insured%20Men%20with%20and%20without%20HIV%20in%20South%20Africa%3A%20A%20Cohort%20Study.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22Ruffieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20V.%22%2C%22lastName%22%3A%22Fernandez%20Villalobos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christiane%22%2C%22lastName%22%3A%22Didden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chido%22%2C%22lastName%22%3A%22Chinogurei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Maartens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Folb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Several%20studies%20have%20found%20lower%20prostate%20cancer%20diagnosis%20rates%20among%20men%20with%20human%20immunodeficiency%20virus%20%28HIV%3B%20MWH%29%20than%20men%20without%20HIV%20but%20reasons%20for%20this%20finding%20remain%20unclear.%20METHODS%3A%20We%20used%20claims%20data%20from%20a%20South%20African%20private%20medical%20insurance%20scheme%20%28July%202017-%20July%202020%29%20to%20assess%20prostate%20cancer%20diagnosis%20rates%20among%20men%20aged%20%26gt%3B%5C%2F%3D%2018%20years%20with%20and%20without%20HIV.%20Using%20flexible%20parametric%20survival%20models%2C%20we%20estimated%20hazard%20ratios%20%28HR%29%20for%20the%20association%20between%20HIV%20and%20incident%20prostate%20cancer%20diagnoses.%20We%20accounted%20for%20potential%20confounding%20by%20age%2C%20population%20group%2C%20and%20sexually%20transmitted%20infections%20%28confounder-adjusted%20model%29%20and%20additionally%20for%20potential%20mediation%20by%20prostatitis%20diagnoses%2C%20prostate-specific%20antigen%20testing%2C%20and%20prostate%20biopsies%20%28fully%20adjusted%20model%29.%20RESULTS%3A%20We%20included%20288%2C194%20men%2C%20of%20whom%2020%2C074%20%287%25%29%20were%20living%20with%20HIV.%20Prostate%20cancer%20was%20diagnosed%20in%201%2C614%20men%20without%20HIV%20%28median%20age%20at%20diagnosis%3A%2067%20years%29%20and%20in%2082%20MWH%20%28median%20age%20at%20diagnosis%3A%2060%20years%29.%20In%20the%20unadjusted%20analysis%2C%20prostate%20cancer%20diagnosis%20rates%20were%2035%25%20lower%20among%20MWH%20than%20men%20without%20HIV%20%5BHR%2C%200.65%3B%2095%25%20confidence%20interval%20%28CI%29%2C%200.52-0.82%5D.%20However%2C%20this%20association%20was%20no%20longer%20evident%20in%20the%20confounder-adjusted%20model%20%28HR%2C%201.03%3B%2095%25%20CI%2C%200.82-1.30%29%20or%20in%20the%20fully%20adjusted%20model%20%28HR%2C%201.14%3B%2095%25%20CI%2C%200.91-1.44%29.%20CONCLUSIONS%3A%20When%20accounting%20for%20potential%20confounders%20and%20mediators%2C%20our%20analysis%20found%20no%20evidence%20of%20lower%20prostate%20cancer%20diagnosis%20rates%20among%20MWH%20than%20men%20without%20HIV%20in%20South%20Africa.%20IMPACT%3A%20Our%20results%20do%20not%20support%20the%20hypothesis%20that%20HIV%20decreases%20the%20risk%20of%20prostate%20cancer.%22%2C%22date%22%3A%222024%20Aug%201%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F1055-9965.EPI-24-0137%22%2C%22ISSN%22%3A%221538-7755%201055-9965%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22MK8Q7EQF%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kalk%20et%20al.%22%2C%22parsedDate%22%3A%222024-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKalk%2C%20Emma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHeekes%2C%20Alexa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLavies%2C%20Diane%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJacobs%2C%20Lizel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSpencer%2C%20Careni%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Population-based%20prevalence%20of%20congenital%20defects%20in%20a%20routine%20sentinel%20site-based%20surveillance%20system%20in%20the%20Western%20Cape%2C%20South%20Africa.%20%26lt%3Bi%26gt%3BBirth%20Defects%20Research%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B116%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20e2388.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fbdr2.2388%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fbdr2.2388%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Population-based%20prevalence%20of%20congenital%20defects%20in%20a%20routine%20sentinel%20site-based%20surveillance%20system%20in%20the%20Western%20Cape%2C%20South%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Kalk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexa%22%2C%22lastName%22%3A%22Heekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diane%22%2C%22lastName%22%3A%22Lavies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lizel%22%2C%22lastName%22%3A%22Jacobs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Careni%22%2C%22lastName%22%3A%22Spencer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%22%2C%22lastName%22%3A%22Boutall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayesha%22%2C%22lastName%22%3A%22Osman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chantal%22%2C%22lastName%22%3A%22Stewart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anika%22%2C%22lastName%22%3A%22van%20Niekerk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Fieggen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ushma%22%2C%22lastName%22%3A%22Mehta%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Lack%20of%20data%20on%20the%20burden%20and%20scope%20of%20congenital%20disorders%20%28CDs%29%20in%20South%20Africa%20undermines%20resource%20allocation%20and%20limits%20the%20ability%20to%20detect%20signals%20from%20potentially%20teratogenic%20pregnancy%20exposures.%5CnMETHODS%3A%20We%20used%20routine%20electronic%20data%20in%20the%20Western%20Cape%20Pregnancy%20Exposure%20Registry%20%28PER%29%20to%20determine%20the%20overall%20and%20individual%20prevalence%20of%20CD%20identified%20on%20neonatal%20surface%20examination%20at%20birth%20in%20the%20Western%20Cape%2C%20South%20Africa%2C%202016-2022.%20CD%20was%20confirmed%20by%20record%20review.%20The%20contribution%20of%20late%20%28%5Cu226424%5Cu2009months%29%20and%20antenatal%20diagnoses%20was%20assessed.%20We%20compared%20demographic%20and%20obstetric%20characteristics%20between%20women%20with%5C%2Fwithout%20pregnancies%20affected%20by%20CD.%5CnRESULTS%3A%20Women%20with%20a%20viable%20pregnancy%20%28%26gt%3B22%5Cu2009weeks%20gestation%3B%20birth%20weight%5Cu2009%5Cu2265%5Cu2009500%5Cu2009g%29%20%28n%5Cu2009%3D%5Cu200932%2C494%29%20were%20included.%20Of%201106%20potential%20CD%20identified%2C%2056.1%25%20were%20confirmed%20on%20folder%20review.%20When%20internal%20and%20minor%20CD%20were%20excluded%20the%20prevalence%20of%20major%20CD%20identified%20on%20surface%20examination%20at%20birth%20was%207.2%5C%2F1000%20births.%20When%20missed%5C%2Flate%20diagnoses%20on%20examination%20%2816.8%25%29%20and%20ultrasound%20%286.8%25%29%20were%20included%2C%20the%20prevalence%20was%209.2%5C%2F1000%20births%3A%208.9%5C%2F1000%20livebirths%20and%2021.5%5C%2F1000%20stillbirths.%20The%20PER%20did%20not%20detect%2021.5%25%20of%20major%20CD%20visible%20at%20birth.%20Older%20maternal%20age%20and%20diabetes%20mellitus%20were%20associated%20with%20an%20increased%20prevalence%20of%20CD.%20Women%20living%20with%5C%2Fwithout%20HIV%20%28or%20the%20timing%20of%20antiretroviral%20therapy%2C%20before%5C%2Fafter%20conception%29%2C%20hypertension%20or%20obesity%20did%20not%20significantly%20affect%20prevalence%20of%20CD.%5CnCONCLUSIONS%3A%20A%20surveillance%20system%20based%20on%20routine%20data%20successfully%20determined%20the%20prevalence%20of%20major%20CD%20identified%20on%20surface%20examination%20at%20birth%20at%20rates%20slightly%20higher%20than%20in%20equivalent%20studies.%20Overall%20rates%2C%20modeled%20at%20~2%25%2C%20are%20likely%20underestimated.%20Strengthening%20routine%20neonatal%20examination%20and%20clinical%20record-keeping%20could%20improve%20CD%20ascertainment.%22%2C%22date%22%3A%222024-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fbdr2.2388%22%2C%22ISSN%22%3A%222472-1727%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-20T13%3A02%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22SIYFL2NM%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nyakato%20et%20al.%22%2C%22parsedDate%22%3A%222024-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNyakato%2C%20Patience%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSchomaker%2C%20Michael%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBoulle%2C%20Andrew%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEuvrard%2C%20Jonathan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWood%2C%20Robin%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Correcting%20mortality%20estimates%20among%20children%20and%20youth%20on%20antiretroviral%20therapy%20in%20southern%20Africa%3A%20A%20comparative%20analysis%20between%20a%20multi-country%20tracing%20study%20and%20linkage%20to%20a%20health%20information%20exchange.%20%26lt%3Bi%26gt%3BTropical%20Medicine%20%26amp%3B%20International%20Health%3A%20TM%20%26amp%3B%20IH%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B29%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20739%26%23x2013%3B751.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Ftmi.14030%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Ftmi.14030%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Correcting%20mortality%20estimates%20among%20children%20and%20youth%20on%20antiretroviral%20therapy%20in%20southern%20Africa%3A%20A%20comparative%20analysis%20between%20a%20multi-country%20tracing%20study%20and%20linkage%20to%20a%20health%20information%20exchange%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patience%22%2C%22lastName%22%3A%22Nyakato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Schomaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benedikt%22%2C%22lastName%22%3A%22Christ%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irene%22%2C%22lastName%22%3A%22Ayakaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Idiovino%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%20B.%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monique%22%2C%22lastName%22%3A%22van%20Lettow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Safari%22%2C%22lastName%22%3A%22Mbewe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20The%20objective%20of%20this%20study%20is%20to%20assess%20the%20outcomes%20of%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%20reported%20as%20lost%20to%20follow-up%2C%20correct%20mortality%20estimates%20for%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%20for%20unascertained%20outcomes%20in%20those%20loss%20to%20follow-up%20%28LTFU%29%20based%20on%20tracing%20and%20linkage%20data%20separately%20using%20data%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20in%20Southern%20Africa.%5CnMETHODS%3A%20We%20included%20data%20from%20two%20different%20populations%20of%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%3B%20%281%29%20clinical%20data%20from%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%20aged%20%5Cu226424%5Cu2009years%20from%20Lesotho%2C%20Malawi%2C%20Mozambique%2C%20Zambia%20and%20Zimbabwe%3B%20%282%29%20clinical%20data%20from%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%20aged%20%5Cu226414%5Cu2009years%20from%20the%20Western%20Cape%20%28WC%29%20in%20South%20Africa.%20Outcomes%20of%20patients%20lost%20to%20follow-up%20were%20available%20from%20%281%29%20a%20tracing%20study%20and%20%282%29%20linkage%20to%20a%20health%20information%20exchange.%20For%20both%20populations%2C%20we%20compared%20six%20methods%20for%20correcting%20mortality%20estimates%20for%20all%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV.%5CnRESULTS%3A%20We%20found%20substantial%20variations%20of%20mortality%20estimates%20among%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%20reported%20as%20lost%20to%20follow-up%20versus%20those%20retained%20in%20care.%20Ascertained%20mortality%20was%20higher%20among%20lost%20and%20traceable%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%20and%20lower%20among%20lost%20and%20linkable%20than%20those%20retained%20in%20care%20%28mortality%3A%2013.4%25%20%5Btraced%5D%20vs.%2012.6%25%20%5Bretained-other%20Southern%20Africa%20countries%5D%3B%203.4%25%20%5Blinked%5D%20vs.%209.4%25%20%5Bretained-WC%5D%29.%20A%20high%20proportion%20of%20lost%20to%20follow-up%20children%2C%20adolescents%20and%20young%20adults%20with%20HIV%20had%20self-transferred%20%2821.0%25%20and%2047.0%25%29%20in%20the%20traced%20and%20linked%20samples%2C%20respectively.%20The%20uncorrected%20method%20of%20non-informative%20censoring%20yielded%20the%20lowest%20mortality%20estimates%20among%20all%20methods%20for%20both%20tracing%20%286.0%25%29%20and%20linkage%20%284.0%25%29%20approaches%20at%202%5Cu2009years%20from%20ART%20start.%20Among%20corrected%20methods%20using%20ascertained%20data%2C%20multiple%20imputation%2C%20incorporating%20ascertained%20data%20%28MI%28asc.%29%29%20and%20inverse%20probability%20weighting%20with%20logistic%20weights%20were%20most%20robust%20for%20the%20tracing%20approach.%20In%20contrast%2C%20for%20the%20linkage%20approach%2C%20MI%28asc.%29%20was%20the%20most%20robust.%5CnCONCLUSIONS%3A%20Our%20findings%20emphasise%20that%20lost%20to%20follow-up%20is%20non-ignorable%20and%20both%20tracing%20and%20linkage%20improved%20outcome%20ascertainment%3A%20tracing%20identified%20substantial%20mortality%20in%20those%20reported%20as%20lost%20to%20follow-up%2C%20whereas%20linkage%20did%20not%20identify%20out-of-facility%20deaths%2C%20but%20showed%20that%20a%20large%20proportion%20of%20those%20reported%20as%20lost%20to%20follow-up%20were%20self-transfers.%22%2C%22date%22%3A%222024-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Ftmi.14030%22%2C%22ISSN%22%3A%221365-3156%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22P55LJZFF%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Beer%20et%20al.%22%2C%22parsedDate%22%3A%222024-07-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3Bde%20Beer%2C%20Shani%20T.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavies%2C%20Mary-Ann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPhelanyane%2C%20Florence%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJones%2C%20Hayley%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BIngle%2C%20Suzanne%20M.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20Retrospective%20Implementation%20of%20Standardized%20In%20Utero%20HIV%20Exposure%20Definitions%20Using%20Routinely%20Collected%20Public%20Sector%20Data%20Across%20the%20Western%20Cape%20Province%2C%20South%20Africa.%20%26lt%3Bi%26gt%3BThe%20Pediatric%20Infectious%20Disease%20Journal%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004486%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004486%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Retrospective%20Implementation%20of%20Standardized%20In%20Utero%20HIV%20Exposure%20Definitions%20Using%20Routinely%20Collected%20Public%20Sector%20Data%20Across%20the%20Western%20Cape%20Province%2C%20South%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shani%20T.%22%2C%22lastName%22%3A%22de%20Beer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Phelanyane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hayley%20E.%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%20M.%22%2C%22lastName%22%3A%22Ingle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20S.%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexa%22%2C%22lastName%22%3A%22Heekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Kalk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Mendelsohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20L.%22%2C%22lastName%22%3A%22Slogrove%22%7D%5D%2C%22abstractNote%22%3A%22Using%20the%20Data%20Evaluation%20and%20Preparation%20for%20HIV-Exposed%20Uninfected%20Child%20Cohorts%20project%26%23039%3Bs%20standardized%20child%20HIV%20exposure%20definitions%2C%2064%25%2C%2064%25%20and%2090%25%20of%20children%20exposed%20to%20HIV%20in%20utero%20could%20be%20classified%20as%20HIV-uninfected%20with%20moderate%20or%20high%20certainty%20at%20the%20ages%20of%201%20and%203%20years%20and%20at%20the%20time%20of%20first%20infectious%20disease%20hospitalization%2C%20respectively.%20These%20definitions%20can%20be%20applied%20retrospectively%20to%20routine%20datasets%20with%20linked%20mother-child%20data.%22%2C%22date%22%3A%222024-07-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FINF.0000000000004486%22%2C%22ISSN%22%3A%221532-0987%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-20T13%3A04%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22DT22IEUB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moolla%20et%20al.%22%2C%22parsedDate%22%3A%222024-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMoolla%2C%20Haroon%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavies%2C%20Mary-Ann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavies%2C%20Claire%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEuvrard%2C%20Jonathan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BProzesky%2C%20Hans%20W.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20effect%20of%20care%20interruptions%20on%20mortality%20in%20adults%20resuming%20antiretroviral%20therapy.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B38%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%201198%26%23x2013%3B1205.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003859%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003859%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20effect%20of%20care%20interruptions%20on%20mortality%20in%20adults%20resuming%20antiretroviral%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haroon%22%2C%22lastName%22%3A%22Moolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%20W.%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20P.%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Orrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Per%22%2C%22lastName%22%3A%22Von%20Groote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20F.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20Southern%20Africa%20%28IeDEA-SA%29%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20estimate%20the%20relative%20rate%20of%20all-cause%20mortality%20amongst%20those%20on%20antiretroviral%20treatment%20%28ART%29%20with%20a%20history%20of%20interruptions%20compared%20with%20those%20with%20no%20previous%20interruptions%20in%20care.%5CnDESIGN%3A%20Retrospective%20cohort%20study.%5CnMETHODS%3A%20We%20used%20data%20from%20four%20South%20African%20cohorts%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20Southern%20Africa%20collaboration.%20We%20included%20adults%20who%20started%20ART%20between%202004%20and%202019.%20We%20defined%20a%20care%20interruption%20as%20a%20gap%20in%20contact%20longer%20than%20180%5Cu200adays.%20Observation%20time%20prior%20to%20interruption%20was%20allocated%20to%20a%20%26%23039%3Bno%20interruption%26%23039%3B%20group.%20Observation%20time%20after%20interruption%20was%20allocated%20to%20one%20of%20two%20groups%20based%20on%20whether%20the%20first%20interruption%20started%20before%206%5Cu200amonths%20of%20ART%20%28%26%23039%3Bearly%20interruption%26%23039%3B%29%20or%20later%20%28%26%23039%3Blate%20interruption%26%23039%3B%29.%20We%20used%20Cox%20regression%20to%20estimate%20hazard%20ratios.%5CnRESULTS%3A%20Sixty-three%20thousand%20six%20hundred%20and%20ninety-two%20participants%20contributed%20162%5Cu200a916%20person-years%20of%20observation.%20There%20were%203469%20deaths.%20Most%20participants%20were%20female%20individuals%20%2867.4%25%29%20and%20the%20median%20age%20at%20ART%20initiation%20was%2033.3%5Cu200ayears%20%28interquartile%20range%3A%2027.5-40.7%29.%20Seventeen%20thousand%20and%20eleven%20%2826.7%25%29%20participants%20experienced%20care%20interruptions.%20Those%20resuming%20ART%20experienced%20increased%20mortality%20compared%20with%20those%20with%20no%20interruptions%3A%20early%20interrupters%20had%20a%20hazard%20ratio%20of%204.37%20%2895%25%20confidence%20interval%20%28CI%29%203.87-4.95%29%20and%20late%20interrupters%20had%20a%20hazard%20ratio%20of%202.74%20%2895%25%20CI%202.39-3.15%29.%20In%20sensitivity%20analyses%2C%20effect%20sizes%20were%20found%20to%20be%20proportional%20to%20the%20length%20of%20time%20used%20to%20define%20interruptions.%5CnCONCLUSION%3A%20Our%20findings%20highlight%20the%20need%20to%20improve%20retention%20in%20care%2C%20regardless%20of%20treatment%20duration.%20Programmes%20to%20encourage%20return%20to%20care%20also%20need%20to%20be%20strengthened.%22%2C%22date%22%3A%222024-07-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000003859%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22UBNXS76T%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Asangbeh-Kerman%20et%20al.%22%2C%22parsedDate%22%3A%222024-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAsangbeh-Kerman%2C%20Serra%20Lem%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavidovi%26%23x107%3B%2C%20Ma%26%23x161%3Ba%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTaghavi%2C%20Katayoun%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDhokotera%2C%20Tafadzwa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BManasyan%2C%20Albert%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Cervical%20cancer%20prevention%20and%20care%20in%20HIV%20clinics%20across%20sub-Saharan%20Africa%3A%20results%20of%20a%20facility-based%20survey.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%287%29%2C%20S.%20e26303.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26303%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26303%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cervical%20cancer%20prevention%20and%20care%20in%20HIV%20clinics%20across%20sub-Saharan%20Africa%3A%20results%20of%20a%20facility-based%20survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serra%20Lem%22%2C%22lastName%22%3A%22Asangbeh-Kerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ma%5Cu0161a%22%2C%22lastName%22%3A%22Davidovi%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katayoun%22%2C%22lastName%22%3A%22Taghavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tafadzwa%22%2C%22lastName%22%3A%22Dhokotera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Manasyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjali%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannock%22%2C%22lastName%22%3A%22Tweya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josephine%22%2C%22lastName%22%3A%22Muhairwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-Gunter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marielle%22%2C%22lastName%22%3A%22Jousse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omenge%22%2C%22lastName%22%3A%22Orang%27o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Bosomprah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Pierre%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Partha%22%2C%22lastName%22%3A%22Basu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20To%20eliminate%20cervical%20cancer%20%28CC%29%2C%20access%20to%20and%20quality%20of%20prevention%20and%20care%20services%20must%20be%20monitored%2C%20particularly%20for%20women%20living%20with%20HIV%20%28WLHIV%29.%20We%20assessed%20implementation%20practices%20in%20HIV%20clinics%20across%20sub-Saharan%20Africa%20%28SSA%29%20to%20identify%20gaps%20in%20the%20care%20cascade%20and%20used%20aggregated%20patient%20data%20to%20populate%20cascades%20for%20WLHIV%20attending%20HIV%20clinics.%5CnMETHODS%3A%20Our%20facility-based%20survey%20was%20administered%20between%20November%202020%20and%20July%202021%20in%2030%20HIV%20clinics%20across%20SSA%20that%20participate%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20We%20performed%20a%20qualitative%20site-level%20assessment%20of%20CC%20prevention%20and%20care%20services%20and%20analysed%20data%20from%20routine%20care%20of%20WLHIV%20in%20SSA.%5CnRESULTS%3A%20Human%20papillomavirus%20%28HPV%29%20vaccination%20was%20offered%20in%2033%25%20of%20sites.%20Referral%20for%20CC%20diagnosis%20%2842%25%29%20and%20treatment%20%2870%25%29%20was%20common%2C%20but%20not%20free%20at%20about%2050%25%20of%20sites.%20Most%20sites%20had%20electronic%20health%20information%20systems%20%2890%25%29%2C%20but%20data%20to%20inform%20indicators%20to%20monitor%20global%20targets%20for%20CC%20elimination%20in%20WLHIV%20were%20not%20routinely%20collected%20in%20these%20sites.%20Data%20were%20collected%20routinely%20in%20only%2036%25%20of%20sites%20that%20offered%20HPV%20vaccination%2C%2033%25%20of%20sites%20that%20offered%20cervical%20screening%20and%2020%25%20of%20sites%20that%20offered%20pre-cancer%20and%20CC%20treatment.%5CnCONCLUSIONS%3A%20Though%20CC%20prevention%20and%20care%20services%20have%20long%20been%20available%20in%20some%20HIV%20clinics%20across%20SSA%2C%20patient%20and%20programme%20monitoring%20need%20to%20be%20improved.%20Countries%20should%20consider%20leveraging%20their%20existing%20health%20information%20systems%20and%20use%20monitoring%20tools%20provided%20by%20the%20World%20Health%20Organization%20to%20improve%20CC%20prevention%20programmes%20and%20access%2C%20and%20to%20track%20their%20progress%20towards%20the%20goal%20of%20eliminating%20CC.%22%2C%22date%22%3A%222024-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26303%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22FCJ7ZZGT%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jacobs%20et%20al.%22%2C%22parsedDate%22%3A%222024-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJacobs%2C%20T.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMorden%2C%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSmith%2C%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3Bvon%20Delft%2C%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKassanjee%2C%20R.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Severe%20outcomes%20among%20adults%20with%20TB%20during%20COVID-19.%20%26lt%3Bi%26gt%3BIJTLD%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B1%26lt%3B%5C%2Fi%26gt%3B%20%287%29%2C%20S.%20292%26%23x2013%3B298.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtldopen.24.0220%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtldopen.24.0220%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Severe%20outcomes%20among%20adults%20with%20TB%20during%20COVID-19.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Jacobs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Morden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22von%20Delft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Mudaly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.-A.%22%2C%22lastName%22%3A%22Davies%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20COVID-19%20pandemic%20prompted%20strict%20public%20health%20measures%20to%20reduce%20SARS-CoV-2%20transmission%2C%20potentially%20interrupting%20TB%20programmes%20in%20the%20Western%20Cape%2C%20South%20Africa.%20METHODS%3A%20We%20conducted%20a%20retrospective%20cohort%20study%2C%20estimating%20changes%20in%20new%20TB%20case%20rates%20and%20risk%20of%20death%20during%20TB-specific%20admissions%20within%206%20months%20of%20TB%20first%20evidence%2C%20during%20the%20pre-pandemic%20%281%20January%202019-26%20March%202020%29%20and%20after%20the%20implementation%20of%20public%20health%20and%20social%20measures%20%28PHSM%29%20periods%20%2826%20March%202020-30%20September%202021%29%2C%20based%20on%20PHSM%20strictness.%20We%20used%20interrupted%20time%20series%20and%20logistic%20regression%20models%20to%20adjust%20for%20key%20characteristics.%20RESULTS%3A%20We%20found%20an%20average%2022%25%20reduction%20%2895%25%20CI%2019-25%29%20in%20monthly%20TB%20cases%20during%20the%20entire%20PHSM%20implementation%20period.%20Additionally%2C%20the%20risk%20of%20death%20during%20TB-specific%20admissions%20increased%2C%20with%20the%20adjusted%20odds%20ratio%20ranging%20across%20PHSM%20levels%20from%201.36%20%2895%25%20CI%201.17-1.57%29%20on%20Level%201%20to%201.44%20%2895%25%20CI%201.16-1.79%29%20on%20Level%202%20compared%20with%20the%20pre-pandemic%20period.%20CONCLUSIONS%3A%20There%20was%20a%20decline%20in%20the%20number%20of%20diagnosed%20TB%20cases%20and%20an%20increased%20risk%20of%20severe%20outcomes%20from%2026%20March%202020%20to%2030%20September%202021%20in%20the%20Western%20Cape.%20TB%20programme%20recovery%20strategies%20must%20be%20prioritised%2C%20and%20TB%20management%20programmes%20must%20be%20integrated%20into%20future%20pandemic%20responses.%22%2C%22date%22%3A%222024%20Jul%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtldopen.24.0220%22%2C%22ISSN%22%3A%223005-7590%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%225LPDHUNH%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Siedentop%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-28%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSiedentop%2C%20Berit%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKachalov%2C%20Viacheslav%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWitzany%2C%20Christopher%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEgger%2C%20Matthias%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKouyos%2C%20Roger%20D.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20effect%20of%20combining%20antibiotics%20on%20resistance%3A%20A%20systematic%20review%20and%20meta-analysis.%20%26lt%3Bi%26gt%3BmedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202023.07.10.23292374.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2023.07.10.23292374%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2023.07.10.23292374%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20effect%20of%20combining%20antibiotics%20on%20resistance%3A%20A%20systematic%20review%20and%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Siedentop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viacheslav%20N.%22%2C%22lastName%22%3A%22Kachalov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Witzany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%20D.%22%2C%22lastName%22%3A%22Kouyos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Bonhoeffer%22%7D%5D%2C%22abstractNote%22%3A%22When%20and%20under%20which%20conditions%20antibiotic%20combination%20therapy%20decelerates%20rather%20than%20accelerates%20resistance%20evolution%20is%20not%20well%20understood.%20We%20examined%20the%20effect%20of%20combining%20antibiotics%20on%20within-patient%20resistance%20development%20across%20various%20bacterial%20pathogens%20and%20antibiotics.%20We%20searched%20CENTRAL%2C%20EMBASE%20and%20PubMed%20for%20%28quasi%29-randomised%20controlled%20trials%20%28RCTs%29%20published%20from%20database%20inception%20to%20November%2024th%2C%202022.%20Trials%20comparing%20antibiotic%20treatments%20with%20different%20numbers%20of%20antibiotics%20were%20included.%20A%20patient%20was%20considered%20to%20have%20acquired%20resistance%20if%2C%20at%20the%20follow-up%20culture%2C%20a%20resistant%20bacterium%20%28as%20defined%20by%20the%20study%20authors%29%20was%20detected%20that%20had%20not%20been%20present%20in%20the%20baseline%20culture.%20We%20combined%20results%20using%20a%20random%20effects%20model%20and%20performed%20meta-regression%20and%20stratified%20analyses.%20The%20trials%26%23039%3B%20risk%20of%20bias%20was%20assessed%20with%20the%20Cochrane%20tool.%2042%20trials%20were%20eligible%20and%2029%2C%20including%205054%20patients%2C%20were%20qualified%20for%20statistical%20analysis.%20In%20most%20trials%2C%20resistance%20development%20was%20not%20the%20primary%20outcome%20and%20studies%20lacked%20power.%20The%20combined%20odds%20ratio%20%28OR%29%20for%20the%20acquisition%20of%20resistance%20comparing%20the%20group%20with%20the%20higher%20number%20of%20antibiotics%20with%20the%20comparison%20group%20was%201.23%20%2895%25%20CI%200.68-2.25%29%2C%20with%20substantial%20between-study%20heterogeneity%20%28I%202%20%3D77%25%29.%20We%20identified%20tentative%20evidence%20for%20potential%20beneficial%20or%20detrimental%20effects%20of%20antibiotic%20combination%20therapy%20for%20specific%20pathogens%20or%20medical%20conditions.%20The%20evidence%20for%20combining%20a%20higher%20number%20of%20antibiotics%20compared%20to%20fewer%20from%20RCTs%20is%20scarce%20and%20overall%2C%20is%20compatible%20with%20both%20benefit%20or%20harm.%20Trials%20powered%20to%20detect%20differences%20in%20resistance%20development%20or%20well-designed%20observational%20studies%20are%20required%20to%20clarify%20the%20impact%20of%20combination%20therapy%20on%20resistance.%22%2C%22date%22%3A%222024-06-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1101%5C%2F2023.07.10.23292374%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A16%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22VNPED45I%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shafi%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShafi%2C%20Jenine%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVirk%2C%20Maneet%20K.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKalk%2C%20Emma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCarlucci%2C%20James%20G.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChepkemoi%2C%20Audrey%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Pharmacovigilance%20in%20Pregnancy%20Studies%2C%20Exposures%20and%20Outcomes%20Ascertainment%2C%20and%20Findings%20from%20Low-%20and%20Middle-Income%20Countries%3A%20A%20Scoping%20Review.%20%26lt%3Bi%26gt%3BDrug%20Safety%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs40264-024-01445-1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs40264-024-01445-1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pharmacovigilance%20in%20Pregnancy%20Studies%2C%20Exposures%20and%20Outcomes%20Ascertainment%2C%20and%20Findings%20from%20Low-%20and%20Middle-Income%20Countries%3A%20A%20Scoping%20Review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenine%22%2C%22lastName%22%3A%22Shafi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maneet%20K.%22%2C%22lastName%22%3A%22Virk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Kalk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20G.%22%2C%22lastName%22%3A%22Carlucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Chepkemoi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20S.%22%2C%22lastName%22%3A%22McHenry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edwin%22%2C%22lastName%22%3A%22Were%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ushma%20C.%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rena%20C.%22%2C%22lastName%22%3A%22Patel%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Pharmacovigilance%20%28PV%29%2C%20or%20the%20ongoing%20safety%20monitoring%20after%20a%20medication%20has%20been%20licensed%2C%20plays%20a%20crucial%20role%20in%20pregnancy%2C%20as%20clinical%20trials%20often%20exclude%20pregnant%20people.%20It%20is%20important%20to%20understand%20how%20pregnancy%20PV%20projects%20operate%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%2C%20where%20there%20is%20a%20disproportionate%20lack%20of%20PV%20data%20yet%20a%5Cu00a0high%20burden%20of%20adverse%20pregnancy%20outcomes.%20We%20conducted%20a%20scoping%20review%20to%20assess%20how%20exposures%20and%20outcomes%20were%20measured%20in%20recently%20published%20pregnancy%20PV%20projects%20in%20LMICs.%5CnMETHODS%3A%20We%20utilized%20a%20search%20string%2C%20secondary%20review%2C%20and%20team%20knowledge%20to%20review%20publications%20focusing%20on%20therapeutic%20or%20vaccine%20exposures%20among%20pregnant%20people%20in%20LMICs.%20We%20screened%20abstracts%20for%20relevance%20before%20conducting%20a%20full%20text%20review%2C%20and%20documented%20measurements%20of%20exposures%20and%20outcomes%20%28categorized%20as%20maternal%2C%20birth%2C%20or%20neonatal%5C%2Finfant%29%20among%20other%20factors%2C%20including%20study%20topic%2C%20setting%2C%20and%20design%2C%20comparator%20groups%2C%20and%20funding%20sources.%5CnRESULTS%3A%20We%20identified%2031%20PV%20publications%20spanning%20at%20least%2024%20LMICs%2C%20all%20focusing%20on%20therapeutics%20or%20vaccines%20for%20infectious%20diseases%2C%20including%20HIV%20%28n%20%3D%2017%29%2C%20tuberculosis%20%28TB%3B%20n%20%3D%209%29%2C%20malaria%20%28n%20%3D%207%29%2C%20pertussis%2C%20tetanus%2C%20and%20diphtheria%20%28n%20%3D%201%29%2C%20and%20influenza%20%28n%20%3D%203%29.%20As%20for%20outcomes%2C%20n%20%3D%2015%2C%20n%20%3D%2031%2C%20and%20n%20%3D%2020%20of%20the%20publications%20covered%20maternal%2C%20birth%2C%20and%20neonatal%5C%2Finfant%20outcomes%2C%20respectively.%20Among%20HIV-specific%20publications%2C%20the%20primary%20exposure-outcome%20relationship%20of%20focus%20was%20exposure%20to%20maternal%20antiretroviral%20therapy%20and%20adverse%20outcomes.%20For%20TB-specific%20publications%2C%20the%20main%20exposures%20of%20interest%20were%20second-line%20drug-resistant%20TB%20and%20isoniazid-based%20prevention%20therapeutics%20for%20pregnant%20people%20living%20with%20HIV.%20For%20malaria-specific%20publications%2C%20the%20primary%20exposure-outcome%20relationship%20of%20interest%20was%20antimalarial%20medication%20exposure%20during%20pregnancy%20and%20adverse%20outcomes.%20Among%20vaccine-focused%20publications%2C%20the%20exposure%20was%20assessed%20during%20a%20specific%20time%20during%20pregnancy%2C%20with%20an%20overall%20interest%20in%20vaccine%20safety%20and%5C%2For%20efficacy.%20The%20study%20settings%20were%20frequently%20from%20Africa%2C%20designs%20varied%20from%20cohort%20or%20cross-sectional%20studies%20to%20clinical%20trials%2C%20and%20funding%20sources%20were%20largely%20from%20high-income%20countries.%5CnCONCLUSION%3A%20The%20published%20pregnancy%20PV%20projects%20were%20largely%20centered%20in%20Africa%20and%20concerned%20with%20infectious%20diseases.%20This%20may%20reflect%20the%20disease%20burden%20in%20LMICs%20but%20also%20funding%20priorities%20from%20high-income%20countries.%20As%20the%20prevalence%20of%20non-communicable%20diseases%20increases%20in%20LMICs%2C%20PV%20projects%20will%20have%20to%20broaden%20their%20scope.%20Birth%20and%20neonatal%5C%2Finfant%20outcomes%20were%20most%20reported%2C%20with%20fewer%20reporting%20on%20maternal%20outcomes%20and%20none%20on%20longer-term%20child%20outcomes%3B%20additionally%2C%20heterogeneity%20existed%20in%20definitions%20and%20ascertainment%20of%20specific%20measures.%20Notably%2C%20almost%20all%20projects%20covered%20a%20single%20therapeutic%20exposure%2C%20missing%20an%20opportunity%20to%20leverage%20their%20projects%20to%20cover%20additional%20exposures%2C%20add%20scientific%20rigor%2C%20create%20uniformity%20across%20health%20services%2C%20and%20bolster%20existing%20health%20systems.%20For%20many%20publications%2C%20the%20timing%20of%20exposure%2C%20specifically%20by%20trimester%2C%20was%20crucial%20to%20maternal%20and%20neonatal%20safety.%20While%20currently%20published%20pregnancy%20PV%20literature%20offer%20insights%20into%20the%20PV%20landscape%20in%20LMICs%2C%20further%20work%20is%20needed%20to%20standardize%20definitions%20and%20measurements%2C%20integrate%20PV%20projects%20across%20health%20services%2C%20and%20establish%20longer-term%20monitoring.%22%2C%22date%22%3A%222024-06-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs40264-024-01445-1%22%2C%22ISSN%22%3A%221179-1942%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222025-03-12T10%3A13%3A33Z%22%7D%7D%2C%7B%22key%22%3A%227VDXV6JE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rossouw%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRossouw%2C%20Laura%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNgcobo%2C%20Nkosinathi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BClouse%2C%20Kate%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNattey%2C%20Cornelius%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTechnau%2C%20Karl-G%26%23xFC%3Bnter%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Augmenting%20maternal%20clinical%20cohort%20data%20with%20administrative%20laboratory%20dataset%20linkages%3A%20a%20validation%20study.%20%26lt%3Bi%26gt%3BmedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202024.06.19.24309149.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.06.19.24309149%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.06.19.24309149%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Augmenting%20maternal%20clinical%20cohort%20data%20with%20administrative%20laboratory%20dataset%20linkages%3A%20a%20validation%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Rossouw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nkosinathi%22%2C%22lastName%22%3A%22Ngcobo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Clouse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cornelius%22%2C%22lastName%22%3A%22Nattey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mhairi%22%2C%22lastName%22%3A%22Maskew%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20use%20of%20big%20data%20and%20large%20language%20models%20in%20healthcare%20can%20play%20a%20key%20role%20in%20improving%20patient%20treatment%20and%20healthcare%20management%2C%20especially%20when%20applied%20to%20large-scale%20administrative%20data.%20A%20major%20challenge%20to%20achieving%20this%20is%20ensuring%20that%20patient%20confidentiality%20and%20personal%20information%20is%20protected.%20One%20way%20to%20overcome%20this%20is%20by%20augmenting%20clinical%20data%20with%20administrative%20laboratory%20dataset%20linkages%20in%20order%20to%20avoid%20the%20use%20of%20demographic%20information.%5CnMETHODS%3A%20We%20explored%20an%20alternative%20method%20to%20examine%20patient%20files%20from%20a%20large%20administrative%20dataset%20in%20South%20Africa%20%28the%20National%20Health%20Laboratory%20Services%2C%20or%20NHLS%29%2C%20by%20linking%20external%20data%20to%20the%20NHLS%20database%20using%20specimen%20barcodes%20associated%20with%20laboratory%20tests.%20This%20offers%20us%20with%20a%20deterministic%20way%20of%20performing%20data%20linkages%20without%20accessing%20demographic%20information.%20In%20this%20paper%2C%20we%20quantify%20the%20performance%20metrics%20of%20this%20approach.%5CnRESULTS%3A%20The%20linkage%20of%20the%20large%20NHLS%20data%20to%20external%20hospital%20data%20using%20specimen%20barcodes%20achieved%20a%2095%25%20success.%20Out%20of%20the%201200%20records%20in%20the%20validation%20sample%2C%2087%25%20were%20exact%20matches%20and%209%25%20were%20matches%20with%20typographic%20correction.%20The%20remaining%205%25%20were%20either%20complete%20mismatches%20or%20were%20due%20to%20duplicates%20in%20the%20administrative%20data.%5CnCONCLUSIONS%3A%20The%20high%20success%20rate%20indicates%20the%20reliability%20of%20using%20barcodes%20for%20linking%20data%20without%20demographic%20identifiers.%20Specimen%20barcodes%20are%20an%20effective%20tool%20for%20deterministic%20linking%20in%20health%20data%2C%20and%20may%20provide%20a%20method%20of%20creating%20large%2C%20linked%20data%20sets%20without%20compromising%20patient%20confidentiality.%22%2C%22date%22%3A%222024-06-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.06.19.24309149%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A22%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22QF8IHYPK%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vinikoor%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BVinikoor%2C%20Michael%20J.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHamusonde%2C%20Kalongo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMuula%2C%20Guy%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAsombang%2C%20Mah%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRiebensahm%2C%20Carlotta%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Long-term%20Hepatitis%20B%20and%20Liver%20Outcomes%20Among%20Adults%20Taking%20Tenofovir-Containing%20Antiretroviral%20Therapy%20for%20HBV%5C%2FHIV%20Coinfection%20in%20Zambia.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B78%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%201583%26%23x2013%3B1590.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciad654%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciad654%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-term%20Hepatitis%20B%20and%20Liver%20Outcomes%20Among%20Adults%20Taking%20Tenofovir-Containing%20Antiretroviral%20Therapy%20for%20HBV%5C%2FHIV%20Coinfection%20in%20Zambia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Vinikoor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kalongo%22%2C%22lastName%22%3A%22Hamusonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mah%22%2C%22lastName%22%3A%22Asombang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlotta%22%2C%22lastName%22%3A%22Riebensahm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Chitundu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronica%22%2C%22lastName%22%3A%22Sunkuntu-Sichizya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debika%22%2C%22lastName%22%3A%22Bhattacharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edford%22%2C%22lastName%22%3A%22Sinkala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georg%22%2C%22lastName%22%3A%22Lauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wilson%22%2C%22lastName%22%3A%22Mbewe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Bosomprah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Long-term%20outcomes%20of%20tenofovir-containing%20antiretroviral%20therapy%20%28ART%29%20for%20hepatitis%20B%20virus%20%28HBV%29%5C%2Fhuman%20immunodeficiency%20virus%20%28HIV%29%20coinfection%20were%20evaluated%20in%20Zambia.%5CnMETHODS%3A%20A%20prospective%20cohort%20of%20adults%20with%20HIV%20and%20hepatitis%20B%20surface%20antigen%20%28HBsAg%29-positivity%20was%20enrolled%20at%20ART%20initiation.%20On%20tenofovir-containing%20ART%2C%20we%20ascertained%20HBV%20viral%20load%20%28VL%29%20non-suppression%2C%20alanine%20aminotransferase%20%28ALT%29%20elevation%2C%20serologic%20end-points%2C%20progression%20of%20liver%20fibrosis%20based%20on%20elastography%2C%20and%20hepatocellular%20carcinoma%20%28HCC%29%20incidence.%20We%20also%20described%20a%20subgroup%20%28low%20HBV%20VL%20and%20no%5C%2Fminimal%20fibrosis%20at%20baseline%29%20that%2C%20under%20current%20international%20guidelines%2C%20would%20not%20have%20been%20treated%20in%20the%20absence%20of%20their%20HIV%20infection.%5CnRESULTS%3A%20Among%20289%20participants%20at%20ART%20start%2C%20median%20age%20was%2034%20years%2C%2040.1%25%20were%20women%2C%20median%20CD4%20count%20was%20191%20cells%5C%2Fmm3%2C%2044.2%25%20were%20hepatitis%20B%20e%20antigen-positive%2C%20and%2028.4%25%20had%20liver%20fibrosis%5C%2Fcirrhosis.%20Over%20median%205.91%20years%20of%20ART%2C%2013.6%25%20developed%20HBV%20viral%20non-suppression%2C%20which%20was%20associated%20with%20advanced%20HIV%20disease.%20ALT%20elevation%20on%20ART%20was%20linked%20with%20HBV%20VL%20non-suppression.%20Regression%20of%20fibrosis%20and%20cirrhosis%20were%20common%2C%20progression%20to%20cirrhosis%20was%20absent%2C%20and%20no%20cases%20of%20HCC%20were%20ascertained.%20HBsAg%20seroclearance%20was%209.4%25%20at%202%20and%2015.4%25%20at%205%20years%2C%20with%20higher%20rates%20among%20patients%20with%20low%20baseline%20HBV%20replication%20markers.%5CnCONCLUSIONS%3A%20Reassuring%20long-term%20liver%20outcomes%20were%20ascertained%20during%20tenofovir-based%20ART%20for%20HBV%5C%2FHIV%20coinfection%20in%20Zambia.%20Higher%20than%20expected%20HBsAg%20seroclearance%20during%20ART%20underscores%20the%20need%20to%20include%20people%20with%20HIV%20in%20HBV%20cure%20research.%22%2C%22date%22%3A%222024-06-14%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciad654%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A14%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22CZI4DY87%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Skrivankova%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSkrivankova%2C%20Veronika%20Whitesell%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHuwa%2C%20Jacqueline%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMuula%2C%20Guy%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChiwaya%2C%20Geldert%20D.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBanda%2C%20Esau%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Virologic%20Failure%20and%20Drug%20Resistance%20After%20Programmatic%20Switching%20to%20Dolutegravir-based%20First-line%20Antiretroviral%20Therapy%20in%20Malawi%20and%20Zambia.%20%26lt%3Bi%26gt%3BClinical%20Infectious%20Diseases%3A%20An%20Official%20Publication%20of%20the%20Infectious%20Diseases%20Society%20of%20America%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20ciae261.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae261%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciae261%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Virologic%20Failure%20and%20Drug%20Resistance%20After%20Programmatic%20Switching%20to%20Dolutegravir-based%20First-line%20Antiretroviral%20Therapy%20in%20Malawi%20and%20Zambia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronika%20Whitesell%22%2C%22lastName%22%3A%22Skrivankova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacqueline%22%2C%22lastName%22%3A%22Huwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geldert%20D.%22%2C%22lastName%22%3A%22Chiwaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esau%22%2C%22lastName%22%3A%22Banda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shameem%22%2C%22lastName%22%3A%22Buleya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Chintedza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannock%22%2C%22lastName%22%3A%22Tweya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thokozani%22%2C%22lastName%22%3A%22Kalua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Hossmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%22%2C%22lastName%22%3A%22Kouyos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Lessells%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20People%20with%20human%20immunodeficiency%20virus%20%28PWH%29%20on%20first-line%2C%20nonnucleoside%20reverse-transcriptase%20inhibitor-based%20antiretroviral%20therapy%20%28ART%29%20were%20routinely%20switched%20to%20tenofovir-lamivudine-dolutegravir.%20We%20examined%20virologic%20outcomes%20and%20drug%20resistance%20in%20ART%20programs%20in%20Malawi%2C%20where%20switching%20was%20irrespective%20of%20viral%20load%2C%20and%20Zambia%2C%20where%20switching%20depended%20on%20a%20viral%20load%20%26lt%3B1000%5Cu2005copies%5C%2FmL%20in%20the%20past%20year.%5CnMETHODS%3A%20We%20compared%20the%20risk%20of%20viremia%20%28%5Cu2265400%5Cu2005copies%5C%2FmL%29%20at%201%20and%202%20years%20by%20viral%20load%20at%20switch%20and%20between%20countries%20using%20exact%20methods%20and%20logistic%20regression%20adjusted%20for%20age%20and%20sex.%20We%20performed%20HIV-1%20pol%20Sanger%20sequencing%20on%20plasma%20samples%20with%20viral%20load%20%5Cu22651000%5Cu2005copies%5C%2FmL.%5CnRESULTS%3A%20A%20total%20of%202832%20PWH%20were%20eligible%20%28Malawi%201422%2C%20Zambia%201410%29%3B%20the%20median%20age%20was%2037%20years%2C%20and%202578%20%2891.0%25%29%20were%20women.%20At%20switch%2C%2077%20%285.4%25%29%20were%20viremic%20in%20Malawi%20and%2042%20%283.0%25%29%20in%20Zambia%20%28P%20%3D%20.001%29.%20Viremia%20at%20switch%20was%20associated%20with%20viremia%20at%201%20year%20%28adjusted%20odds%20ratio%20%28OR%29%2C%206.15%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%203.13-11.4%29%20and%202%20years%20%287.0%3B%2095%25%20CI%2C%203.73-12.6%29.%20Viremia%20was%20less%20likely%20in%20Zambia%20than%20in%20Malawi%20at%201%20year%20%28OR%2C%200.55%3B%200.32-0.94%29%20and%202%20years%20%28OR%2C%200.33%3B%200.18-0.57%29.%20Integrase%20sequencing%20was%20successful%20for%2079%20of%20113%20eligible%20samples.%20Drug%20resistance%20mutations%20were%20found%20in%205%20PWH%20%28Malawi%204%2C%20Zambia%201%29%3B%202%20had%20major%20mutations%20%28G118R%2C%20E138K%2C%20T66A%20and%20G118R%2C%20E138K%29%20leading%20to%20high-level%20dolutegravir%20resistance.%5CnCONCLUSIONS%3A%20Restricting%20switching%20to%20dolutegravir-based%20ART%20to%20PWH%20with%20a%20viral%20load%20%26lt%3B1000%5Cu2005copies%5C%2FmL%20may%20reduce%20subsequent%20viremia%20and%2C%20consequently%2C%20the%20emergence%20of%20dolutegravir%20drug%20resistance%20mutations.%5CnCLINICAL%20TRIALS%20REGISTRATION%3A%20Clinicaltrials.gov%20%28NCT04612452%29.%22%2C%22date%22%3A%222024-06-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciae261%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A14%3A32Z%22%7D%7D%2C%7B%22key%22%3A%224VTZ6XT2%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kassanjee%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKassanjee%2C%20Reshma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavies%2C%20Mary-Ann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHeekes%2C%20Alexa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMahomed%2C%20Hassan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHawkridge%2C%20Anthony%20J.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20COVID-19%20Vaccine%20Uptake%20and%20Effectiveness%20by%20Time%20since%20Vaccination%20in%20the%20Western%20Cape%20Province%2C%20South%20Africa%3A%20An%20Observational%20Cohort%20Study%20during%202020-2022.%20%26lt%3Bi%26gt%3BVaccines%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%20628.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fvaccines12060628%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fvaccines12060628%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22COVID-19%20Vaccine%20Uptake%20and%20Effectiveness%20by%20Time%20since%20Vaccination%20in%20the%20Western%20Cape%20Province%2C%20South%20Africa%3A%20An%20Observational%20Cohort%20Study%20during%202020-2022%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexa%22%2C%22lastName%22%3A%22Heekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hassan%22%2C%22lastName%22%3A%22Mahomed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20J.%22%2C%22lastName%22%3A%22Hawkridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erna%22%2C%22lastName%22%3A%22Morden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theuns%22%2C%22lastName%22%3A%22Jacobs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheryl%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harry%22%2C%22lastName%22%3A%22Moultrie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Lessells%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolette%22%2C%22lastName%22%3A%22Van%20Der%20Walt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juanita%20O.%22%2C%22lastName%22%3A%22Arendse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Wolter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sibongile%22%2C%22lastName%22%3A%22Walaza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Waasila%22%2C%22lastName%22%3A%22Jassat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22von%20Gottberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20L.%22%2C%22lastName%22%3A%22Hannan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R.%22%2C%22lastName%22%3A%22Feikin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%22%2C%22lastName%22%3A%22Cloete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%5D%2C%22abstractNote%22%3A%22There%20are%20few%20data%20on%20the%20real-world%20effectiveness%20of%20COVID-19%20vaccines%20and%20boosting%20in%20Africa%2C%20which%20experienced%20widespread%20SARS-CoV-2%20infection%20before%20vaccine%20availability.%20We%20assessed%20the%20association%20between%20vaccination%20and%20severe%20COVID-19%20in%20the%20Western%20Cape%2C%20South%20Africa%2C%20in%20an%20observational%20cohort%20study%20of%20%26gt%3B2%20million%20adults%20during%202020-2022.%20We%20described%20SARS-CoV-2%20testing%2C%20COVID-19%20outcomes%2C%20and%20vaccine%20uptake%20over%20time.%20We%20used%20multivariable%20cox%20models%20to%20estimate%20the%20association%20of%20BNT162b2%20and%20Ad26.COV2.S%20vaccination%20with%20COVID-19-related%20hospitalization%20and%20death%2C%20adjusting%20for%20demographic%20characteristics%2C%20underlying%20health%20conditions%2C%20socioeconomic%20status%20proxies%2C%20and%20healthcare%20utilization.%20We%20found%20that%20by%20the%20end%20of%202022%2C%2041%25%20of%20surviving%20adults%20had%20completed%20vaccination%20and%208%25%20had%20received%20a%20booster%20dose.%20Recent%20vaccination%20was%20associated%20with%20notable%20reductions%20in%20severe%20COVID-19%20during%20periods%20dominated%20by%20Delta%2C%20and%20Omicron%20BA.1%5C%2F2%20and%20BA.4%5C%2F5%20%28sub%29lineages.%20During%20the%20latest%20Omicron%20BA.4%5C%2F5%20wave%2C%20within%203%20months%20of%20vaccination%20or%20boosting%2C%20BNT162b2%20and%20Ad26.COV2.S%20were%20each%2084%25%20effective%20against%20death%20%2895%25%20CIs%3A%2057-94%20and%2049-95%2C%20respectively%29.%20However%2C%20distinct%20reductions%20of%20effectiveness%20occurred%20at%20longer%20times%20post%20completing%20or%20boosting%20vaccination.%20Results%20highlight%20the%20importance%20of%20continued%20emphasis%20on%20COVID-19%20vaccination%20and%20boosting%20for%20those%20at%20high%20risk%20of%20severe%20COVID-19%2C%20even%20in%20settings%20with%20widespread%20infection-induced%20immunity.%22%2C%22date%22%3A%222024-06-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fvaccines12060628%22%2C%22ISSN%22%3A%222076-393X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22FVGYB2LG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nyakato%20et%20al.%22%2C%22parsedDate%22%3A%222024-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNyakato%2C%20Patience%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBoulle%2C%20Andrew%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWood%2C%20Robin%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEley%2C%20Brian%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRabie%2C%20Helena%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Self-transfers%2C%20Hospital%20Admissions%20and%20Mortality%20Among%20Children%20and%20Adolescents%20Lost%20to%20Follow-up%20From%20Antiretroviral%20Therapy%20Programs%20in%20the%20Western%20Cape%2C%20South%20Africa%20Between%202004%20and%202019%3A%20Linkage%20to%20Provincial%20Records.%20%26lt%3Bi%26gt%3BThe%20Pediatric%20Infectious%20Disease%20Journal%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B43%26lt%3B%5C%2Fi%26gt%3B%20%285%29%2C%20S.%20430%26%23x2013%3B436.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004281%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FINF.0000000000004281%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Self-transfers%2C%20Hospital%20Admissions%20and%20Mortality%20Among%20Children%20and%20Adolescents%20Lost%20to%20Follow-up%20From%20Antiretroviral%20Therapy%20Programs%20in%20the%20Western%20Cape%2C%20South%20Africa%20Between%202004%20and%202019%3A%20Linkage%20to%20Provincial%20Records%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patience%22%2C%22lastName%22%3A%22Nyakato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%22%2C%22lastName%22%3A%22Rabie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Pediatric%20programs%20face%20a%20high%20rate%20of%20loss%20to%20follow-up%20%28LTFU%29%20among%20children%20and%20adolescents%20living%20with%20HIV%20%28CAHIV%29.%20We%20assessed%20true%20outcomes%20and%20predictors%20of%20these%20among%20CAHIV%20who%20were%20LTFU%20using%20linkage%20to%20the%20Western%20Cape%20Provincial%20Health%20Data%20Centre%20at%20Western%20Cape%20sites%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS-Southern%20Africa%20collaboration.%5CnMETHODS%3A%20We%20examined%20factors%20associated%20with%20self-transfer%2C%20hospital%20admission%20and%20mortality%20using%20competing%20risks%20regression%20in%20a%20retrospective%20cohort%20of%20CAHIV%20initiating%20antiretroviral%20therapy%20%26lt%3B15%20years%20old%20between%202004%20and%202019%20and%20deemed%20LTFU%20%28no%20recorded%20visit%20at%20the%20original%20facility%20for%20%5Cu2265180%20days%20from%20the%20last%20visit%20date%20before%20database%20closure%20and%20not%20known%20to%20have%20officially%20transferred%20out%20or%20deceased%29.%5CnRESULTS%3A%20Of%20the%201720%20CAHIV%20deemed%20LTFU%2C%20802%20%2846.6%25%29%20had%20self-transferred%20and%20were%20receiving%20care%20elsewhere%20within%20the%20Western%20Cape%2C%20463%20%2826.9%25%29%20had%20been%20hospitalized%20and%2045%20%282.6%25%29%20CAHIV%20had%20died.%20The%20overall%20rates%20of%20self-transfer%2C%20hospitalization%2C%20mortality%20and%20LTFU%20were%209.4%20%5B95%25%20confidence%20interval%20%28CI%29%3A%208.8-10.1%5D%2C%205.4%20%2895%25%20CI%3A%205.0-6.0%29%2C%200.5%20%2895%25%20CI%3A%200.4-0.7%29%20and%204.8%20%2895%25%20CI%3A%204.4-5.3%29%20per%20100%20person-years%20respectively.%20Increasing%20duration%20on%20antiretroviral%20therapy%20before%20LTFU%20was%20associated%20with%20self-transfers%20while%20male%20sex%2C%20older%20age%20at%20last%20visit%20%28%5Cu226510%20years%20vs.%20younger%29%20were%20associated%20with%20hospital%20admission%20and%20immune%20suppression%20at%20last%20visit%20was%20associated%20with%205%20times%20higher%20mortality.%5CnCONCLUSIONS%3A%20Nearly%20half%20of%20CAHIV%20classified%20as%20LTFU%20had%20self-transferred%20to%20another%20health%20facility%2C%20a%20quarter%20had%20been%20hospitalized%20and%20a%20small%20proportion%20had%20died.%22%2C%22date%22%3A%222024-05-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FINF.0000000000004281%22%2C%22ISSN%22%3A%221532-0987%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-20T12%3A30%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22EDIV7L8F%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kebede%20et%20al.%22%2C%22parsedDate%22%3A%222024-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKebede%2C%20Samuel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFreeman%2C%20Aimee%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMuwonge%2C%20Timothy%20R.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChoi%2C%20Jun%20Yong%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Preexposure%20prophylaxis%20availability%20among%20health%20facilities%20participating%20in%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20%26lt%3Bi%26gt%3BAIDS%20%28London%2C%20England%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B38%26lt%3B%5C%2Fi%26gt%3B%20%285%29%2C%20S.%20751%26%23x2013%3B756.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003824%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003824%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preexposure%20prophylaxis%20availability%20among%20health%20facilities%20participating%20in%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Kebede%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%20M.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Muwonge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Yong%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renee%22%2C%22lastName%22%3A%22de%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Athanase%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20Kristoffer%20U.%22%2C%22lastName%22%3A%22Pasayan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alisho%22%2C%22lastName%22%3A%22Shongo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Low%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20recognized%20as%20a%20key%20HIV%20prevention%20strategy%2C%20preexposure%20prophylaxis%20%28PrEP%29%20availability%20and%20accessibility%20are%20not%20well%20documented%20globally.%20We%20aimed%20to%20describe%20PrEP%20drug%20registration%20status%20and%20the%20availability%20of%20PrEP%20services%20across%20HIV%20care%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium.%5CnMETHODS%3A%20We%20used%20country-level%20PrEP%20drug%20registration%20status%20from%20the%20AIDS%20Vaccine%20Advocacy%20Coalition%20and%20data%20from%20IeDEA%20surveys%20conducted%20in%202014%2C%202017%20and%202020%20among%20participating%20HIV%20clinics%20in%20seven%20global%20regions.%20We%20used%20descriptive%20statistics%20to%20assess%20PrEP%20availability%20across%20IeDEA%20sites%20serving%20adult%20patients%20in%202020%20and%20examined%20trends%20in%20PrEP%20availability%20among%20sites%20that%20responded%20to%20all%20three%20surveys.%5CnRESULTS%3A%20Of%20199%20sites%20that%20completed%20the%202020%20survey%2C%20PrEP%20was%20available%20in%20161%20%2881%25%29.%20PrEP%20availability%20was%20highest%20at%20sites%20in%20North%20America%20%2829%5C%2F30%3B%2097%25%29%20and%20East%20Africa%20%2870%5C%2F74%3B%2095%25%29%20and%20lowest%20at%20sites%20in%20Central%20%2810%5C%2F20%3B%2050%25%29%20and%20West%20Africa%20%281%5C%2F6%3B%2017%25%29.%20PrEP%20availability%20was%20higher%20among%20sites%20in%20countries%20where%20PrEP%20was%20officially%20registered%20%28146%5C%2F161%3B%2091%25%29%20than%20where%20it%20was%20not%20%2814%5C%2F32%3B%2044%25%29.%20Availability%20was%20higher%20at%20health%20centers%20%28109%5C%2F120%3B%2090%25%29%20and%20district%20hospitals%20%2814%5C%2F16%3B%2088%25%29%20compared%20to%20regional%5C%2Fteaching%20hospitals%20%2836%5C%2F63%29.%20Among%20the%2094%20sites%20that%20responded%20to%20all%20three%20surveys%2C%20PrEP%20availability%20increased%20from%2047%25%20in%202014%20to%2060%25%20in%202017%20and%2076%25%20in%202020.%5CnCONCLUSION%3A%20PrEP%20availability%20has%20substantially%20increased%20since%202014%20and%20is%20now%20available%20at%20most%20IeDEA%20sites.%20However%2C%20PrEP%20service%20provision%20varies%20markedly%20across%20global%20regions.%22%2C%22date%22%3A%222024-04-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000003824%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22GNS9IMDT%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Plaisy%20et%20al.%22%2C%22parsedDate%22%3A%222024-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPlaisy%2C%20Marie%20Kerbie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMinga%2C%20Albert%20K.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWandeler%2C%20Gilles%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMurenzi%2C%20Gad%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSamala%2C%20Niharika%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Metabolic%20causes%20of%20liver%20disease%20among%20adults%20living%20with%20HIV%20from%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20e26238.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26238%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26238%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Metabolic%20causes%20of%20liver%20disease%20among%20adults%20living%20with%20HIV%20from%20low-%20and%20middle-income%20countries%3A%20a%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Kerbie%22%2C%22lastName%22%3A%22Plaisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20K.%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niharika%22%2C%22lastName%22%3A%22Samala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ephrem%22%2C%22lastName%22%3A%22Mensah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ren%5Cu00e9e%22%2C%22lastName%22%3A%22de%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20H.%22%2C%22lastName%22%3A%22Kuniholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonali%22%2C%22lastName%22%3A%22Salvi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Attia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ardele%22%2C%22lastName%22%3A%22Mandiriri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Shumbusho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22Goodrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhanushi%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%22%2C%22lastName%22%3A%22Alarcon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Perrazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Sentinel%20Research%20Network%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Liver%20disease%20is%20a%20leading%20cause%20of%20morbidity%20and%20mortality%20among%20persons%20living%20with%20HIV%20%28PLHIV%29.%20While%20chronic%20viral%20hepatitis%20has%20been%20extensively%20studied%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%2C%20there%20is%20limited%20information%20about%20the%20burden%20of%20metabolic%20disorders%20on%20liver%20disease%20in%20PLHIV.%5CnMETHODS%3A%20We%20conducted%20a%20cross-sectional%20analysis%20of%20baseline%20data%20collected%20between%20October%202020%20and%20July%202022%20from%20the%20IeDEA-Sentinel%20Research%20Network%2C%20a%20prospective%20cohort%20enrolling%20PLHIV%20%5Cu226540%20years%20on%20antiretroviral%20treatment%20%28ART%29%20for%20%5Cu22656%20months%20from%20eight%20clinics%20in%20Asia%2C%20Americas%2C%20and%20central%2C%20East%2C%20southern%20and%20West%20Africa.%20Clinical%20assessments%2C%20laboratory%20testing%20on%20fasting%20blood%20samples%20and%20liver%20stiffness%20measurement%20%28LSM%29%5C%2Fcontrolled%20attenuation%20parameter%20%28CAP%29%20by%20vibration-controlled%20transient%20elastography%20were%20performed.%20Multivariable%20logistic%20regression%20models%20assessed%20factors%20associated%20with%20liver%20fibrosis%20%28LSM%20%5Cu22657.1%20kPa%29%20and%20steatosis%20%28CAP%20%5Cu2265248%20dB%5C%2Fm%29.%20Population%20attributable%20fraction%20%28PAF%29%20of%20each%20variable%20associated%20with%20significant%20liver%20fibrosis%20was%20estimated%20using%20Levin%26%23039%3Bs%20formula.%5CnRESULTS%3A%20Overall%2C%202120%20PLHIV%20%2856%25%20female%2C%20median%20age%2050%20%5Binterquartile%20range%3A%2045-56%5D%20years%29%20were%20included.%20The%20prevalence%20of%20obesity%20was%2019%25%2C%2012%25%20had%20type%202%20diabetes%20mellitus%20%28T2DM%29%2C%2029%25%20had%20hypertension%20and%2053%25%20had%20dyslipidaemia.%20The%20overall%20prevalence%20of%20liver%20fibrosis%20and%20steatosis%20was%207.6%25%20%2895%25%20confidence%20interval%20%5BCI%5D%206.1-8.4%29%20and%2028.4%25%20%2895%25%20CI%2026.5-30.7%29%2C%20respectively%2C%20with%20regional%20variability.%20Male%20sex%20at%20birth%20%28odds%20ratio%20%5BOR%5D%201.62%2C%20CI%201.10-2.40%29%2C%20overweight%5C%2Fobesity%20%28OR%20%3D%202.50%2C%2095%25%20CI%201.69-3.75%29%2C%20T2DM%20%28OR%202.26%2C%2095%25%20CI%201.46-3.47%29%20and%20prolonged%20exposure%20to%20didanosine%20%28OR%203.13%2C%2095%25%20CI%201.46-6.49%29%20were%20associated%20with%20liver%20fibrosis.%20Overweight%5C%2Fobesity%20and%20T2DM%20accounted%20for%2042%25%20and%2011%25%20of%20the%20PAF%20for%20liver%20fibrosis%2C%20while%20HBsAg%20and%20anti-HCV%20accounted%20for%203%25%20and%201%25%2C%20respectively.%20Factors%20associated%20with%20steatosis%20included%20overweight%5C%2Fobesity%20%28OR%204.25%2C%2095%25%20CI%203.29-5.51%29%2C%20T2DM%20%28OR%202.06%2C%2095%25%20CI%201.47-2.88%29%2C%20prolonged%20exposure%20to%20stavudine%20%28OR%201.69%2C%2095%25%20CI%201.27-2.26%29%20and%20dyslipidaemia%20%28OR%201.68%2C%2095%25%20CI%201.31-2.16%29.%5CnCONCLUSIONS%3A%20Metabolic%20disorders%20were%20significant%20risk%20factors%20for%20liver%20disease%20among%20PLHIV%20in%20LMICs.%20Early%20recognition%20of%20metabolic%20disorders%20risk%20factors%20might%20be%20helpful%20to%20guide%20clinical%20and%20lifestyle%20interventions.%20Further%20prospective%20studies%20are%20needed%20to%20determine%20the%20causative%20natures%20of%20these%20findings.%22%2C%22date%22%3A%222024-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26238%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-17T13%3A02%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22Y6NAACJN%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Phillips%20et%20al.%22%2C%22parsedDate%22%3A%222024-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPhillips%2C%20Tamsin%20Kate%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKassanjee%2C%20Reshma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMaxwell%2C%20Nicola%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAnderson%2C%20Kim%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJohnson%2C%20Leigh%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20ART%20history%20prior%20to%20conception%3A%20trends%20and%20association%20with%20postpartum%20disengagement%20from%20HIV%20care%20in%20Khayelitsha%2C%20South%20Africa%20%282013-2019%29%3A%20a%20retrospective%20cohort%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%284%29%2C%20S.%20e26236.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26236%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26236%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ART%20history%20prior%20to%20conception%3A%20trends%20and%20association%20with%20postpartum%20disengagement%20from%20HIV%20care%20in%20Khayelitsha%2C%20South%20Africa%20%282013-2019%29%3A%20a%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamsin%20Kate%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haroon%22%2C%22lastName%22%3A%22Moolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Landon%22%2C%22lastName%22%3A%22Myer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20H.%22%2C%22lastName%22%3A%22Chi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renee%22%2C%22lastName%22%3A%22de%20Waal%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%20recent%20years%2C%20the%20expansion%20of%20HIV%20treatment%20eligibility%20has%20resulted%20in%20an%20increase%20in%20people%20with%20antiretroviral%20therapy%20%28ART%29%20experience%20prior%20to%20pregnancy%20but%20little%20is%20known%20about%20postpartum%20engagement%20in%20care%20in%20this%20population.%20We%20examined%20differences%20in%20disengagement%20from%20HIV%20care%20after%20delivery%20by%20maternal%20ART%20history%20before%20conception.%5CnMETHODS%3A%20We%20analysed%20data%20from%20people%20living%20with%20HIV%20%28aged%2015-49%29%20in%20Khayelitsha%2C%20South%20Africa%2C%20with%20%5Cu22651%20live%20birth%20between%20April%202013%20and%20March%202019.%20We%20described%20trends%20over%20time%20in%20ART%20history%20prior%20to%20estimated%20conception%2C%20classifying%20ART%20history%20groups%20as%3A%20%28A%29%20on%20ART%20with%20no%20disengagement%20%28%26gt%3B270%20days%20with%20no%20evidence%20of%20HIV%20care%29%3B%20%28B%29%20returned%20before%20pregnancy%20following%20disengagement%3B%20%28C%29%20restarted%20ART%20in%20pregnancy%20after%20disengagement%3B%20and%20%28D%29%20ART%20new%20start%20in%20pregnancy.%20We%20used%20Kaplan-Meier%20curves%20and%20proportional-hazards%20models%20%28adjusted%20for%20maternal%20age%2C%20number%20of%20pregnancy%20records%20and%20year%20of%20delivery%29%20to%20examine%20the%20time%20to%20disengagement%20from%20delivery%20to%202%20years%20postpartum.%5CnRESULTS%3A%20Among%207309%20pregnancies%20%28in%206680%20individuals%29%2C%20the%20proportion%20on%20ART%20%28A%29%20increased%20from%2019%25%20in%202013%20to%2041%25%20in%202019.%20The%20proportions%20of%20those%20who%20returned%20%28B%29%20and%20restarted%20%28C%29%20increased%20from%202%25%20to%2013%25%20and%20from%202%25%20to%2010%25%2C%20respectively.%20There%20was%20a%20corresponding%20decline%20in%20the%20proportion%20of%20new%20starts%20%28D%29%20from%2077%25%20in%202013%20to%2036%25%20in%202019.%20In%20the%20first%20recorded%20pregnancy%20per%20person%20in%20the%20study%20period%2C%2026%25%20%2895%25%20CI%2025-27%25%29%20had%20disengaged%20from%20care%20by%201%20year%20and%2034%25%20%2895%25%20CI%2033-36%25%29%20by%202%20years%20postpartum.%20Individuals%20who%20returned%20%28B%3A%20aHR%202.10%2C%2095%25%20CI%201.70-2.60%29%2C%20restarted%20%28C%3A%20aHR%203.32%2C%2095%25%20CI%202.70-4.09%29%20and%20newly%20started%20ART%20%28D%3A%20aHR%202.41%2C%2095%25%20CI%202.12-2.74%29%20had%20increased%20hazards%20of%20postpartum%20disengagement%20compared%20to%20those%20on%20ART%20%28A%29.%5CnCONCLUSIONS%3A%20There%20is%20a%20growing%20population%20of%20people%20with%20ART%20experience%20prior%20to%20conception%20and%20postpartum%20disengagement%20varies%20substantially%20by%20ART%20history.%20Antenatal%20care%20presents%20an%20important%20opportunity%20to%20understand%20prior%20ART%20experiences%20and%20an%20entry%20into%20interventions%20for%20strengthened%20engagement%20in%20HIV%20care.%22%2C%22date%22%3A%222024-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26236%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A14%3A56Z%22%7D%7D%2C%7B%22key%22%3A%226EZFH9QC%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anderson%20et%20al.%22%2C%22parsedDate%22%3A%222024-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAnderson%2C%20Kim%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKalk%2C%20Emma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHeekes%2C%20Alexa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPhelanyane%2C%20Florence%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJacob%2C%20Nisha%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Factors%20associated%20with%20vertical%20transmission%20of%20HIV%20in%20the%20Western%20Cape%2C%20South%20Africa%3A%20a%20retrospective%20cohort%20analysis.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e26235.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26235%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26235%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factors%20associated%20with%20vertical%20transmission%20of%20HIV%20in%20the%20Western%20Cape%2C%20South%20Africa%3A%20a%20retrospective%20cohort%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Kalk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexa%22%2C%22lastName%22%3A%22Heekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Phelanyane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nisha%22%2C%22lastName%22%3A%22Jacob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ushma%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gayathri%22%2C%22lastName%22%3A%22Sridhar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%22%2C%22lastName%22%3A%22Ragone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vani%22%2C%22lastName%22%3A%22Vannappagari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Monitoring%20mother-infant%20pairs%20with%20HIV%20exposure%20is%20needed%20to%20assess%20the%20effectiveness%20of%20vertical%20transmission%20%28VT%29%20prevention%20programmes%20and%20progress%20towards%20VT%20elimination.%5CnMETHODS%3A%20We%20used%20routinely%20collected%20data%20on%20infants%20with%20HIV%20exposure%2C%20born%20May%202018-April%202021%20in%20the%20Western%20Cape%2C%20South%20Africa%2C%20with%20follow-up%20through%20mid-2022.%20We%20assessed%20the%20proportion%20of%20infants%20diagnosed%20with%20HIV%20at%20birth%20%28%5Cu22647%20days%29%2C%2010%20weeks%20%28%26gt%3B1%20to%2014%20weeks%29%20and%20%26gt%3B14%20weeks%20as%20proxies%20for%20intrauterine%2C%20intrapartum%5C%2Fearly%20breastfeeding%20and%20late%20breastfeeding%20transmission%2C%20respectively.%20We%20used%20mixed-effects%20Poisson%20regression%20to%20assess%20factors%20associated%20with%20VT%20in%20mothers%20known%20with%20HIV%20by%20delivery.%5CnRESULTS%3A%20We%20included%2050%2C461%20infants%20born%20to%20mothers%20known%20with%20HIV%20by%20delivery.%20HIV%20was%20diagnosed%20in%20894%20%281.8%25%29%20infants.%20Among%20mothers%2C%2051%25%20started%20antiretroviral%20treatment%20%28ART%29%20before%20and%2027%25%20during%20pregnancy%3B%2017%25%20restarted%20during%20pregnancy%20after%20%5Cu22656%20months%20interruption%3B%20and%206%25%20had%20no%20recorded%20ART%20during%20pregnancy.%20Most%20pregnancy%20ART%20regimens%20included%20non-nucleoside%20reverse%20transcriptase%20inhibitors%20%2883%25%29.%20Of%20mothers%20with%20available%20results%20%2890%25%20with%20viral%20load%20%5BVL%5D%3B%2070%25%20with%20CD4%29%2C%20VL%20nearest%20delivery%20was%20%26lt%3B100%20copies%5C%2Fml%20in%2078%25%20and%20CD4%20count%20%5Cu2265350%20cells%5C%2F%5Cu03bcl%20in%2062%25.%20HIV-PCR%20results%20were%20available%20for%2086%25%2C%2067%25%20and%2048%25%20of%20eligible%20infants%20at%20birth%2C%2010%20weeks%20and%20%26gt%3B14%20weeks.%20Among%20these%20infants%2C%200.9%25%2C%200.4%25%20and%201.5%25%20were%20diagnosed%20positive%20at%20birth%2C%2010%20weeks%20and%20%26gt%3B14%20weeks%2C%20respectively.%20Among%20infants%20diagnosed%20with%20HIV%2C%2043%25%2C%2016%25%20and%2041%25%20were%20diagnosed%20at%20these%20respective%20time%20periods.%20Among%20mothers%20with%20VL%26lt%3B100%2C%20100-999%2C%201000-99%2C000%20and%20%5Cu2265100%2C000%20copies%5C%2Fml%20nearest%20delivery%2C%20infant%20HIV%20diagnosis%20incidence%20was%200.4%25%2C%202.3%25%2C%206.6%25%20and%2018.4%25%2C%20respectively.%20Increased%20VT%20was%20strongly%20associated%20with%20recent%20elevated%20maternal%20VL%20with%20a%20seven-fold%20increased%20rate%20with%20even%20modestly%20elevated%20VL%20%28100-999%20vs.%20%26lt%3B100%20copies%5C%2Fml%29.%20VT%20was%20also%20associated%20with%20unknown%5C%2Flow%20maternal%20CD4%2C%20maternal%20age%20%26lt%3B20%20years%2C%20no%20antenatal%20ART%2C%20later%20maternal%20ART%20start%5C%2Frestart%20in%20pregnancy%20and%20ART%20gaps.%5CnCONCLUSIONS%3A%20Despite%20high%20maternal%20ART%20coverage%20and%20routine%20postnatal%20prophylaxis%2C%20ongoing%20VT%20remains%20a%20concern.%20Timing%20of%20infant%20HIV%20diagnoses%20suggests%20intrapartum%20and%5C%2For%20breastfeeding%20transmission%20in%20nearly%2060%25.%20Interventions%20to%20ensure%20retention%20on%20ART%20and%20sustained%20maternal%20viral%20suppression%20are%20needed%20to%20reduce%20VT.%22%2C%22date%22%3A%222024-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26235%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22EKX688G4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222024-03%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBrazier%2C%20Ellen%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTymejczyk%2C%20Olga%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWools-Kaloustian%2C%20Kara%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJiamsakul%2C%20Awachana%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTorres%2C%20Marco%20Tulio%20Luque%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Long-term%20HIV%20care%20outcomes%20under%20universal%20HIV%20treatment%20guidelines%3A%20A%20retrospective%20cohort%20study%20in%2025%20countries.%20%26lt%3Bi%26gt%3BPLoS%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%20%283%29%2C%20S.%20e1004367.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1004367%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1004367%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-term%20HIV%20care%20outcomes%20under%20universal%20HIV%20treatment%20guidelines%3A%20A%20retrospective%20cohort%20study%20in%2025%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%20Luque%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20S.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Abuogi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vohith%22%2C%22lastName%22%3A%22Khol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mej%5Cu00eda%20Cordero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20While%20national%20adoption%20of%20universal%20HIV%20treatment%20guidelines%20has%20led%20to%20improved%2C%20timely%20uptake%20of%20antiretroviral%20therapy%20%28ART%29%2C%20longer-term%20care%20outcomes%20are%20understudied.%20There%20is%20little%20data%20from%20real-world%20service%20delivery%20settings%20on%20patient%20attrition%2C%20viral%20load%20%28VL%29%20monitoring%2C%20and%20viral%20suppression%20%28VS%29%20at%2024%20and%2036%20months%20after%20HIV%20treatment%20initiation.%5CnMETHODS%20AND%20FINDINGS%3A%20For%20this%20retrospective%20cohort%20analysis%2C%20we%20used%20observational%20data%20from%2025%20countries%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%26%23039%3Bs%20Asia-Pacific%2C%20Central%20Africa%2C%20East%20Africa%2C%20Central%5C%2FSouth%20America%2C%20and%20North%20America%20regions%20for%20patients%20who%20were%20ART%20na%5Cu00efve%20and%20aged%20%5Cu226515%20years%20at%20care%20enrollment%20between%2024%20months%20before%20and%2012%20months%20after%20national%20adoption%20of%20universal%20treatment%20guidelines%2C%20occurring%202012%20to%202018.%20We%20estimated%20crude%20cumulative%20incidence%20of%20loss-to-clinic%20%28CI-LTC%29%20at%2012%2C%2024%2C%20and%2036%20months%20after%20enrollment%20among%20patients%20enrolling%20in%20care%20before%20and%20after%20guideline%20adoption%20using%20competing%20risks%20regression.%20Guideline%20change-associated%20hazard%20ratios%20of%20LTC%20at%20each%20time%20point%20after%20enrollment%20were%20estimated%20via%20cause-specific%20Cox%20proportional%20hazards%20regression%20models.%20Modified%20Poisson%20regression%20was%20used%20to%20estimate%20relative%20risks%20of%20retention%2C%20VL%20monitoring%2C%20and%20VS%20at%2012%2C%2024%2C%20and%2036%20months%20after%20ART%20initiation.%20There%20were%2066%2C963%20patients%20enrolling%20in%20HIV%20care%20at%20109%20clinics%20with%20%5Cu226512%20months%20of%20follow-up%20time%20after%20enrollment%20%2846%2C484%20%5B69.4%25%5D%20enrolling%20before%20guideline%20adoption%20and%2020%2C479%20%5B30.6%25%5D%20enrolling%20afterwards%29.%20More%20than%20half%20%2854.9%25%29%20were%20females%2C%20and%20median%20age%20was%2034%20years%20%28interquartile%20range%20%5BIQR%5D%3A%2027%20to%2043%29.%20Mean%20follow-up%20time%20was%2051%20months%20%28standard%20deviation%3A%2017%20months%3B%20range%3A%2012%2C%20110%20months%29.%20Among%20patients%20enrolling%20before%20guideline%20adoption%2C%20crude%20CI-LTC%20was%2023.8%25%20%2895%25%20confidence%20interval%20%5B95%25%20CI%5D%2023.4%2C%2024.2%29%20at%2012%20months%2C%2031.0%25%20%2895%25%20CI%20%5B30.6%2C%2031.5%5D%29%20at%2024%20months%2C%20and%2037.2%25%20%2895%25%20%5BCI%2036.8%2C%2037.7%5D%29%20at%2036%20months%20after%20enrollment.%20Adjusting%20for%20sex%2C%20age%20group%2C%20enrollment%20CD4%2C%20clinic%20location%20and%20type%2C%20and%20country%20income%20level%2C%20enrolling%20in%20care%20and%20initiating%20ART%20after%20guideline%20adoption%20was%20associated%20with%20increased%20hazard%20of%20LTC%20at%2012%20months%20%28adjusted%20hazard%20ratio%20%5BaHR%5D%201.25%20%5B95%25%20CI%201.08%2C%201.44%5D%3B%20p%20%3D%200.003%29%3B%2024%20months%20%28aHR%201.38%20%5B95%25%20CI%201.19%2C%201.59%5D%3B%20p%20%26lt%3B%20.001%29%3B%20and%2036%20months%20%28aHR%201.34%20%5B95%25%20CI%201.18%2C%201.53%5D%2C%20p%20%26lt%3B%20.001%29%20compared%20with%20enrollment%20before%20guideline%20adoption%2C%20with%20no%20before-after%20differences%20among%20patients%20with%20no%20record%20of%20ART%20initiation%20by%20end%20of%20follow-up.%20Among%20patients%20retained%20after%20ART%20initiation%2C%20VL%20monitoring%20was%20low%2C%20with%20marginal%20improvements%20associated%20with%20guideline%20adoption%20only%20at%2012%20months%20after%20ART%20initiation.%20Among%20those%20with%20VL%20monitoring%2C%20VS%20was%20high%20at%20each%20time%20point%20among%20patients%20enrolling%20before%20guideline%20adoption%20%2886.0%25%20to%2088.8%25%29%20and%20afterwards%20%2886.2%25%20to%2090.3%25%29%2C%20with%20no%20substantive%20difference%20associated%20with%20guideline%20adoption.%20Study%20limitations%20include%20lags%20in%20and%20potential%20underascertainment%20of%20care%20outcomes%20in%20real-world%20service%20delivery%20data%20and%20potential%20lack%20of%20generalizability%20beyond%20IeDEA%20sites%20and%20regions%20included%20in%20this%20analysis.%5CnCONCLUSIONS%3A%20In%20this%20study%2C%20adoption%20of%20universal%20HIV%20treatment%20guidelines%20was%20associated%20with%20lower%20retention%20after%20ART%20initiation%20out%20to%2036%20months%20of%20follow-up%2C%20with%20little%20change%20in%20VL%20monitoring%20or%20VS%20among%20retained%20patients.%20Monitoring%20long-term%20HIV%20care%20outcomes%20remains%20critical%20to%20identify%20and%20address%20causes%20of%20attrition%20and%20gaps%20in%20HIV%20care%20quality.%22%2C%22date%22%3A%222024-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1004367%22%2C%22ISSN%22%3A%221549-1676%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A31Z%22%7D%7D%2C%7B%22key%22%3A%226V46IUCA%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mesa-Vieira%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMesa-Vieira%2C%20Cristina%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDidden%2C%20Christiane%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSchomaker%2C%20Michael%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMouton%2C%20Johannes%20P.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFolb%2C%20Naomi%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Post-traumatic%20stress%20disorder%20as%20a%20risk%20factor%20for%20major%20adverse%20cardiovascular%20events%3A%20a%20cohort%20study%20of%20a%20South%20African%20medical%20insurance%20scheme.%20%26lt%3Bi%26gt%3BEpidemiology%20and%20Psychiatric%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B33%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20e5.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2FS2045796024000052%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2FS2045796024000052%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Post-traumatic%20stress%20disorder%20as%20a%20risk%20factor%20for%20major%20adverse%20cardiovascular%20events%3A%20a%20cohort%20study%20of%20a%20South%20African%20medical%20insurance%20scheme%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Mesa-Vieira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christiane%22%2C%22lastName%22%3A%22Didden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Schomaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20P.%22%2C%22lastName%22%3A%22Mouton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Folb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20L.%22%2C%22lastName%22%3A%22van%20den%20Heuvel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Gastaldon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oscar%20H.%22%2C%22lastName%22%3A%22Franco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soraya%22%2C%22lastName%22%3A%22Seedat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%5D%2C%22abstractNote%22%3A%22AIMS%3A%20Prior%20research%2C%20largely%20focused%20on%20US%20male%20veterans%2C%20indicates%20an%20increased%20risk%20of%20cardiovascular%20disease%20among%20individuals%20with%20post-traumatic%20stress%20disorder%20%28PTSD%29.%20Data%20from%20other%20settings%20and%20populations%20are%20scarce.%20The%20objective%20of%20this%20study%20is%20to%20examine%20PTSD%20as%20a%20risk%20factor%20for%20incident%20major%20adverse%20cardiovascular%20events%20%28MACEs%29%20in%20South%20Africa.%5CnMETHODS%3A%20We%20analysed%20reimbursement%20claims%20%282011-2020%29%20of%20a%20cohort%20of%20South%20African%20medical%20insurance%20scheme%20beneficiaries%20aged%2018%5Cu00a0years%20or%20older.%20We%20calculated%20adjusted%20hazard%20ratios%20%28aHRs%29%20for%20associations%20between%20PTSD%20and%20MACEs%20using%20Cox%20proportional%20hazard%20models%20and%20calculated%20the%20effect%20of%20PTSD%20on%20MACEs%20using%20longitudinal%20targeted%20maximum%20likelihood%20estimation.%5CnRESULTS%3A%20We%20followed%201%2C009%2C113%20beneficiaries%20over%20a%20median%20of%203.0%5Cu00a0years%20%28IQR%201.1-6.0%29.%20During%20follow-up%2C%2012%2C662%20%281.3%25%29%20persons%20were%20diagnosed%20with%20PTSD%20and%2039%2C255%20%283.9%25%29%20had%20a%20MACE.%20After%20adjustment%20for%20sex%2C%20HIV%20status%2C%20age%2C%20population%20group%2C%20substance%20use%20disorders%2C%20psychotic%20disorders%2C%20major%20depressive%20disorder%2C%20sleep%20disorders%20and%20the%20use%20of%20antipsychotic%20medication%2C%20PTSD%20was%20associated%20with%20a%2016%25%20increase%20in%20the%20risk%20of%20MACEs%20%28aHR%201.16%2C%2095%25%20confidence%20interval%20%28CI%29%201.05-1.28%29.%20The%20risk%20ratio%20for%20the%20effect%20of%20PTSD%20on%20MACEs%20decreased%20from%201.59%20%2895%25%20CI%201.49-1.68%29%20after%201%5Cu00a0year%20of%20follow-up%20to%201.14%20%2895%25%20CI%201.11-1.16%29%20after%208%5Cu00a0years%20of%20follow-up.%5CnCONCLUSION%3A%20Our%20study%20provides%20empirical%20support%20for%20an%20increased%20risk%20of%20MACEs%20in%20males%20and%20females%20with%20PTSD%20from%20a%20general%20population%20sample%20in%20South%20Africa.%20These%20findings%20highlight%20the%20importance%20of%20monitoring%20cardiovascular%20risk%20among%20individuals%20diagnosed%20with%20PTSD.%22%2C%22date%22%3A%222024-02-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1017%5C%2FS2045796024000052%22%2C%22ISSN%22%3A%222045-7979%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22VH2UK4RU%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Davidovi%5Cu0107%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavidovi%26%23x107%3B%2C%20Ma%26%23x161%3Ba%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAsangbeh%2C%20Serra%20Lem%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTaghavi%2C%20Katayoun%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDhokotera%2C%20Tafadzwa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BJaquet%2C%20Antoine%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Facility-Based%20Indicators%20to%20Manage%20and%20Scale%20Up%20Cervical%20Cancer%20Prevention%20and%20Care%20Services%20for%20Women%20Living%20With%20HIV%20in%20Sub-Saharan%20Africa%3A%20a%20Three-Round%20Online%20Delphi%20Consensus%20Method.%20%26lt%3Bi%26gt%3BJournal%20of%20Acquired%20Immune%20Deficiency%20Syndromes%20%281999%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B95%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20170%26%23x2013%3B178.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003343%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAI.0000000000003343%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Facility-Based%20Indicators%20to%20Manage%20and%20Scale%20Up%20Cervical%20Cancer%20Prevention%20and%20Care%20Services%20for%20Women%20Living%20With%20HIV%20in%20Sub-Saharan%20Africa%3A%20a%20Three-Round%20Online%20Delphi%20Consensus%20Method%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ma%5Cu0161a%22%2C%22lastName%22%3A%22Davidovi%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serra%20Lem%22%2C%22lastName%22%3A%22Asangbeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katayoun%22%2C%22lastName%22%3A%22Taghavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tafadzwa%22%2C%22lastName%22%3A%22Dhokotera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cari%22%2C%22lastName%22%3A%22Van%20Schalkwyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Schwappach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orang%27o%20Elkanah%22%2C%22lastName%22%3A%22Omenge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20Pierre%22%2C%22lastName%22%3A%22Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Per%22%2C%22lastName%22%3A%22von%20Groote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Of%20women%20with%20cervical%20cancer%20%28CC%29%20and%20HIV%2C%2085%25%20live%20in%20sub-Saharan%20Africa%2C%20where%2021%25%20of%20all%20CC%20cases%20are%20attributable%20to%20HIV%20infection.%20We%20aimed%20to%20generate%20internationally%20acceptable%20facility-based%20indicators%20to%20monitor%20and%20guide%20scale%20up%20of%20CC%20prevention%20and%20care%20services%20offered%20on-site%20or%20off-site%20by%20HIV%20clinics.%5CnMETHODS%3A%20We%20reviewed%20the%20literature%20and%20extracted%20relevant%20indicators%2C%20grouping%20them%20into%20domains%20along%20the%20CC%20control%20continuum.%20From%20February%202021%20to%20March%202022%2C%20we%20conducted%20a%20three-round%2C%20online%20Delphi%20process%20to%20reach%20consensus%20on%20indicators.%20We%20invited%20106%20experts%20to%20participate.%20Through%20an%20anonymous%2C%20iterative%20process%2C%20participants%20adapted%20the%20indicators%20to%20their%20context%20%28round%201%29%2C%20then%20rated%20them%20for%205%20criteria%20on%20a%205-point%20Likert-type%20scale%20%28rounds%202%20and%203%29%20and%20then%20ranked%20their%20importance%20%28round%203%29.%5CnRESULTS%3A%20We%20reviewed%2039%20policies%20from%2021%20African%20countries%20and%207%20from%20international%20organizations%3B%2072%20experts%20from%2015%20sub-Saharan%20Africa%20countries%20or%20international%20organizations%20participated%20in%20our%20Delphi%20process.%20Response%20rates%20were%2034%25%20in%20round%201%2C%2040%25%20in%20round%202%2C%20and%2044%25%20in%20round%203.%20Experts%20reached%20consensus%20for%2017%20indicators%20in%20the%20following%20domains%3A%20primary%20prevention%20%28human%20papillomavirus%20prevention%2C%20n%20%3D%202%29%2C%20secondary%20prevention%20%28screening%2C%20triage%2C%20treatment%20of%20precancerous%20lesions%2C%20n%20%3D%2011%29%2C%20tertiary%20prevention%20%28CC%20diagnosis%20and%20care%2C%20n%20%3D%202%29%2C%20and%20long-term%20impact%20of%20the%20program%20and%20linkage%20to%20HIV%20service%20%28n%20%3D%202%29.%5CnCONCLUSION%3A%20We%20recommend%20that%20HIV%20clinics%20that%20offer%20CC%20control%20services%20in%20sub-Saharan%20Africa%20implement%20the%2017%20indicators%20stepwise%20and%20adapt%20them%20to%20context%20to%20improve%20monitoring%20along%20the%20CC%20control%20cascade.%22%2C%22date%22%3A%222024-02-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000003343%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A29Z%22%7D%7D%2C%7B%22key%22%3A%223K3AFYPR%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lancaster%20et%20al.%22%2C%22parsedDate%22%3A%222024-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLancaster%2C%20Kathryn%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BStockton%2C%20Melissa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRemch%2C%20Molly%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BWester%2C%20C.%20William%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNash%2C%20Denis%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Availability%20of%20substance%20use%20screening%20and%20treatment%20within%20HIV%20clinical%20sites%20across%20seven%20geographic%20regions%20within%20the%20IeDEA%20consortium.%20%26lt%3Bi%26gt%3BThe%20International%20Journal%20on%20Drug%20Policy%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B124%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%20104309.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.drugpo.2023.104309%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.drugpo.2023.104309%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20substance%20use%20screening%20and%20treatment%20within%20HIV%20clinical%20sites%20across%20seven%20geographic%20regions%20within%20the%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20E.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%22%2C%22lastName%22%3A%22Remch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Finlayson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Breanna%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%20Kamaru%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayne%20Lewis%22%2C%22lastName%22%3A%22Kulzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuti%22%2C%22lastName%22%3A%22Merati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judiacel%22%2C%22lastName%22%3A%22Tine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Per%20von%22%2C%22lastName%22%3A%22Groote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Jennifer%22%2C%22lastName%22%3A%22Edelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Overwhelming%20evidence%20highlights%20the%20negative%20impact%20of%20substance%20use%20on%20HIV%20care%20and%20treatment%20outcomes.%20Yet%2C%20the%20extent%20to%20which%20alcohol%20use%20disorder%20%28AUD%29%20and%20other%20substance%20use%20disorders%20%28SUD%29%20services%20have%20been%20integrated%20within%20HIV%20clinical%20settings%20is%20limited.%20We%20describe%20AUD%5C%2FSUD%20screening%20and%20treatment%20availability%20in%20HIV%20clinical%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%3A%20In%202020%2C%20223%20IeDEA%20HIV%20clinical%20sites%20from%2041%20countries%20across%20seven%20geographic%20regions%20completed%20a%20survey%20on%20capacity%20and%20practices%20related%20to%20management%20of%20AUD%5C%2F%20SUD.%20Sites%20provided%20information%20on%20AUD%20and%20other%20SUD%20screening%20and%20treatment%20practices.%5CnRESULTS%3A%20Sites%20were%20from%20low-income%20countries%20%2823%25%29%2C%20lower-middle-income%20countries%20%2838%25%29%2C%20upper-middle%20income%20countries%20%2817%25%29%20and%20high-income%20counties%20%2823%25%29.%20AUD%20and%20SUD%20screening%20using%20validated%20instruments%20were%20reported%20at%2032%25%20%28n%3D71%20located%20in%2012%20countries%29%20and%2012%25%20%28n%3D27%20located%20in%206%20countries%29%20of%20the%20223%20sites%20from%2041%20countries%2C%20respectively.%20The%20North%20American%20region%20had%20the%20highest%20proportion%20of%20clinics%20that%20reported%20AUD%20screening%20%2876%25%29%2C%20followed%20by%20East%20Africa%20%2846%25%29%3B%20none%20of%20the%20sites%20in%20West%20or%20Central%20Africa%20reported%20AUD%20screening.%2031%25%20%28n%3D69%29%20reported%20both%20AUD%20screening%20and%20counseling%2C%20brief%20intervention%2C%20psychotherapy%2C%20or%20Screening%2C%20Brief%20Intervention%2C%20and%20Referral%20to%20Treatment%3B%208%25%20%28n%3D18%29%20reported%20AUD%20screening%20and%20detox%20hospitalization%3B%20and%2010%25%20%28n%3D24%29%20reported%20both%20AUD%20screening%20and%20medication.%20While%20the%20proportion%20of%20clinics%20providing%20treatment%20for%20SUD%20was%20lower%20than%20those%20treating%20AUD%2C%20the%20prevalence%20estimates%20of%20treatment%20availability%20were%20similar.%5CnCONCLUSIONS%3A%20Availability%20of%20screening%20and%20treatment%20for%20AUD%5C%2FSUD%20in%20HIV%20care%20settings%20is%20limited%2C%20leaving%20a%20substantial%20gap%20for%20integration%20into%20ongoing%20HIV%20care.%20A%20critical%20understanding%20is%20needed%20of%20the%20multilevel%20implementation%20factors%20or%20feasible%20implementation%20strategies%20for%20integrating%20screening%20and%20treatment%20of%20AUD%5C%2FSUD%20into%20HIV%20care%20settings%2C%20particularly%20for%20resource-constrained%20regions.%22%2C%22date%22%3A%222024-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.drugpo.2023.104309%22%2C%22ISSN%22%3A%221873-4758%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22PXW76NAV%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shamu%20et%20al.%22%2C%22parsedDate%22%3A%222024-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShamu%2C%20Tinei%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEgger%2C%20Matthias%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMudzviti%2C%20Tinashe%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChimbetete%2C%20Cleophas%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BManasa%2C%20Justen%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Body%20weight%20and%20blood%20pressure%20changes%20on%20dolutegravir-%2C%20efavirenz-%20or%20atazanavir-based%20antiretroviral%20therapy%20in%20Zimbabwe%3A%20a%20longitudinal%20study.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20e26216.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26216%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26216%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Body%20weight%20and%20blood%20pressure%20changes%20on%20dolutegravir-%2C%20efavirenz-%20or%20atazanavir-based%20antiretroviral%20therapy%20in%20Zimbabwe%3A%20a%20longitudinal%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinei%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinashe%22%2C%22lastName%22%3A%22Mudzviti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justen%22%2C%22lastName%22%3A%22Manasa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Dolutegravir%20%28DTG%29%20is%20widely%20used%20for%20antiretroviral%20therapy%20%28ART%29.%20We%20compared%20weight%20and%20blood%20pressure%20trends%20and%20examined%20the%20association%20between%20high%20blood%20pressure%20and%20weight%20gain%20among%20people%20living%20with%20HIV%20%28PLHIV%29%20switching%20to%20or%20starting%20DTG-based%2C%20efavirenz%20%28EFV%29-based%20and%20ritonavir-boosted%20atazanavir%20%28ATV%5C%2Fr%29-based%20ART%20in%20Zimbabwe.%5CnMETHODS%3A%20PLHIV%20aged%2018%20years%20or%20older%20who%20started%20or%20switched%20to%20DTG%2C%20EFV%20or%20ATV%5C%2Fr-based%20ART%20between%20January%202004%20and%20June%202022%20at%20Newlands%20Clinic%20in%20Harare%2C%20Zimbabwe%2C%20were%20eligible.%20Weight%20was%20measured%20at%20all%20visits%20%28Seca%20floor%20scales%29%3B%20blood%20pressure%20only%20at%20clinician-led%20visits%20%28Omron%20M2%20sphygmomanometer%29.%20We%20used%20Bayesian%20additive%20models%20to%20estimate%20trends%20in%20weight%20gain%20and%20the%20proportion%20with%20high%20blood%20pressure%20%28systolic%20%26gt%3B140%20mmHg%20or%20diastolic%20%26gt%3B90%20mmHg%29%20in%20the%20first%202%20years%20after%20starting%20or%20switching%20the%20regimen.%20Finally%2C%20we%20examined%20whether%20trends%20in%20the%20proportion%20with%20high%20blood%20pressure%20were%20related%20to%20weight%20change.%5CnRESULTS%3A%20We%20analysed%2099%2C969%20weight%20and%2035%2C449%20blood%20pressure%20records%20from%209487%20adults%20%28DTG%3A%204593%3B%20EFV%3A%203599%3B%20ATV%5C%2Fr%3A%201295%29.%20At%2024%20months%20after%20starting%20or%20switching%20to%20DTG%2C%20estimated%20median%20weight%20gains%20were%204.54%20kg%20%2890%25%20credibility%20interval%203.88-5.28%20kg%29%20in%20women%20and%203.71%20kg%20%283.07-4.45%20kg%29%20in%20men%2C%20around%20twice%20that%20observed%20for%20ATV%5C%2Fr%20and%20over%20four-times%20the%20gain%20observed%20for%20EFV.%20Prevalence%20of%20high%20blood%20pressure%20among%20PLHIV%20receiving%20DTG-based%20ART%20increased%20from%20around%205%25%20at%20baseline%20to%20over%2020%25%20at%2024%20months%2C%20with%20no%20change%20in%20PLHIV%20receiving%20EFV-%20or%20ATV%5C%2Fr-based%20ART.%20High%20blood%20pressure%20in%20PLHIV%20switching%20to%20DTG%20was%20associated%20with%20weight%20gain%2C%20with%20stronger%20increases%20in%20the%20proportion%20with%20high%20blood%20pressure%20for%20larger%20weight%20gains.%5CnCONCLUSIONS%3A%20Among%20PLHIV%20starting%20ART%20or%20switching%20to%20a%20new%20regimen%2C%20DTG-based%20ART%20was%20associated%20with%20larger%20weight%20gains%20and%20a%20substantial%20increase%20in%20the%20prevalence%20of%20high%20blood%20pressure.%20Routine%20weight%20and%20blood%20pressure%20measurement%20and%20interventions%20to%20lower%20blood%20pressure%20could%20benefit%20PLHIV%20on%20DTG-based%20ART.%20Further%20studies%20are%20needed%20to%20elucidate%20the%20mechanisms%20and%20reversibility%20of%20these%20changes%20after%20discontinuation%20of%20DTG.%22%2C%22date%22%3A%222024-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26216%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A14%3A49Z%22%7D%7D%2C%7B%22key%22%3A%228S7DKRXA%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kassanjee%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-25%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKassanjee%2C%20Reshma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavies%2C%20Mary-Ann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHeekes%2C%20Alexa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMahomed%2C%20Hassan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHawkridge%2C%20Anthony%20J.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20COVID-19%20vaccine%20uptake%20and%20effectiveness%20by%20time%20since%20vaccination%20in%20the%20Western%20Cape%20province%2C%20South%20Africa%3A%20An%20observational%20cohort%20study%20during%202020-2022.%20%26lt%3Bi%26gt%3BmedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%202024.01.24.24301721.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.01.24.24301721%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.01.24.24301721%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22COVID-19%20vaccine%20uptake%20and%20effectiveness%20by%20time%20since%20vaccination%20in%20the%20Western%20Cape%20province%2C%20South%20Africa%3A%20An%20observational%20cohort%20study%20during%202020-2022%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexa%22%2C%22lastName%22%3A%22Heekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hassan%22%2C%22lastName%22%3A%22Mahomed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20J.%22%2C%22lastName%22%3A%22Hawkridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milani%22%2C%22lastName%22%3A%22Wolmarans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erna%22%2C%22lastName%22%3A%22Morden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theuns%22%2C%22lastName%22%3A%22Jacobs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheryl%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harry%22%2C%22lastName%22%3A%22Moultrie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Lessells%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolette%22%2C%22lastName%22%3A%22Van%20Der%20Walt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juanita%20O.%22%2C%22lastName%22%3A%22Arendse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hilary%22%2C%22lastName%22%3A%22Goeiman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Mudaly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Wolter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sibongile%22%2C%22lastName%22%3A%22Walaza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Waasila%22%2C%22lastName%22%3A%22Jassat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22von%20Gottberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20L.%22%2C%22lastName%22%3A%22Hannan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petro%22%2C%22lastName%22%3A%22Rousseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Feikin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%22%2C%22lastName%22%3A%22Cloete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20There%20are%20few%20data%20on%20the%20real-world%20effectiveness%20of%20COVID-19%20vaccines%20and%20boosting%20in%20Africa%2C%20which%20experienced%20high%20levels%20of%20SARS-CoV-2%20infection%20in%20a%20mostly%20vaccine-na%5Cu00efve%20population%2C%20and%20has%20limited%20vaccine%20coverage%20and%20competing%20health%20service%20priorities.%20We%20assessed%20the%20association%20between%20vaccination%20and%20severe%20COVID-19%20in%20the%20Western%20Cape%2C%20South%20Africa.%5CnMETHODS%3A%20We%20performed%20an%20observational%20cohort%20study%20of%20%26gt%3B2%20million%20adults%20during%202020-2022.%20We%20described%20SARS-CoV-2%20testing%2C%20COVID-19%20outcomes%2C%20and%20vaccine%20uptake%20over%20time.%20We%20used%20multivariable%20cox%20models%20to%20estimate%20the%20association%20of%20BNT162b2%20and%20Ad26.COV2.S%20vaccination%20with%20COVID-19-related%20hospitalisation%20and%20death%2C%20adjusting%20for%20demographic%20characteristics%2C%20underlying%20health%20conditions%2C%20socioeconomic%20status%20proxies%20and%20healthcare%20utilisation.%5CnRESULTS%3A%20By%20end%202022%2C%20only%2041%25%20of%20surviving%20adults%20had%20completed%20vaccination%20and%208%25%20a%20booster%20dose%2C%20despite%20several%20waves%20of%20severe%20COVID-19.%20Recent%20vaccination%20was%20associated%20with%20notable%20reductions%20in%20severe%20COVID-19%20during%20distinct%20analysis%20periods%20dominated%20by%20Delta%2C%20Omicron%20BA.1%5C%2F2%20and%20BA.4%5C%2F5%20%28sub%29lineages%3A%20within%206%20months%20of%20completing%20vaccination%20or%20boosting%2C%20vaccine%20effectiveness%20was%2046-92%25%20for%20death%20%28range%20across%20periods%29%2C%2045-92%25%20for%20admission%20with%20severe%20disease%20or%20death%2C%20and%2025-90%25%20for%20any%20admission%20or%20death.%20During%20the%20Omicron%20BA.4%5C%2F5%20wave%2C%20within%203%20months%20of%20vaccination%20or%20boosting%2C%20BNT162b2%20and%20Ad26.COV2.S%20were%20each%2084%25%20effective%20against%20death%20%2895%25%20CIs%3A%2057-94%20and%2049-95%2C%20respectively%29.%20However%2C%20there%20were%20distinct%20reductions%20of%20VE%20at%20larger%20times%20post%20completing%20or%20boosting%20vaccination.%5CnCONCLUSIONS%3A%20Continued%20emphasis%20on%20regular%20COVID-19%20vaccination%20including%20boosting%20is%20important%20for%20those%20at%20high%20risk%20of%20severe%20COVID-19%20even%20in%20settings%20with%20widespread%20infection-induced%20immunity.%22%2C%22date%22%3A%222024-01-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.01.24.24301721%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222024-03-18T10%3A47%3A11Z%22%7D%7D%2C%7B%22key%22%3A%229C2H29RK%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dhokotera%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDhokotera%2C%20Tafadzwa%20G.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMuchengeti%2C%20Mazvita%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavidovi%26%23x107%3B%2C%20Ma%26%23x161%3Ba%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRohner%2C%20Eliane%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BOlago%2C%20Victor%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Gynaecologic%20and%20breast%20cancers%20in%20women%20living%20with%20HIV%20in%20South%20Africa%3A%20A%20record%20linkage%20study.%20%26lt%3Bi%26gt%3BInternational%20Journal%20of%20Cancer%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B154%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20284%26%23x2013%3B296.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fijc.34712%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fijc.34712%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Gynaecologic%20and%20breast%20cancers%20in%20women%20living%20with%20HIV%20in%20South%20Africa%3A%20A%20record%20linkage%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tafadzwa%20G.%22%2C%22lastName%22%3A%22Dhokotera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mazvita%22%2C%22lastName%22%3A%22Muchengeti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ma%5Cu0161a%22%2C%22lastName%22%3A%22Davidovi%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Olago%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%5D%2C%22abstractNote%22%3A%22Breast%20and%20gynaecologic%20cancers%20account%20for%20approximately%20half%20of%20all%20cancers%20diagnosed%20amongst%20women%20in%20South%20Africa%2C%20many%20of%20whom%20also%20live%20with%20HIV.%20We%20aimed%20to%20determine%20the%20incidence%20of%20and%20risk%20factors%20for%20developing%20breast%20and%20gynaecologic%20cancers%20in%20women%20living%20with%20HIV%20%28WLHIV%29%20in%20South%20Africa.%20This%20is%20a%20longitudinal%20analysis%20of%20the%20South%20African%20HIV%20Cancer%20Match%20study%20including%20women%20aged%20%5Cu226515%5Cu2009years%20with%20two%20or%20more%20HIV-related%20laboratory%20tests.%20We%20used%20Cox%20proportional%20hazard%20models%20to%20determine%20the%20association%20of%20Human%20Papilloma%20Virus%20%28HPV%29-related%20and%20hormone-related%20gynaecologic%20cancer%20with%20patient-%20and%20municipal-level%20characteristics.%20From%203%5Cu2009447%5Cu2009908%20women%20and%2010.5%20million%20years%20of%20follow-up%2C%20we%20identified%2011%5Cu2009384%20incident%20and%207612%20prevalent%20gynaecologic%20and%20breast%20cancers.%20The%20overall%20crude%20incidence%20rate%20was%20108%5C%2F1%5Cu200900%5Cu2009000%20person-years%20%28pyears%29%20%2895%25%20confidence%20interval%20%5BCI%5D%3A%20106-110%29%2C%20with%20the%20highest%20incidence%20observed%20for%20cervical%20cancer%20%2870%5C%2F1%5Cu200900%5Cu2009000%20pyears%3B%2095%25%20CI%3A%2068.5-71.7%29.%20Low%20CD4%20cell%20counts%20and%20high%20HIV%20RNA%20viral%20loads%20increased%20the%20risk%20of%20cervical%20and%20other%20HPV-related%20cancers.%20Age%20was%20associated%20with%20both%20HPV-related%20and%20hormone-related%20cancers.%20Women%20accessing%20health%20facilities%20in%20high%20socioeconomic%20position%20%28SEP%29%20municipalities%20were%20more%20likely%20to%20be%20diagnosed%20with%20HPV-related%20cancers%20and%20breast%20cancer%20than%20women%20accessing%20care%20in%20low%20SEP%20municipalities.%20It%20is%20important%20to%20improve%20the%20immunologic%20status%20of%20WLHIV%20as%20part%20of%20cancer%20prevention%20strategies%20in%20WLHIV.%20Cancer%20prevention%20and%20early%20detection%20programmes%20should%20be%20tailored%20to%20the%20needs%20of%20women%20ageing%20with%20HIV.%20In%20addition%2C%20SEP%20disparities%20in%20cancer%20diagnostic%20services%20have%20to%20be%20addressed.%22%2C%22date%22%3A%222024-01-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fijc.34712%22%2C%22ISSN%22%3A%221097-0215%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-20T13%3A04%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22YKFGHM7H%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fern%5Cu00e1ndez%20Villalobos%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BFern%26%23xE1%3Bndez%20Villalobos%2C%20Nathalie%20Ver%26%23xF3%3Bnica%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRuffieux%2C%20Yann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHaas%2C%20Andreas%20D.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChinogurei%2C%20Chido%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCornell%2C%20Morna%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Cervical%20precancer%20and%20cancer%20incidence%20among%20insured%20women%20with%20and%20without%20HIV%20in%20South%20Africa.%20%26lt%3Bi%26gt%3BInternational%20Journal%20of%20Cancer%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B154%26lt%3B%5C%2Fi%26gt%3B%20%282%29%2C%20S.%20273%26%23x2013%3B283.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fijc.34707%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fijc.34707%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cervical%20precancer%20and%20cancer%20incidence%20among%20insured%20women%20with%20and%20without%20HIV%20in%20South%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Ver%5Cu00f3nica%22%2C%22lastName%22%3A%22Fern%5Cu00e1ndez%20Villalobos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22Ruffieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chido%22%2C%22lastName%22%3A%22Chinogurei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katayoun%22%2C%22lastName%22%3A%22Taghavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Folb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Maartens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%5D%2C%22abstractNote%22%3A%22HIV%20infection%20increases%20the%20risk%20of%20developing%20cervical%20cancer%3B%20however%2C%20longitudinal%20studies%20in%20sub-Saharan%20Africa%20comparing%20cervical%20cancer%20rates%20between%20women%20living%20with%20HIV%20%28WLWH%29%20and%20women%20without%20HIV%20are%20scarce.%20To%20address%20this%20gap%2C%20we%20compared%20cervical%20precancer%20and%20cancer%20incidence%20rates%20between%20WLWH%20and%20women%20without%20HIV%20in%20South%20Africa%20using%20reimbursement%20claims%20data%20from%20a%20medical%20insurance%20scheme%20from%20January%202011%20to%20June%202020.%20We%20used%20Royston-Parmar%20flexible%20parametric%20survival%20models%20to%20estimate%20cervical%20precancer%20and%20cancer%20incidence%20rates%20as%20a%20continuous%20function%20of%20age%2C%20stratified%20by%20HIV%20status.%20Our%20study%20population%20consisted%20of%20518%5Cu2009048%20women%2C%20with%20exclusions%20based%20on%20the%20endpoint%20of%20interest.%20To%20analyse%20cervical%20cancer%20incidence%2C%20we%20included%20517%5Cu2009312%20women%2C%20of%20whom%20564%20developed%20cervical%20cancer.%20WLWH%20had%20an%20~3-fold%20higher%20risk%20of%20developing%20cervical%20precancer%20and%20cancer%20than%20women%20without%20HIV%20%28adjusted%20hazard%20ratio%20for%20cervical%20cancer%3A%202.99%3B%2095%25%20confidence%20interval%20%5BCI%5D%3A%202.40-3.73%29.%20For%20all%20endpoints%20of%20interest%2C%20the%20estimated%20incidence%20rates%20were%20higher%20in%20WLWH%20than%20women%20without%20HIV.%20Cervical%20cancer%20rates%20among%20WLWH%20increased%20at%20early%20ages%20and%20peaked%20at%2049%5Cu2009years%20%28122%5C%2F100%5Cu2009000%20person-years%3B%2095%25%20CI%3A%20100-147%29%2C%20whereas%2C%20in%20women%20without%20HIV%2C%20incidence%20rates%20peaked%20at%2056%5Cu2009years%20%2840%5C%2F100%5Cu2009000%20person-years%3B%2095%25%20CI%3A%2036-45%29.%20Cervical%20precancer%20rates%20peaked%20in%20women%20in%20their%2030s.%20Analyses%20of%20age-specific%20cervical%20cancer%20rates%20by%20HIV%20status%20are%20essential%20to%20inform%20the%20design%20of%20targeted%20cervical%20cancer%20prevention%20policies%20in%20Southern%20Africa%20and%20other%20regions%20with%20a%20double%20burden%20of%20HIV%20and%20cervical%20cancer.%22%2C%22date%22%3A%222024-01-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fijc.34707%22%2C%22ISSN%22%3A%221097-0215%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-20T13%3A03%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22JUI8ZCRG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Enane%20et%20al.%22%2C%22parsedDate%22%3A%222024-01-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEnane%2C%20Leslie%20A.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDuda%2C%20Stephany%20N.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChanyachukul%2C%20Thida%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBolton-Moore%2C%20Carolyn%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNavuluri%2C%20Neelima%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20Tuberculosis%20Sentinel%20Research%20Network%20%28TB-SRN%29%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%3A%20protocol%20for%20a%20prospective%20cohort%20study%20in%20Africa%2C%20Southeast%20Asia%20and%20Latin%20America.%20%26lt%3Bi%26gt%3BBMJ%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e079138.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2023-079138%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2023-079138%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Tuberculosis%20Sentinel%20Research%20Network%20%28TB-SRN%29%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%3A%20protocol%20for%20a%20prospective%20cohort%20study%20in%20Africa%2C%20Southeast%20Asia%20and%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Chanyachukul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neelima%22%2C%22lastName%22%3A%22Navuluri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mbonze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22LaQuita%20R.%22%2C%22lastName%22%3A%22McDade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20Cruvinel%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Akpata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Flore%22%2C%22lastName%22%3A%22Pierre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhanushi%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22de%20Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martine%22%2C%22lastName%22%3A%22Tabala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Huebner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Tuberculosis%20%28TB%29%20is%20a%20leading%20infectious%20cause%20of%20death%20globally.%20It%20is%20the%20most%20common%20opportunistic%20infection%20in%20people%20living%20with%20HIV%2C%20and%20the%20most%20common%20cause%20of%20their%20morbidity%20and%20mortality.%20Following%20TB%20treatment%2C%20surviving%20individuals%20may%20be%20at%20risk%20for%20post-TB%20lung%20disease.%20The%20TB%20Sentinel%20Research%20Network%20%28TB-SRN%29%20provides%20a%20platform%20for%20coordinated%20observational%20TB%20research%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%20AND%20ANALYSIS%3A%20This%20prospective%2C%20observational%20cohort%20study%20will%20assess%20treatment%20and%20post-treatment%20outcomes%20of%20pulmonary%20TB%20%28microbiologically%20confirmed%20or%20clinically%20diagnosed%29%20among%202600%20people%20aged%20%5Cu226515%20years%2C%20with%20and%20without%20HIV%20coinfection%2C%20consecutively%20enrolled%20at%2016%20sites%20in%2011%20countries%2C%20across%206%20of%20IeDEA%26%23039%3Bs%20global%20regions.%20Data%20regarding%20clinical%20and%20sociodemographic%20factors%2C%20mental%20health%2C%20health-related%20quality%20of%20life%2C%20pulmonary%20function%2C%20and%20laboratory%20and%20radiographic%20findings%20will%20be%20collected%20using%20standardised%20questionnaires%20and%20data%20collection%20tools%2C%20beginning%20from%20the%20initiation%20of%20TB%20treatment%20and%20through%2012%20months%20after%20the%20end%20of%20treatment.%20Data%20will%20be%20aggregated%20for%20proposed%20analyses.%5CnETHICS%20AND%20DISSEMINATION%3A%20Ethics%20approval%20was%20obtained%20at%20all%20implementing%20study%20sites%2C%20including%20the%20Vanderbilt%20University%20Medical%20Center%20Human%20Research%20Protections%20Programme.%20Participants%20will%20provide%20informed%20consent%3B%20for%20minors%2C%20this%20includes%20both%20adolescent%20assent%20and%20the%20consent%20of%20their%20parent%20or%20primary%20caregiver.%20Protections%20for%20vulnerable%20groups%20are%20included%2C%20in%20alignment%20with%20local%20standards%20and%20considerations%20at%20sites.%20Procedures%20for%20requesting%20use%20and%20analysis%20of%20TB-SRN%20data%20are%20publicly%20available.%20Findings%20from%20TB-SRN%20analyses%20will%20be%20shared%20with%20national%20TB%20programmes%20to%20inform%20TB%20programming%20and%20policy%2C%20and%20disseminated%20at%20regional%20and%20global%20conferences%20and%20other%20venues.%22%2C%22date%22%3A%222024-01-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2023-079138%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222024-02-06T15%3A01%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22ENZDPGXT%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Olago%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BOlago%2C%20Victor%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BNimako%2C%20Gideon%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBartels%2C%20Lina%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBohlius%2C%20Julia%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDhokotera%2C%20Tafadzwa%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Cancer%20diagnostic%20service%20use%20in%20people%20living%20with%20HIV%20in%20South%20Africa%3A%20A%20cross-sectional%20study.%20%26lt%3Bi%26gt%3BPloS%20One%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%20e0291897.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0291897%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0291897%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cancer%20diagnostic%20service%20use%20in%20people%20living%20with%20HIV%20in%20South%20Africa%3A%20A%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Olago%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gideon%22%2C%22lastName%22%3A%22Nimako%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lina%22%2C%22lastName%22%3A%22Bartels%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tafadzwa%22%2C%22lastName%22%3A%22Dhokotera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elvira%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mazvita%22%2C%22lastName%22%3A%22Sengayi-Muchengeti%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20The%20objective%20of%20this%20study%20was%20to%20map%20place%20of%20cancer%20diagnosis%20in%20relation%20to%20Human%20Immunodeficiency%20Virus%20%28HIV%29%20care%20centre%20among%20people%20living%20with%20HIV%20%28PLHIV%29%20within%20South%20Africa%20%28SA%29%20using%20national%20laboratory%20database.%5CnDESIGN%3A%20We%20linked%20HIV%20and%20cancer%20laboratory%20data%20from%202004-2014%20using%20supervised%20machine-learning%20algorithms.%20We%20performed%20a%20cross-sectional%20analysis%20comparing%20province%20where%20individuals%20accessed%20their%20HIV%20care%20versus%20where%20they%20had%20their%20cancer%20diagnosis.%5CnSETTING%3A%20We%20used%20laboratory%20test%20records%20related%20to%20HIV%20diagnostics%20and%20care%2C%20such%20as%20CD4%20cell%20counts%20and%20percentages%2C%20rapid%20tests%2C%20qualitative%20Polymerase%20Chain%20Reaction%20%28PCR%29%2C%20antibody%20and%20antigen%20tests%20for%20HIV%20data%20that%20was%20documented%20as%20HIV%20positive%20and%20laboratory%20diagnosed%20cancer%20records%20from%20SA.%5CnSTUDY%20POPULATION%3A%20Our%20study%20population%20consisted%20of%20HIV%20records%20from%20the%20National%20Health%20Laboratory%20Service%20%28NHLS%29%20that%20linked%20to%20cancer%20record%20at%20the%20National%20Cancer%20Registry%20%28NCR%29%20between%202004-2014.%5CnPRIMARY%20AND%20SECONDARY%20OUTCOMES%3A%20We%20linked%20HIV%20records%20from%20NHLS%20to%20cancer%20records%20at%20NCR%20in%20order%20to%20study%20the%20inherent%20characteristics%20of%20the%20population%20with%20both%20HIV%20and%20cancer.%5CnRESULTS%3A%20The%20study%20population%20was%2068%2C284%20individuals%20with%20cancer%20and%20documented%20HIV%20related%20laboratory%20test.%20The%20median%20age%20at%20cancer%20diagnosis%20was%2040%20%5BIQR%2C%2033-48%5D%20years%20for%20the%20study%20population%20with%20most%20cancers%20in%20PLHIV%20diagnosed%20in%20females%2070.9%25%20%5Bn%20%3D%2046%2C313%5D.%20Of%20all%20the%20PLHIV%20and%20cancer%2C%2025%25%20%28n%20%3D%2016%2C364%20p%20%26lt%3B%200.001%29%20sought%20treatment%20outside%20their%20province%20of%20residence%20with%2060.7%25%20%28n%20%3D%2010%2C235%29%20travelling%20to%20Gauteng.%20KZN%20had%2046.6%25%20%28n%20%3D%204%2C107%29%20of%20its%20PLHIV%20getting%20cancer%20diagnosis%20in%20Gauteng.%20Western%20Cape%20had%2095%25%20%28n%20%3D%206%2C200%29%20of%20PLHIV%20getting%20cancer%20diagnosis%20within%20the%20province.%5CnCONCLUSIONS%3A%20Our%20results%20showed%20health%20systems%20inequalities%20across%20provinces%20in%20SA%20with%20respect%20to%20cancer%20diagnosis.%20KZN%20for%20example%20had%20nearly%20half%20of%20the%20PLHIV%20getting%20cancer%20diagnosis%20outside%20the%20province%20while%20Western%20Cape%20is%20able%20to%20offer%20cancer%20diagnostic%20services%20to%20most%20of%20the%20PLHIV%20in%20the%20province.%20Gauteng%20is%20getting%20over%20burdened%20with%20referral%20for%20cancer%20diagnosis%20from%20other%20provinces.%20More%20effort%20is%20required%20to%20ensure%20equitable%20access%20to%20cancer%20diagnostic%20services%20within%20the%20country.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0291897%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A15%3A15Z%22%7D%7D%2C%7B%22key%22%3A%2269CKNZMW%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Taghavi%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTaghavi%2C%20Katayoun%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMoono%2C%20Misinzo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMwanahamuntu%2C%20Mulindi%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BRoumet%2C%20Marie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BLimacher%2C%20Andreas%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Accuracy%20of%20screening%20tests%20for%20cervical%20precancer%20in%20women%20living%20with%20HIV%20in%20low-resource%20settings%3A%20a%20paired%20prospective%20study%20in%20Lusaka%2C%20Zambia.%20%26lt%3Bi%26gt%3BBMJ%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B3%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e000111.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjonc-2023-000111%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjonc-2023-000111%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accuracy%20of%20screening%20tests%20for%20cervical%20precancer%20in%20women%20living%20with%20HIV%20in%20low-resource%20settings%3A%20a%20paired%20prospective%20study%20in%20Lusaka%2C%20Zambia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katayoun%22%2C%22lastName%22%3A%22Taghavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Misinzo%22%2C%22lastName%22%3A%22Moono%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mulindi%22%2C%22lastName%22%3A%22Mwanahamuntu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Roumet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Limacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Herbert%22%2C%22lastName%22%3A%22Kapesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thamsanqa%22%2C%22lastName%22%3A%22Madliwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Rutjes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Partha%22%2C%22lastName%22%3A%22Basu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Low%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Manasyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20This%20study%20aimed%20to%20provide%20evidence%20to%20improve%20cervical%20screening%20for%20women%20living%20with%20HIV%20%28WLHIV%29.%20We%20assessed%20the%20accuracy%20of%20screening%20tests%20that%20can%20be%20used%20in%20low-resource%20settings%20and%20give%20results%20at%20the%20same%20visit.%5CnMETHODS%20AND%20ANALYSIS%3A%20We%20conducted%20a%20paired%2C%20prospective%20study%20among%20consecutive%20eligible%20WLHIV%2C%20aged%2018-65%20years%2C%20receiving%20cervical%20cancer%20screening%20at%20one%20hospital%20in%20Lusaka%2C%20Zambia.%20The%20histopathological%20reference%20standard%20was%20multiple%20biopsies%20taken%20at%20two%20time%20points.%20The%20target%20condition%20was%20cervical%20intraepithelial%20neoplasia%20grade%202%20and%20above%20%28CIN2%2B%29.%20The%20index%20tests%20were%20high-risk%20human%20papillomavirus%20detection%20%28hrHPV%2C%20Xpert%20HPV%2C%20Cepheid%29%2C%20portable%20colposcopy%20%28Gynocular%2C%20Gynius%29%20and%20visual%20inspection%20with%20acetic%20acid%20%28VIA%29.%20Accuracy%20of%20stand-alone%20and%20test%20combinations%20were%20calculated%20as%20the%20point%20estimate%20with%2095%25%20CIs.%20A%20sensitivity%20analysis%20considered%20disease%20when%20only%20visible%20lesions%20were%20biopsied.%5CnRESULTS%3A%20Women%20included%20in%20the%20study%20had%20well-controlled%20HIV%20infection%20%28median%20CD4%20count%3D542%20cells%5C%2Fmm3%29%20and%20all%20except%20one%20were%20on%20antiretroviral%20therapy.%20Among%20371%20participants%20with%20histopathological%20results%2C%2027%25%20%28101%5C%2F371%29%20women%20had%20CIN2%2B%20and%2023%25%20%2823%5C%2F101%29%20were%20not%20detected%20by%20any%20index%20test.%20Sensitivity%20and%20specificity%20for%20stand-alone%20tests%20were%3A%20hrHPV%2C%2067.3%25%20%2895%25%20CI%2057.7%25%20to%2075.7%25%29%20and%2065.3%25%20%2895%25%20CI%2059.4%25%20to%2070.7%25%29%3B%20Gynocular%2051.5%25%20%2895%25%20CI%2041.9%25%20to%2061.0%25%29%20and%2080.0%25%20%2895%25%20CI%2074.8%25%20to%2084.3%25%29%3B%20and%20VIA%2022.8%25%20%2895%25%20CI%2015.7%25%20to%2031.9%25%29%20and%2092.6%25%20%2895%25%20CI%2088.8%25%20to%2095.2%25%29%2C%20respectively.%20Combining%20tests%20did%20not%20improve%20test%20accuracy%20measures.%20All%20test%20accuracies%20improved%20in%20sensitivity%20analysis.%5CnCONCLUSION%3A%20The%20low%20accuracy%20of%20screening%20tests%20assessed%20might%20be%20explained%20by%20our%20reference%20standard%2C%20which%20reduced%20verification%20and%20misclassification%20biases.%20Better%20screening%20strategies%20for%20WLHIV%20in%20low-resource%20settings%20are%20urgently%20needed.%5CnTRIAL%20REGISTRATION%20NUMBER%3A%20NCT03931083.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjonc-2023-000111%22%2C%22ISSN%22%3A%222752-7948%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-17T08%3A46%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22JTJFSID4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Atkinson%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BAtkinson%2C%20Andrew%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKraus%2C%20David%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBanholzer%2C%20Nicolas%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMiro%2C%20Jose%20M.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BReiss%2C%20Peter%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20HIV%20replication%20and%20tuberculosis%20risk%20among%20people%20living%20with%20HIV%20in%20Europe%3A%20A%20multicohort%20analysis%2C%201983-2015.%20%26lt%3Bi%26gt%3BPloS%20One%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%20%2810%29%2C%20S.%20e0312035.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0312035%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0312035%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20replication%20and%20tuberculosis%20risk%20among%20people%20living%20with%20HIV%20in%20Europe%3A%20A%20multicohort%20analysis%2C%201983-2015.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Atkinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Kraus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Banholzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20M.%22%2C%22lastName%22%3A%22Miro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Reiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Kirk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Mussini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Morlat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daria%22%2C%22lastName%22%3A%22Podlekareva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20D.%22%2C%22lastName%22%3A%22Grant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Sabin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22van%20der%20Valk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Le%20Moing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Remonie%22%2C%22lastName%22%3A%22Seng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonella%22%2C%22lastName%22%3A%22Castagna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niels%22%2C%22lastName%22%3A%22Obel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastasia%22%2C%22lastName%22%3A%22Antoniadou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Salmon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Zwahlen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephane%22%2C%22lastName%22%3A%22de%20Wit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hansjakob%22%2C%22lastName%22%3A%22Furrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20HIV%20replication%20leads%20to%20a%20change%20in%20lymphocyte%20phenotypes%20that%20impairs%20immune%20protection%20against%20opportunistic%20infections.%20We%20examined%20current%20HIV%20replication%20as%20an%20independent%20risk%20factor%20for%20tuberculosis%20%28TB%29.%20METHODS%3A%20We%20included%20people%20living%20with%20HIV%20from%2025%20European%20cohorts%201983-2015.%20Individuals%20%26lt%3B16%20years%20or%20with%20previous%20TB%20were%20excluded.%20Person-time%20was%20calculated%20from%20enrolment%20%28baseline%29%20to%20the%20date%20of%20TB%20diagnosis%20or%20last%20follow-up%20information.%20We%20used%20adjusted%20Poisson%20regression%20and%20general%20additive%20regression%20models.%20RESULTS%3A%20We%20included%20272%2C548%20people%20with%20a%20median%20follow-up%20of%205.9%20years%20%28interquartile%20range%20%5BIQR%5D%202.3-10.9%29.%20At%20baseline%2C%20the%20median%20CD4%20cell%20count%20was%20355%20cells%5C%2FmuL%20%28IQR%20193-540%29%20and%20the%20median%20HIV-RNA%20level%2022%2C000%20copies%5C%2FmL%20%28IQR%201%2C300-103%2C000%29.%20During%201%2C923%2C441%20person-years%20of%20follow-%20up%2C%205%2C956%20%282.2%25%29%20people%20developed%20TB.%20Overall%2C%20TB%20incidence%20was%203.1%20per%201%2C000%20person-years%20%2895%25%20confidence%20interval%20%5BCI%5D%203.02-3.18%29%20and%20was%20four%20times%20higher%20in%20patients%20with%20HIV-RNA%20levels%20of%2010%2C000%20compared%20with%20levels%20%26lt%3B400%20copies%5C%2FmL%20in%20any%20CD4%20stratum.%20CD4%20and%20HIV-RNA%20time-updated%20analyses%20showed%20that%20the%20association%20between%20HIV-RNA%20and%20TB%20incidence%20was%20independent%20of%20CD4.%20The%20TB%20incidence%20rate%20ratio%20for%20people%20born%20in%20TB-%20endemic%20countries%20compared%20with%20those%20born%20in%20Europe%20was%201.8%20%2895%25%20CI%201.5-2.2%29.%20CONCLUSIONS%3A%20Our%20results%20indicate%20that%20ongoing%20HIV%20replication%20%28suboptimal%20HIV%20control%29%20is%20an%20important%20risk%20factor%20for%20TB%2C%20independent%20of%20CD4%20count.%20Those%20at%20highest%20risk%20of%20TB%20are%20people%20from%20TB-endemic%20countries.%20Close%20monitoring%20and%20TB%20preventive%20therapy%20for%20people%20with%20suboptimal%20HIV%20control%20is%20important.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0312035%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22PHYPFD3I%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Davidovic%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavidovic%2C%20Masa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDhokotera%2C%20Tafadzwa%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDos-Santos-Silva%2C%20Isabel%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBohlius%2C%20Julia%26lt%3B%5C%2Fspan%26gt%3B%20%26amp%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSengayi-Muchengeti%2C%20Mazvita%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Breast%20cancer%20in%20women%20by%20HIV%20status%3A%20A%20report%20from%20the%20South%20African%20National%20Cancer%20Registry.%20%26lt%3Bi%26gt%3BPloS%20One%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%20%286%29%2C%20S.%20e0305274.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0305274%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0305274%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Breast%20cancer%20in%20women%20by%20HIV%20status%3A%20A%20report%20from%20the%20South%20African%20National%20Cancer%20Registry.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masa%22%2C%22lastName%22%3A%22Davidovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tafadzwa%22%2C%22lastName%22%3A%22Dhokotera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Dos-Santos-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mazvita%22%2C%22lastName%22%3A%22Sengayi-Muchengeti%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Breast%20cancer%20%28BC%29%20is%20the%20leading%20cause%20of%20cancer-related%20morbidity%20and%20mortality%20in%20women%20living%20in%20South%20Africa%2C%20a%20country%20with%20a%20high%20HIV%20burden.%20However%2C%20characteristics%20of%20the%20double%20burden%20of%20HIV%20and%20BC%20in%20South%20Africa%20have%20not%20been%20properly%20investigated.%20We%20described%20characteristics%20of%20BC%20cases%20by%20HIV%20status%20in%20South%20Africa.%20METHODS%3A%20In%20this%20nationwide%20South%20African%20study%2C%20we%20obtained%20BC%20records%20for%20women%20aged%20%26gt%3B%5C%2F%3D15%20years%20diagnosed%20in%20the%20public%20health%20sector%20between%20January%202004%20and%20December%202014.%20We%20included%20records%20from%20the%20National%20Cancer%20Registry%20that%20had%20been%20linked%20to%20HIV-related%20laboratory%20records%20from%20the%20National%20Health%20Laboratory%20Service.%20We%20assessed%20the%20odds%20of%20being%20HIV%20positive%20versus%20HIV%20negative%20in%20relation%20to%20patient-%2C%20cancer-%2C%20and%20municipality-related%20characteristics.%20RESULTS%3A%20From%202004-2014%2C%2040%20520%20BC%20cases%20were%20diagnosed%20in%20women%20aged%20%26gt%3B%5C%2F%3D15%20years.%20Of%20these%2C%2073.5%25%20had%20unknown%20HIV%20status%2C%2018.7%25%20were%20HIV%20negative%2C%20and%207.7%25%20were%20HIV%20positive.%20The%20median%20age%20at%20BC%20diagnosis%20was%2043%20years%20%28interquartile%20range%20%5BIQR%5D%3A%2037-52%29%20in%20HIV%20positive%20and%2057%20years%20%28IQR%3A%2046-68%29%20in%20HIV%20negative%20women%2C%20respectively.%20The%20odds%20of%20being%20HIV%20positive%20was%20higher%20for%20women%20who%20were%20aged%2030-34%20years%20compared%20to%20women%20aged%2035-39%20years%20at%20cancer%20diagnosis%20%28odds%20ratio%20%5BOR%5D%201.38%2C%2095%25%20confidence%20interval%20%5BCI%5D%201.10-1.71%29%2C%20Black%20versus%20non-Black%20%28OR%206.41%2C%2095%25%20CI%205.68-7.23%29%2C%20diagnosed%20with%20cancer%20in%20rural%20versus%20urban%20areas%20%28OR%201.59%2C%2095%25%20CI%201.40-1.82%29%20and%20diagnosed%20in%20municipalities%20with%20low%20and%20middle%20%28OR%203.46%2C%2095%25%20CI%202.48-4.82%29%20versus%20high%20socioeconomic%20position%20%28OR%202.69%2C%2095%25%20CI%202.11-3.42%29.%20CONCLUSION%3A%20HIV%20status%20was%20unknown%20for%20the%20majority%20of%20BC%20patients.%20Among%20those%20with%20known%20HIV%20status%2C%20being%20HIV%20positive%20was%20associated%20with%20a%20younger%20age%20at%20cancer%20diagnosis%2C%20being%20Black%20and%20receiving%20care%20in%20municipalities%20of%20poor%20socioeconomic%20position.%20Future%20studies%20should%20examine%20opportunities%20to%20integrate%20HIV%20and%20BC%20control%20programs.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0305274%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22HQ278P6Y%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sharma%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSharma%2C%20Anjali%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMwamba%2C%20Chanda%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSt%20Clair-Sullivan%2C%20Natalie%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BChihota%2C%20Belinda%20V.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BPry%2C%20Jake%20M.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20The%20Social%20Construction%20of%20Aging%20Among%20a%20Clinic-Based%20Population%20and%20Their%20Healthcare%20Workers%20in%20Zambia.%20%26lt%3Bi%26gt%3BInternational%20Journal%20of%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B69%26lt%3B%5C%2Fi%26gt%3B%2C%20S.%201606607.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Fijph.2024.1606607%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Fijph.2024.1606607%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Social%20Construction%20of%20Aging%20Among%20a%20Clinic-Based%20Population%20and%20Their%20Healthcare%20Workers%20in%20Zambia.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjali%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chanda%22%2C%22lastName%22%3A%22Mwamba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22St%20Clair-Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%20V.%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jake%20M.%22%2C%22lastName%22%3A%22Pry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Vinikoor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%20K.%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harriet%22%2C%22lastName%22%3A%22Daultrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joel%22%2C%22lastName%22%3A%22Gittelsohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lloyd%20B.%22%2C%22lastName%22%3A%22Mulenga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Namasiku%22%2C%22lastName%22%3A%22Siyumbwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaime%20H.%22%2C%22lastName%22%3A%22Vera%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%3A%20We%20sought%20to%20understand%20the%20social%20construction%20of%20aging%20in%20a%20clinic-based%20population%2C%20with%20and%20without%20HIV%2C%20to%20address%20gaps%20in%20care%20for%20older%20individuals%20living%20with%20HIV%20in%20Zambia.%20Methods%3A%20Our%20exploratory%20qualitative%20study%20included%2036%20in-depth%20interviews%20with%20clinic%20clients%20and%20four%20focus%20group%20discussions%20with%2036%20professional%20and%20lay%20healthcare%20workers%20providing%20services%20to%20the%20clients.%20We%20identified%20themes%20based%20on%20social%20construction%20theory.%20Results%3A%20At%20the%20individual%20level%2C%20aging%20was%20multidimensional%2C%20perceived%20both%20as%20an%20achievement%20in%20the%20HIV%20era%20and%20as%20a%20period%20of%20cognitive%2C%20physical%2C%20and%20economic%20decline.%20In%20social%20interactions%2C%20older%20individuals%20were%20often%20stereotyped%20and%20treated%20as%20helpless%2C%20poor%2C%20and%20%26quot%3Bwitches.%26quot%3B%20Those%20living%20with%20HIV%20faced%20the%20additional%20stigma%20of%20being%20labeled%20as%20promiscuous.%20Some%20of%20the%20participants%20living%20without%20HIV%20refused%20to%20take%20daily%20medication%20for%20non-communicable%20diseases%20to%20avoid%20being%20mistaken%20for%20taking%20antiretroviral%20therapy%20for%20HIV.%20Older%20individuals%20wanted%20quality%20healthcare%20and%20family%20support%20to%20address%20the%20intersectional%20stigma%20of%20aging%2C%20poverty%2C%20and%20chronic%20illness.%20Conclusion%3A%20Multifaceted%20interventions%20are%20required%20to%20combat%20age-related%20prejudice%2C%20intersectional%20stigma%2C%20and%20discriminatory%20practices%2C%20particularly%20for%20people%20living%20with%20HIV.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Fijph.2024.1606607%22%2C%22ISSN%22%3A%221661-8564%201661-8556%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-06T10%3A56%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22EUYZJYMH%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tsondai%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTsondai%2C%20Priscilla%20R.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BDavies%2C%20Mary-Ann%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSingtoroj%2C%20Thida%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMaxwell%2C%20Nicola%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BTechnau%2C%20Karl-G%26%23xFC%3Bnter%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Creating%20a%20data%20collection%20and%20management%20platform%20to%20support%20measurement%20of%20adolescent%20HIV%20care%20transition%20processes%20within%20low-%20and%20middle-income%20countries%3A%20The%20GRADUATE%20project.%20%26lt%3Bi%26gt%3BPLOS%20Global%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B4%26lt%3B%5C%2Fi%26gt%3B%20%288%29%2C%20S.%20e0002705.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0002705%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0002705%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Creating%20a%20data%20collection%20and%20management%20platform%20to%20support%20measurement%20of%20adolescent%20HIV%20care%20transition%20processes%20within%20low-%20and%20middle-income%20countries%3A%20The%20GRADUATE%20project%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20R.%22%2C%22lastName%22%3A%22Tsondai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Singtoroj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kulkanya%22%2C%22lastName%22%3A%22Chokephaibulkit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pagakrong%22%2C%22lastName%22%3A%22Lumbiganon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Global%20fRAmework%20of%20Data%20collection%20Used%20for%20Adolescent%20HIV%20Transition%20Evaluation%20%28GRADUATE%29%20Advisory%20Group%22%7D%5D%2C%22abstractNote%22%3A%22Few%20national%20programs%20and%20research%20cohorts%20within%20low-%20and%20middle-income%20countries%20%28LMICs%29%20document%20transition-related%20processes%20and%20outcomes%20for%20adolescents%20and%20young%20adults%20living%20with%20HIV%20%28AYLH%29%20transitioning%20to%20adulthood.%20Between%202017-2020%2C%20The%20Global%20fRAmework%20of%20Data%20collection%20Used%20for%20Adolescent%20HIV%20Transition%20Evaluation%20%28GRADUATE%29%20project%20convened%20a%20collaborative%20advisory%20group%20to%20identify%20key%20variables%20and%20definitions%20capturing%20the%20process%2C%20predictors%2C%20and%20outcomes%20across%20the%20transition%20period.%20In%20total%2C%20114%20variables%20identified%20as%20essential%20to%20measuring%20AYLH%20transition-related%20data%20were%20identified%20and%20formatted%20into%20a%20GRADUATE%20Data%20Exchange%20Standard%20%28DES%29%2C%20which%20was%20added%20to%20and%20harmonized%20with%20the%20existing%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20DES.%20In%202019%2C%20the%20GRADUATE%20DES%20was%20pilot%20tested%20at%20four%20IeDEA%20facilities%20in%20Malawi%2C%20South%20Africa%2C%20and%20Thailand%20through%20a%20cross-sectional%20study.%20Upon%20comparing%20the%20variables%20to%20routine%20medical%20records%2C%20available%20data%20were%20too%20limited%20to%20adequately%20capture%20transition-related%20processes%20and%20outcomes.%20However%2C%20additional%20data%20collection%20using%20GRADUATE%20tools%20was%20feasible%20and%20improved%20completeness.%20Of%20the%20100%20%2852%25%20female%29%20AYLH%20included%20in%20the%20pilot%20study%2C%2071%25%20had%20transitioned%5C%2Ftransferred%20to%20adult%20care%2C%20with%2042%25%20transitioning%20from%20an%20adolescent-specific%20model%20of%20care%20within%20an%20integrated%20family%20clinic%20to%20having%20their%20clinic%20visits%20scheduled%20on%20a%20different%20day%20of%20the%20week%20while%2058%25%20transferred%20from%20a%20pediatric%20facility%20to%20one%20offering%20adult%20HIV%20care.%20While%20almost%20all%20%2894%25%29%20had%20a%20transition-related%20discussion%20with%20their%20healthcare%20providers%20prior%20to%20the%20transition%2C%20we%20found%20that%2069%25%20%2895%25%20CI%2049-85%25%29%20were%20somewhat%20or%20very%20satisfied%5C%2Fcomfortable%20with%20the%20post-transfer%20clinic%20and%20the%20staff.%20Utilization%20of%20the%20GRADUATE%20DES%20better%20characterized%20AYLH%20transitioning%20to%20adulthood%20across%20LMICs%2C%20and%20optimally%20measured%20transition%20preparation%20activities%20and%20outcomes.%20Utilization%20of%20the%20GRADUATE%20DES%20in%20other%20settings%20could%20facilitate%20comparisons%20and%20identify%20gaps%20in%20the%20care%20of%20transitioning%20adolescents%20that%20need%20to%20be%20addressed.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pgph.0002705%22%2C%22ISSN%22%3A%222767-3375%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%5D%2C%22dateModified%22%3A%222025-03-06T12%3A14%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22LWE5DNAR%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Banholzer%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBanholzer%2C%20Nicolas%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSchmutz%2C%20Remo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMiddelkoop%2C%20Keren%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BHella%2C%20Jerry%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEgger%2C%20Matthias%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282024%29.%20Airborne%20transmission%20risks%20of%20tuberculosis%20and%20COVID-19%20in%20schools%20in%20South%20Africa%2C%20Switzerland%2C%20and%20Tanzania%3A%20Modeling%20of%20environmental%20data.%20%26lt%3Bi%26gt%3BPLOS%20Global%20Public%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B4%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e0002800.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0002800%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0002800%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Airborne%20transmission%20risks%20of%20tuberculosis%20and%20COVID-19%20in%20schools%20in%20South%20Africa%2C%20Switzerland%2C%20and%20Tanzania%3A%20Modeling%20of%20environmental%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Banholzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Remo%22%2C%22lastName%22%3A%22Schmutz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keren%22%2C%22lastName%22%3A%22Middelkoop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerry%22%2C%22lastName%22%3A%22Hella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%5D%2C%22abstractNote%22%3A%22The%20COVID-19%20pandemic%20renewed%20interest%20in%20airborne%20transmission%20of%20respiratory%20infections%2C%20particularly%20in%20congregate%20indoor%20settings%2C%20such%20as%20schools.%20We%20modeled%20transmission%20risks%20of%20tuberculosis%20%28caused%20by%20Mycobacterium%20tuberculosis%2C%20Mtb%29%20and%20COVID-19%20%28caused%20by%20SARS-CoV-2%29%20in%20South%20African%2C%20Swiss%20and%20Tanzanian%20secondary%20schools.%20We%20estimated%20the%20risks%20of%20infection%20with%20the%20Wells-Riley%20equation%2C%20expressed%20as%20the%20median%20with%202.5%25%20and%2097.5%25%20quantiles%20%28credible%20interval%20%5BCrI%5D%29%2C%20based%20on%20the%20ventilation%20rate%20and%20the%20duration%20of%20exposure%20to%20infectious%20doses%20%28so-called%20quanta%29.%20We%20computed%20the%20air%20change%20rate%20%28ventilation%29%20using%20carbon%20dioxide%20%28CO2%29%20as%20a%20tracer%20gas%20and%20modeled%20the%20quanta%20generation%20rate%20based%20on%20reported%20estimates%20from%20the%20literature.%20The%20share%20of%20infectious%20students%20in%20the%20classroom%20is%20determined%20by%20country-specific%20estimates%20of%20pulmonary%20TB.%20For%20SARS-CoV-2%2C%20the%20number%20of%20infectious%20students%20was%20estimated%20based%20on%20excess%20mortality%20to%20mitigate%20the%20bias%20from%20country-specific%20reporting%20and%20testing.%20Average%20CO2%20concentration%20%28parts%20per%20million%20%5Bppm%5D%29%20was%201%2C610%20ppm%20in%20South%20Africa%2C%201%2C757%20ppm%20in%20Switzerland%2C%20and%20648%20ppm%20in%20Tanzania.%20The%20annual%20risk%20of%20infection%20for%20Mtb%20was%2022.1%25%20%28interquartile%20range%20%5BIQR%5D%202.7%25-89.5%25%29%20in%20South%20Africa%2C%200.7%25%20%28IQR%200.1%25-6.4%25%29%20in%20Switzerland%2C%20and%200.5%25%20%28IQR%200.0%25-3.9%25%29%20in%20Tanzania.%20For%20SARS-CoV-2%2C%20the%20monthly%20risk%20of%20infection%20was%206.8%25%20%28IQR%200.8%25-43.8%25%29%20in%20South%20Africa%2C%201.2%25%20%28IQR%200.1%25-8.8%25%29%20in%20Switzerland%2C%20and%200.9%25%20%28IQR%200.1%25-6.6%25%29%20in%20Tanzania.%20The%20differences%20in%20transmission%20risks%20primarily%20reflect%20a%20higher%20incidence%20of%20SARS-CoV-2%20and%20particularly%20prevalence%20of%20TB%20in%20South%20Africa%2C%20but%20also%20higher%20air%20change%20rates%20due%20to%20better%20natural%20ventilation%20of%20the%20classrooms%20in%20Tanzania.%20Global%20comparisons%20of%20the%20modeled%20risk%20of%20infectious%20disease%20transmission%20in%20classrooms%20can%20provide%20high-level%20information%20for%20policy-making%20regarding%20appropriate%20infection%20control%20strategies.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pgph.0002800%22%2C%22ISSN%22%3A%222767-3375%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222024-03-18T10%3A49%3A05Z%22%7D%7D%5D%7D
Ruffieux, Yann; Mwansa-Kambafwile, Judith; Metekoua, Carole; Tombe-Nyahuma, Tinashe; Bohlius, Julia et al. (2024). HIV-1 Viremia and Cancer Risk in 2.8 Million People: the South African HIV Cancer Match Study. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, S. ciae652. http://doi.org/10.1093/cid/ciae652.
Siedentop, Berit; Kachalov, Viacheslav N.; Witzany, Christopher; Egger, Matthias; Kouyos, Roger D. et al. (2024). The effect of combining antibiotics on resistance: A systematic review and meta-analysis. eLife, 13, S. RP93740. http://doi.org/10.7554/eLife.93740.
Carlucci, James G.; Huntington, Thomas; Technau, Karl-Gunter; Yotebieng, Marcel; Leroy, Valeriane et al. (2024). High Prevalence of Unconfirmed Positive HIV Polymerase Chain Reaction Test Results Among African Infants With HIV Exposure in the International Epidemiology Databases to Evaluate AIDS Consortium. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 79 (6), S. 1475–1478. http://doi.org/10.1093/cid/ciae251.
Phillips, Tamsin K.; Gomba, Yolanda; Mogoba, Pheposadi; Phelanyane, Florence; Anderson, Kim et al. (2024). Routine Electronic Mother-Infant Data (REMInD): a proof-of-concept Data to Care study to support retention in maternal HIV treatment and infant HIV testing in Cape Town, South Africa. Research Square, S. rs.3.rs-5626699. http://doi.org/10.21203/rs.3.rs-5626699/v1.
Brenner, Isaac Ravi; Flanagan, Clare F.; Penazzato, Martina; Webb, Karen A.; Horsfall, Stephanie B. et al. (2024). Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis. The Lancet. Global Health, 12 (12), S. e2068–e2079. http://doi.org/10.1016/S2214-109X(24)00381-4.
Musonda, Taonga; Wallace, Michael S.; Patel, Hailey; Martin, Owen P.; Oetheimer, Christopher et al. (2024). New Window Into Hepatitis B in Africa: Liver Sampling Combined With Single-Cell Omics Enables Deep and Longitudinal Assessment of Intrahepatic Immunity in Zambia. The Journal of Infectious Diseases, 230 (5), S. e1171–e1175. http://doi.org/10.1093/infdis/jiae054.
de Waal, Reneé; Wools-Kaloustian, Kara; Brazier, Ellen; Althoff, Keri N.; Jaquet, Antoine et al. (2024). Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiation. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, S. ciae548. http://doi.org/10.1093/cid/ciae548.
Yotebieng, Marcel; Zotova, Natalia; Bernard, Charlotte; Goodrich, Suzanne; Awoh, Ajeh Rogers et al. (2024). Accuracy of nine-item Patient Health Questionnaire against psychiatric diagnosis for depression among people with HIV. AIDS (London, England), 38 (12), S. 1765–1773. http://doi.org/10.1097/QAD.0000000000003963.
Anderson, Kim; van Zyl, Gert; Hsiao, Nei-Yuan; Claassen, Mathilda; Mudaly, Vanessa et al. (2024). HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa. The Pediatric Infectious Disease Journal, 43 (10), S. 970–976. http://doi.org/10.1097/INF.0000000000004482.
Parcesepe, Angela M.; Stockton, Melissa; Bernard, Charlotte; Kanguya, Tukiya; Kwobah, Edith Kamaru et al. (2024). Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study. Journal of the International AIDS Society, 27 (10), S. e26359. http://doi.org/10.1002/jia2.26359.
Schwab, Tiana Carina; Perrig, Lisa; Goller, Pauline Carlotta; Guebely De la Hoz, Freddy Fernando; Lahousse, Adrien Philippe et al. (2024). Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis. The Lancet. Infectious Diseases, 24 (10), S. 1162–1176. http://doi.org/10.1016/S1473-3099(24)00263-9.
Technau, Karl-Günter; Maskew, Mhairi; Nattey, Cornelius; Hwang, Candice; van Dongen, Nicola et al. (2024). Cohort profile: Rahima Moosa Mother and Child Hospital maternal HIV cohort, Johannesburg, South Africa. BMJ Open, 14 (9), S. e085082. http://doi.org/10.1136/bmjopen-2024-085082.
Kuniholm, Mark H.; Murenzi, Gad; Shumbusho, Fabienne; Brazier, Ellen; Plaisy, Marie K. et al. (2024). Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004012.
Zaniewski, Elizabeth; Skrivankova, Veronika Whitesell; Brazier, Ellen; Avihingsanon, Anchalee; Cardoso, Sandra Wagner et al. (2024). Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics. AIDS (London, England). http://doi.org/10.1097/QAD.0000000000004007.
Ruffieux, Yann; Folb, Naomi; Grimsrud, Anna; Hislop, Michael; Dunn, Liezl et al. (2024). Courier delivery of antiretroviral therapy: a cohort study of a South African private-sector HIV programme. Journal of the International AIDS Society, 27 (9), S. e26360. http://doi.org/10.1002/jia2.26360.
Egger, Matthias; Sauermann, Mamatha; Loosli, Tom; Hossmann, Stefanie; Riedo, Selma et al. (2024). HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST). BMJ Open, 14 (8), S. e085819. http://doi.org/10.1136/bmjopen-2024-085819.
Ruffieux, Yann; Fernandez Villalobos, Nathalie V.; Didden, Christiane; Haas, Andreas D.; Chinogurei, Chido et al. (2024). Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 33 (8), S. 1057–1064. http://doi.org/10.1158/1055-9965.EPI-24-0137.
Kalk, Emma; Heekes, Alexa; Lavies, Diane; Jacobs, Lizel; Spencer, Careni et al. (2024). Population-based prevalence of congenital defects in a routine sentinel site-based surveillance system in the Western Cape, South Africa. Birth Defects Research, 116 (8), S. e2388. http://doi.org/10.1002/bdr2.2388.
Nyakato, Patience; Schomaker, Michael; Boulle, Andrew; Euvrard, Jonathan; Wood, Robin et al. (2024). Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi-country tracing study and linkage to a health information exchange. Tropical Medicine & International Health: TM & IH, 29 (8), S. 739–751. http://doi.org/10.1111/tmi.14030.
de Beer, Shani T.; Davies, Mary-Ann; Phelanyane, Florence; Jones, Hayley E.; Ingle, Suzanne M. et al. (2024). The Retrospective Implementation of Standardized In Utero HIV Exposure Definitions Using Routinely Collected Public Sector Data Across the Western Cape Province, South Africa. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000004486.
Moolla, Haroon; Davies, Mary-Ann; Davies, Claire; Euvrard, Jonathan; Prozesky, Hans W. et al. (2024). The effect of care interruptions on mortality in adults resuming antiretroviral therapy. AIDS (London, England), 38 (8), S. 1198–1205. http://doi.org/10.1097/QAD.0000000000003859.
Asangbeh-Kerman, Serra Lem; Davidović, Maša; Taghavi, Katayoun; Dhokotera, Tafadzwa; Manasyan, Albert et al. (2024). Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey. Journal of the International AIDS Society, 27 (7), S. e26303. http://doi.org/10.1002/jia2.26303.
Jacobs, T.; Morden, E.; Smith, M.; von Delft, A.; Kassanjee, R. et al. (2024). Severe outcomes among adults with TB during COVID-19. IJTLD Open, 1 (7), S. 292–298. http://doi.org/10.5588/ijtldopen.24.0220.
Siedentop, Berit; Kachalov, Viacheslav N.; Witzany, Christopher; Egger, Matthias; Kouyos, Roger D. et al. (2024). The effect of combining antibiotics on resistance: A systematic review and meta-analysis. medRxiv: The Preprint Server for Health Sciences, S. 2023.07.10.23292374. http://doi.org/10.1101/2023.07.10.23292374.
Shafi, Jenine; Virk, Maneet K.; Kalk, Emma; Carlucci, James G.; Chepkemoi, Audrey et al. (2024). Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review. Drug Safety. http://doi.org/10.1007/s40264-024-01445-1.
Rossouw, Laura; Ngcobo, Nkosinathi; Clouse, Kate; Nattey, Cornelius; Technau, Karl-Günter et al. (2024). Augmenting maternal clinical cohort data with administrative laboratory dataset linkages: a validation study. medRxiv: The Preprint Server for Health Sciences, S. 2024.06.19.24309149. http://doi.org/10.1101/2024.06.19.24309149.
Vinikoor, Michael J.; Hamusonde, Kalongo; Muula, Guy; Asombang, Mah; Riebensahm, Carlotta et al. (2024). Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 78 (6), S. 1583–1590. http://doi.org/10.1093/cid/ciad654.
Skrivankova, Veronika Whitesell; Huwa, Jacqueline; Muula, Guy; Chiwaya, Geldert D.; Banda, Esau et al. (2024). Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, S. ciae261. http://doi.org/10.1093/cid/ciae261.
Kassanjee, Reshma; Davies, Mary-Ann; Heekes, Alexa; Mahomed, Hassan; Hawkridge, Anthony J. et al. (2024). COVID-19 Vaccine Uptake and Effectiveness by Time since Vaccination in the Western Cape Province, South Africa: An Observational Cohort Study during 2020-2022. Vaccines, 12 (6), S. 628. http://doi.org/10.3390/vaccines12060628.
Nyakato, Patience; Boulle, Andrew; Wood, Robin; Eley, Brian; Rabie, Helena et al. (2024). Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records. The Pediatric Infectious Disease Journal, 43 (5), S. 430–436. http://doi.org/10.1097/INF.0000000000004281.
Kebede, Samuel; Brazier, Ellen; Freeman, Aimee M.; Muwonge, Timothy R.; Choi, Jun Yong et al. (2024). Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. AIDS (London, England), 38 (5), S. 751–756. http://doi.org/10.1097/QAD.0000000000003824.
Plaisy, Marie Kerbie; Minga, Albert K.; Wandeler, Gilles; Murenzi, Gad; Samala, Niharika et al. (2024). Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study. Journal of the International AIDS Society, 27 (4), S. e26238. http://doi.org/10.1002/jia2.26238.
Phillips, Tamsin Kate; Kassanjee, Reshma; Maxwell, Nicola; Anderson, Kim; Johnson, Leigh et al. (2024). ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013-2019): a retrospective cohort study. Journal of the International AIDS Society, 27 (4), S. e26236. http://doi.org/10.1002/jia2.26236.
Anderson, Kim; Kalk, Emma; Heekes, Alexa; Phelanyane, Florence; Jacob, Nisha et al. (2024). Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis. Journal of the International AIDS Society, 27 (3), S. e26235. http://doi.org/10.1002/jia2.26235.
Brazier, Ellen; Tymejczyk, Olga; Wools-Kaloustian, Kara; Jiamsakul, Awachana; Torres, Marco Tulio Luque et al. (2024). Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries. PLoS Medicine, 21 (3), S. e1004367. http://doi.org/10.1371/journal.pmed.1004367.
Mesa-Vieira, Cristina; Didden, Christiane; Schomaker, Michael; Mouton, Johannes P.; Folb, Naomi et al. (2024). Post-traumatic stress disorder as a risk factor for major adverse cardiovascular events: a cohort study of a South African medical insurance scheme. Epidemiology and Psychiatric Sciences, 33, S. e5. http://doi.org/10.1017/S2045796024000052.
Davidović, Maša; Asangbeh, Serra Lem; Taghavi, Katayoun; Dhokotera, Tafadzwa; Jaquet, Antoine et al. (2024). Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method. Journal of Acquired Immune Deficiency Syndromes (1999), 95 (2), S. 170–178. http://doi.org/10.1097/QAI.0000000000003343.
Lancaster, Kathryn E.; Stockton, Melissa; Remch, Molly; Wester, C. William; Nash, Denis et al. (2024). Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. The International Journal on Drug Policy, 124, S. 104309. http://doi.org/10.1016/j.drugpo.2023.104309.
Shamu, Tinei; Egger, Matthias; Mudzviti, Tinashe; Chimbetete, Cleophas; Manasa, Justen et al. (2024). Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal study. Journal of the International AIDS Society, 27 (2), S. e26216. http://doi.org/10.1002/jia2.26216.
Kassanjee, Reshma; Davies, Mary-Ann; Heekes, Alexa; Mahomed, Hassan; Hawkridge, Anthony J. et al. (2024). COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022. medRxiv: The Preprint Server for Health Sciences, S. 2024.01.24.24301721. http://doi.org/10.1101/2024.01.24.24301721.
Dhokotera, Tafadzwa G.; Muchengeti, Mazvita; Davidović, Maša; Rohner, Eliane; Olago, Victor et al. (2024). Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study. International Journal of Cancer, 154 (2), S. 284–296. http://doi.org/10.1002/ijc.34712.
Fernández Villalobos, Nathalie Verónica; Ruffieux, Yann; Haas, Andreas D.; Chinogurei, Chido; Cornell, Morna et al. (2024). Cervical precancer and cancer incidence among insured women with and without HIV in South Africa. International Journal of Cancer, 154 (2), S. 273–283. http://doi.org/10.1002/ijc.34707.
Enane, Leslie A.; Duda, Stephany N.; Chanyachukul, Thida; Bolton-Moore, Carolyn; Navuluri, Neelima et al. (2024). The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America. BMJ Open, 14 (1), S. e079138. http://doi.org/10.1136/bmjopen-2023-079138.
Olago, Victor; Nimako, Gideon; Bartels, Lina; Bohlius, Julia; Dhokotera, Tafadzwa et al. (2024). Cancer diagnostic service use in people living with HIV in South Africa: A cross-sectional study. PloS One, 19 (6), S. e0291897. http://doi.org/10.1371/journal.pone.0291897.
Taghavi, Katayoun; Moono, Misinzo; Mwanahamuntu, Mulindi; Roumet, Marie; Limacher, Andreas et al. (2024). Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia. BMJ Oncology, 3 (1), S. e000111. http://doi.org/10.1136/bmjonc-2023-000111.
Atkinson, Andrew; Kraus, David; Banholzer, Nicolas; Miro, Jose M.; Reiss, Peter et al. (2024). HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015. PloS One, 19 (10), S. e0312035. http://doi.org/10.1371/journal.pone.0312035.
Davidovic, Masa; Dhokotera, Tafadzwa; Dos-Santos-Silva, Isabel; Bohlius, Julia & Sengayi-Muchengeti, Mazvita (2024). Breast cancer in women by HIV status: A report from the South African National Cancer Registry. PloS One, 19 (6), S. e0305274. http://doi.org/10.1371/journal.pone.0305274.
Sharma, Anjali; Mwamba, Chanda; St Clair-Sullivan, Natalie; Chihota, Belinda V.; Pry, Jake M. et al. (2024). The Social Construction of Aging Among a Clinic-Based Population and Their Healthcare Workers in Zambia. International Journal of Public Health, 69, S. 1606607. http://doi.org/10.3389/ijph.2024.1606607.
Tsondai, Priscilla R.; Davies, Mary-Ann; Singtoroj, Thida; Maxwell, Nicola; Technau, Karl-Günter et al. (2024). Creating a data collection and management platform to support measurement of adolescent HIV care transition processes within low- and middle-income countries: The GRADUATE project. PLOS Global Public Health, 4 (8), S. e0002705. http://doi.org/10.1371/journal.pgph.0002705.
Banholzer, Nicolas; Schmutz, Remo; Middelkoop, Keren; Hella, Jerry; Egger, Matthias et al. (2024). Airborne transmission risks of tuberculosis and COVID-19 in schools in South Africa, Switzerland, and Tanzania: Modeling of environmental data. PLOS Global Public Health, 4 (1), S. e0002800. http://doi.org/10.1371/journal.pgph.0002800.
Contact Us